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Bone marrow (BM) stromal cells are ascribed two key functions, 1) stem 
cells for non-hematopoietic tissues (MSC) and 2) as components of the 
hematopoietic stem cell niche. Current approaches studying the stromal cell 
system in the mouse are complicated by the low yield of clonogenic progenitors 
(CFU-F). Given the perivascular location of MSC in BM, we developed an 
alternative methodology to isolate MSC from mBM. An intact ‘plug’ of bone 
marrow is expelled from bones and enzymatically disaggregated to yield a single 
cell suspension. The recovery of CFU-F (1917.95+199) reproducibly exceeds 
that obtained using the standard BM flushing technique (14.32+1.9) by at least 2 
orders of magnitude (P<0.001; N = 8) with an accompanying 196-fold enrichment 
of CFU-F frequency. 
Purified BM stromal and vascular endothelial cell populations are readily 
obtained by FACS. A detailed immunophenotypic analysis of lineage depleted 
BM identified PDGFRαβPOS stromal cell subpopulations distinguished by their 
expression of CD105. Both subpopulations retained their original phenotype of 
CD105 expression in culture and demonstrate MSC properties of multi-lineage 
differentiation and the ability to transfer the hematopoietic microenvironment in 
vivo. To determine the capacity of either subpopulation to support long-term 
multi-lineage reconstituting HSCs, we fractionated BM stromal cells into either 
the LinNEGPDGFRαβPOSCD105POS and LINNEGPDGFRαβPOSCD105LOW/- 
populations and tested their capacity to support LT-HSC by co-culturing each 
population with either 1 or 10 HSCs for 10 days. Following the 10 day co-culture 
period, both populations supported transplantable HSCs from 10 cells/well co- 
  
cultures demonstrating high levels of donor repopulation with an average of 
65+23.6% chimerism from CD105POS co-cultures and 49.3+19.5% chimerism 
from the CD105NEG co-cultures. However, we observed a significant difference 
when mice were transplanted with the progeny of a single co-cultured HSC. In 
these experiments, CD105POS co-cultures (100%) demonstrated long-term multi- 
lineage reconstitution, while only 4 of 8 mice (50%) from CD105NEG -single HSC 
co-cultures demonstrated long-term reconstitution, suggesting a more limited 
expansion of functional stem cells. Taken together, these results demonstrate 
 
that the PDGFRαβCD105POS stromal cell subpopulation is distinguished by a 
unique capacity to support the expansion of long-term reconstituting HSCs in 
vitro. 
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CHAPTER 1:  
OVERVIEW AND AIMS 
 
 
 
 
 
 
 
 
 
 
 
  2 
1-1: THE HEMATOPOIETIC SYSTEM: OVERVIEW 
  
 The hematopoietic system is one of the most highly regenerative systems in 
mammals with approximately 1011 mature blood cells being replaced each day in 
humans [1]. Along with the inception of BM transplantations nearly 40 years ago [1], 
a significant amount of progress has been gained from a growing knowledge 
regarding the identification, localization and regulation of hematopoietic stem cells 
(HSC) and has, as a consequence, ushered in the development of cellular and 
molecular therapies for hematological disease such as leukemia. Key observations 
of individuals who died of hematopoietic failure following the fall out from radiation 
exposure after the atomic bomb explosions in Hiroshima and Nagasaki in 1945, 
became a paradigm to study the hematopoietic system in humans and mice. 
Seminal experiments in hematopoietic cell transplantation, began following the 
observation that morbidity due to radiation poisoning could be prevented in mice by 
protecting the spleen with a lead shield [2, 3] and subsequently by transplanting 
spleen or bone marrow cells into irradiated host [4, 5].  
 Currently, bone marrow transplantation remains a widely used treatment 
modality for many human genetic disorders, bone marrow failure and cancers [6, 7]. 
Traditionally whole bone marrow was used as the primary source of hematopoietic 
stem/progenitors (HSPCs) for donor derived blood reconstitution in patients. 
Additionally, the cytokine granulocyte colony-stimulating factor (G-CSF) is given 
either to patients or donors to mobilize HSPCs into circulation from which the cells 
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can then be recovered by aphaeresis and transplanted into patients. Although 
successful for many patients, bone marrow transplantation from these adult sources 
comes with both limitations and caveats. One such limitation is that adult cell 
sources of HSPCs from either BM or mobilized peripheral blood require a high 
degree of matching of the Histocompatibility complex leukocyte antigen (HLA) 
between donor and recipient to reduce the risk of graft versus host disease [8]. As a 
consequence, many patients are left without the option of an appropriately matched 
donor.   
 More recently, umbilical cord blood (UCB) units are becoming an increasingly 
used source of HSPCs for cellular therapy. In 1988 Dr. Elaine Gluckman and 
colleagues [9] performed the first successful transplantation using a cryo-preserved 
UCB unit. Since the first reported UCB transplant, many patients have been 
successfully treated with cryo-preserved UCB units for a variety of malignant and 
non-malignant hematological disorders [10]. UCB transplantations do not require the 
same stringent level of HLA matching as adult cell sources. However, a significant 
limitation associated with the use of UCB is the low number of HSPCs per UCB unit 
which results in delayed engraftment rate for neutrophils and platelets and a 
markedly protracted rate of lymphoid reconstitution [11]. Currently, due to the 
reduced HSPC number, UCB units are generally only considered sufficient for 
transplantation of children and progress in the application of CB in the adult setting 
has been significantly hampered by delayed engraftment kinetics [12, 13]. Therefore, 
it is the interest of many labs to overcome the limitations hampering progress in 
many adult stem cell fields encompassed in the rarity of the resident adult stem cell 
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populations and the largely inability to maintain and/or expand functional stem cells 
ex vivo. Consequently, there remains a pressing clinical need to develop improved 
strategies for ex vivo propagation of functional hematopoietic stem cells in order to 
be able to fully realize the therapeutic potential of UCB. Like many adult tissue stem 
cells, HSCs are localized to and regulated by extrinsic cues from highly specialized 
‘microenvironments’ referred to as stem cell ‘niches’ [14, 15]. Evidence from many 
model organisms suggests that the local microenvironment is key in regulating stem 
cell behavior such as self-renewal, proliferation and differentiation [14, 15]. Recent 
progress has seen the concept of the hematopoietic niche, first proposed by Ray 
Schofield, reduced to a discrete cellular entity within the bone marrow [16]. Current 
data suggest that hematopoietic stem cells (HSC) exist both in association with 
osteoblasts at the endosteal surface of bone (Osteoblastic niche) [17-19] and also 
in contiguity with the bone marrow vasculature and perivascular stromal cells 
(Vascular niche) [20-21]. Additionally, recent data suggests that the perivascular 
cells situated around sinusoidal endothelial cells (adventitial reticular cells) not only 
comprise a critical cellular component of the vascular niche, but also serve as a 
resident population of stromal stem/progenitor cells, also known as ‘skeletal’ and 
‘mesenchymal’ stem cells (MSCs) [22-25].  
 These findings bring together the long standing idea that not only do two 
distinct lineages of adult stem cell populations exist within the same tissue, the adult 
BM; but they are also intimately associated with one another such that one 
population, the stromal stem/progenitor cells, is beginning to emerge as a key 
cellular constituent of the hematopoietic microenvironment with a direct role in 
  5 
governing HSC behavior (26).  In light of these findings, the mouse model provides 
an excellent experimental system to further identify and characterize the molecules 
governing the extrinsic regulation of HSCs with the prospect of being able to use 
these molecules found within the in vivo microenvironment in order to develop 
improved strategies for the ex vivo expansion of HSCs. When considering 
addressing this very interesting hypothesis, one must also bear in mind the difficulty 
found in studying two rare adult stem cell populations simultaneously. Although the 
cell surface phenotype for the purification of murine HSCs has been well defined 
[20], cell surface markers allowing for the isolation of purified populations of 
mesenchymal stromal stem/progenitor cells from mouse bone marrow is still greatly 
lacking [27]. Unfortunately much of what is known in the mouse regarding the 
stromal cell compartment is largely based on retrospective analysis of a 
heterogeneous population of cultured bone marrow stromal cells (BMSCs) and as 
such there is little reproduced data suggesting the identity and location of MSCs in 
vivo. Furthermore, technical limitations and the lack of adequate isolation strategies 
for working with bone marrow tissue, in addition to the large percentage of 
hematopoietic cells comprising bone marrow cellularity have hampered progress in 
using the mouse model. 
 A major outstanding question in the field of mouse MSC biology has been the 
identification and localization of the cells responsible for establishing the 
hematopoietic microenvironment in vivo and whether or not the cells studied in 
laboratories actually have identical counterparts in vivo. In the human BM, the in vivo 
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location and the ability to isolate MSCs has recently been described [22, 27], 
however in the mouse system there remains much more confusion.  
 This thesis has been centered on addressing some of these difficulties and 
has gained significant scientific understanding of the intricacies involved in both 
MSC and HSC biology. The following chapters (1) describe a robust and 
reproducible approach to both identify and isolate cellular components of the 
vascular niche [28], (2) provide evidence of distinct stromal stem/progenitor 
populations that exist in vivo within the BM and exhibit transcriptional programs that 
suggest different physiological roles, and (3) functional data supporting their role as 
hematopoietic niche cellular elements.   
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1-2: AIMS 
  
 The overall objective of this dissertation is to investigate the properties of 
defined subpopulations of mouse bone marrow stromal cells. This study is aimed at 
understanding the biology of the bone marrow vascular/perivascular niche and in 
elucidating the role of bone marrow derived stromal stem/progenitor cells in 
regulating hematopoietic stem cell (HSC) behavior. The specific goals are to 
prospectively isolate candidate populations by means of their distinct cell surface 
immunophenotype, to investigate the multilineage differentiation potential of each 
stromal cell subpopulation and to measure their ability to support the maintenance of 
long-term repopulating hematopoietic stem cells (HSCs) in vitro. Accordingly, a 
combination of in vitro and in vivo functional assays were utilized to first evaluate the 
stem cell properties of distinct stromal cell populations. Additionally, co-culture and 
in vivo long-term blood reconstitution assays were employed to investigate the ability 
of the bone morrow stromal progenitor populations to support and/or expand mouse 
LSKCD48-CD150+ (LSKSLAM) HSCs. Given recent reports demonstrating that the 
vascular niche comprises both sinusoidal endothelial cells and the subendothelial 
perivascular cells surrounding the sinusoidal wall [20, 25], this co-culture system 
therefore serves as an experimental platform from which to identify novel molecules, 
associated with the vascular niche, involved in regulating the survival and 
proliferation of functional hematopoietic stem cells. Furthermore, the knowledge 
gained from these studies will inform the development of more effective approaches 
to recapitulate hematopoietic vascular niche function ex vivo resulting in improved 
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methodologies for the cultivation and expansion of HSCs for therapeutic benefit. 
 To begin addressing these objectives, it was necessary to first develop a 
reproducible methodology that would allow the identification of a specific 
immunophenotype for the prospective isolation of subpopulations of bone marrow 
stromal stem/progenitor cells (MSCs). Current evidence from numerous 
investigators has demonstrated that MSC occupy a perivascular location within a 
number of tissues, including the bone marrow [22, 23, 26,115, 116]. Therefore, we 
postulated that preservation of the vasculature would be critical to maximizing the 
yield MSC physically situated along the abluminal surface of blood vessels.  
 In the Chapter 3 of this thesis, I describe a methodology I developed based 
on a step-wise enzymatic disaggregation of bone marrow tissue, which led to 
significant findings of a complex cellular organization contained within the bone 
marrow stromal compartment. These initial results led us to hypothesize that the 
adult mouse bone marrow contains phenotypically distinct populations of 
MSC, which contribute to the maintenance of HSCs associated with the BM 
stem cell niches and are prospectively isolatable by distinct 
immunophenotypes.  
 In Chapter 4, I investigate the multipotency of phenotypically defined 
candidate stromal stem/progenitor populations. I demonstrate, for the first time, that 
the cells commonly referred to in the literature as ‘mesenchymal stem cells’ are in 
fact derive from distinct, phenotypically defined subpopulations of stromal cells in 
mouse bone marrow. The canonical MSC properties (i.e. differentiation to bone, 
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adipose and cartilage tissue) of these stromal cell subpopulations were analyzed by 
both in vitro and in vivo assays. Furthermore, transcriptional profiling was used to 
gain insight into their biological roles in vivo and these data suggest that each 
population is enriched in a small set of genes governing specific biological functions.  
 In Chapter 5, I determine the ability of each population to recapitulate the 
functional properties of the hematopoietic microenvironment in vitro by their 
capacity, using co-culture assays, to maintain and/or expand long-term repopulating 
mouse HSCs. For these studies a CD45.1/CD45.2 congenic transplant model was 
utilized to investigate the potential of co-cultured mouse HSCs to provide long-term 
multi-lineage repopulation in lethally irradiated host. I began these studies by first 
utilizing the FACS-based methodology described by Kiel, et al. [20] to isolate HSC 
from mouse bone marrow and validating their potency in the congenic transplant 
model. Using this rigorous, well-validated transplant model, a quantitative 
assessment was conducted to determine the capacity of different stromal cell 
subpopulations to support the maintenance and/or numerical expansion of 
competitive long-term repopulating HSCs. 
 The studies proposed herein are unique in several important respects. First, 
this project for the first time demonstrates that the cells commonly referred to in the 
literature as ‘mesenchymal stem cells’ in fact derive from distinct populations of 
stromal cells within mouse BM. Secondly, these studies demonstrate that the 
hematopoietic supportive capacity of marrow stromal cells resides in discrete 
subpopulations that can be prospectively isolated by phenotype and contain the 
functional attributes associated with MSC. These data consequently provide 
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important additional insights into the ongoing debate, demonstrating that marrow 
stromal cells (MSC) with HSC-supportive functions and mesenchymal stem cells 
(MSC) are represented within distinct populations of bone marrow stromal cells. 
Furthermore, the identification of unique stromal cell subpopulations with enhanced 
HSC maintenance potential in vitro provide the basis for future studies directed at 
defining the molecular mechanisms responsible for maintaining hematopoietic stem 
cell function during ex vivo expansion protocols.  
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CHAPTER 2: INTRODUCTION 
HEMATOPOIETIC STEM CELLS (HSC) : ARCHETYPAL  
ADULT STEM CELLS  
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2-1: DISCOVERY OF HEMATOPOIETIC STEM CELLS 
  
 Stem cells are classically defined by three principal characteristics; the ability 
to self-renew, extensive proliferative potential and the ability to differentiate into 
multiple lineages providing a paradigm for tissue formation and maintenance during 
turnover (Figure 2-1) [1]. The hematopoietic system continues to be one of the most 
well characterized systems used in studying mammalian adult stem cells [6]. 
Importantly, hematopoietic stem cells are able to undergo self-renewal for the life of 
an organism and subsequently provide progenitor cells responsible for replenishing 
the entire hematopoietic system [29]. Pioneering work by Till and McCulloch in the 
early 1960’s led to the identification of a subset of cells within the bone marrow 
(BM), which upon transplantation into lethally irradiated recipients, contained 
properties of differentiation, multi-potentiality and self-renewal by forming 
macroscopic colonies in the spleen of recipient animals, from which they coined the 
term colony forming unit-spleen (CFU-S) [30]. Originally thought to be hematopoietic 
stem cells, the colonies that formed in the spleen were initiated by progenitor cells 
and were comprised largely of cells of the myeloid lineage such as erythrocytes, 
granulocytes and megakaryocytes. However, subsequent work by these authors 
later identified additional colonies comprised of cells from the lymphoid lineage [31].  
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Figure 2-1: Principles of Stem Cell Biology. Stem cells are largely quiescent cells 
in vivo but can be induced, during times of stress, injury or during maintenance of 
tissue homeostasis, to undergo self-renewal generating more stem cells in order to 
maintain the stem cell pool and/or to proliferate generating progenitor cells which 
then become mature cell types of the resident tissue. 
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Additionally, a subset of these colony-forming cells could reform multi-potent CFU-S 
in the spleens when transplanted into secondary recipients [32]. These pioneering 
experiments led Till and McCulloch to propose the idea that some of the cells 
responsible for forming colonies of multiple hematopoietic lineages were 
hematopoietic stem cells, owing to the ability to undergo self-renewal and multi-
potential differentiation [3]. However, although the cells responsible for forming the 
colonies in the spleen were of clonal origin [33], they were not derived from 
hematopoietic stem cells as initially thought. It was later demonstrated by work from 
Norman Iscove and colleagues in the 1980’s that these early CFU-S cells were 
instead derived from oligopotent progenitors [34].  
 While these findings were instrumental in developing the concept of a 
hematopoietic stem cell that generates all mature blood cell types, it was not until 
the late 1980’s and 1990’s that populations could be isolated which were 
demonstrated to be enriched in HSCs. Furthermore, tools from both mouse genetics 
and molecular biology became available for researches to develop functional assays 
to quantitatively measure HSCs within distinct phenotypically defined populations 
[35]. Work from Dr. Irving Weissman’s lab has led the field in search for cell-surface 
markers that allowed for the prospective isolation of populations of hematopoietic 
cells enriched in functional HSCs. As such, the work by his group and others have 
led to the development of a distinct immuno-phenotype for isolating HSCs in addition 
to more lineage restricted progenitor populations [20, 36-38]. It is now widely 
accepted that HSCs are contained within a rare population of cell within the adult 
bone marrow that are negative for mature hematopoietic markers (both of myeloid 
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and lymphoid lineages) (Lin-), but express both Sca-1 (stem cell antigen-1) [36] and 
c-kit [39], most commonly referred to in the literature as LSK.  
 Of equal importance to the ability to isolate enriched populations of HSCs was 
the development of functional assays to measure the frequency of HSCs within a 
defined population. Boyse and colleagues [40] were instrumental in developing 
congenic mouse strains, which would overcome the barrier of immune rejection. By 
generating mouse strains that differed only in one allele for the leukocyte common 
antigen Ly5/CD45 that is expressed on the cell surface of all hematopoietic cells, it 
now became possible with the use of specific monoclonal antibodies to distinguish 
the strain of hematopoietic cells derived from the host from that of the donor cells 
under in vivo transplantation assays [3].  These assays are now regarded as the 
gold standard for assessing HSC function and are commonly used by all labs 
interested in addressing fundamental questions in hematopoietic stem cell biology. 
More recently with the development of these powerful tools, researchers have been 
able to isolate single HSCs which upon transplantation into a lethally irradiated host 
can reconstitute the entire blood system thereby definitively demonstrating the 
enormous regenerative potential of HSCs. Work from Sean Morrison’s lab has led to 
an immunophenotype using the SLAM family molecules, CD48 and CD150, that has 
led to the highest level of enrichment of HSCs to date, whereby 1 of every 2 cells 
within the LSKCD48-CD150+ population were able to provide long-term multi-
lineage reconstitution of the entire hematopoietic system [20]. 
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2-2: HEMATOPOIETIC HIERARCHY  
  
 Because HSCs are now routinely isolated and are defined by rigorous long-
term reconstitution transplantation assays, significant progress has been made in 
not only characterizing HSCs but also in establishing a model for the differentiation 
of HSCs into multiple lineages. The hematopoietic system is structured such that the 
rare multipotent, self-renewing hematopoietic stem cells (HSCs) are located at the 
apex of a three-tiered hierarchy (Figure 2-2) [1, 41]. According to this model, HSCs 
give rise to daughter cells, some of which will remain as stem cells while others will 
undergo successive progression of differentiation pathways into individual blood 
lineages [42]. Long-term blood reconstituting HSCs (LT-HSCs) are able to self-
renew for the life of the organism and also give rise to short-term reconstituting 
HSCs (ST-HSCs), which are able to maintain self-renewing properties for 
approximately 8 weeks upon transplantation into lethally irradiated recipients [43]. 
Although ST-HSCs have a limited self-renewal capacity, they have extensive 
proliferative potential and are able to serve as a supply source for various lineage 
restricted progenitor populations [38]. The IL-17 receptor positive population gives 
rise to the common lymphoid progenitors (CLP) producing mature cells committed to 
lymphoid fates. B cells, T cells, natural killer (NK) cells and dendritic cells are all 
descendents of the CLP progenitor population. The common myeloid progenitor 
(CMP) population gives rise to lineage restricted progenitor cells of both the myeloid  
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 Figure 2-2: Schematic Illustration of the Hematopoietic Developmental 
Hierarchy. Self-renewing hematopoietic stem cells reside at the top of a tiered 
hierarchy giving rise to multipotent progenitor daughter cells. The multipotent 
progenitor cells then give rise to oligo-potent progenitors of either the common 
myeloid progenitors (CMP) or common lymphoid progenitors. These oligo-potent 
progenitors give rise to a number of lineage restricted intermediate progenitors 
which in turn differentiate into the mature effector cells of the hematopoietic 
system. (Image generated by Nathalie Brouard, PhD) 
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and erythroid lineages. Mature granulocyte and macrophage effector cells are 
derived from the granulocyte-macrophage progenitor (GMP) population and mature 
megakaryocytes and erythroid cells are generated from the megakaryocyte-erythroid 
progenitor (MEP) fraction of lineage restricted progenitor cells [3].  
 The hierarchical organization of hematopoiesis is long established and well 
validated and as a consequence, is often cited as a paradigm for the organization of 
stem and progenitors in other constitutively renewing tissues. Within the defined 
layers of the hierarchy, the entire hematopoietic system is maintained in a tightly 
coordinated manner in which self-renewal versus differentiation programs are 
balanced based on the prevailing need of the organism (i.e. under normal steady 
state homeostasis or under stress conditions such as occur during infection) without 
depleting the critical source of HSCs. There are several well-defined intrinsic 
regulators, such as lineage specific transcription factors, that play critical roles in 
maintaining the organizational structure of hematopoiesis. However, this balanced 
effort is also coordinated by external regulation from distinct micro-environmental 
cues, which form critical cellular and extra-cellular components in regulating self-
renewal in addition to lineage specific differentiation pathways [44]. 
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2-3: ONTOGENY OF HEMATOPOIESIS 
  
 Ontogeny of the hematopoietic system is established in two waves throughout 
embryo development. Interestingly, HSC development is marked by temporally 
regulated changes in anatomical location [45, 46], whereby at each stage HSCs are 
exposed to qualitatively different microenvironments endowing specific functions 
(Figure 2-3). The mammalian yolk sac is the first site for the emergence of 
hematopoiesis, termed primitive hematopoiesis. Here the primary focus is placed on 
the generation of erythrocytes to facilitate tissue oxygenation of the rapidly growing 
mouse embryo at 7-7.5 dpc [41, 47]. Experimental evidence from Goldie et al. 
demonstrated that at a clonal level, a population of specialized endothelial cells 
isolated from mouse E8.25 yolk sack were able to generate hematopoietic 
progenitor cells [48].  
 Following the formation of primitive hematopoiesis within the yolk sac, Godin 
and colleagues defined the para-aortic splanchnopleur region as the site of 
emergence of definitive pluripotent HSCs in mice at 10.5 dpc, [49, 50].  The para-
aortic splanchnopleur region further differentiates into the aorta-gonad-mesonephros 
region (AGM). Some of the most convincing evidence, supporting the role of the 
AMG as the site of emergence of definitive HSCs, was demonstrated by in vivo long-
term multi-lineage repopulation provided by intra-embryonic hematopoietic 
precursors in lethally irradiated adult recipients [51]. These precursors were able to 
give rise to lymphoid and myeloid lineages eight months after transplantation. More 
recently, strong experimental evidence has demonstrated that specialized embryonic 
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endothelial cells within the AGM, termed hemogenic endothelium, actually serve as 
the source for de novo generation of definitive hematopoiesis [52]. 
 Following the emergence of definitive hematopoiesis in the AGM, the fetal 
liver becomes the primary site of hematopoiesis at E11.0 dpc. From E11.0 to E15.5, 
HSCs in the fetal liver are actively in the cell cycle and undergo rapid expansion 
followed by a decline prior to colonizing other hematopoietic organs such as the 
spleen and bone marrow where HSCs are found to be largely quiescent [38]. 
Studies by Christensen et al., demonstrated that long-term repopulating HSCs are 
found in circulation throughout fetal development and begin to colonize the fetal 
bone marrow at E17.5 after the onset of bone and vasculature development [53].  
Throughout murine adult life the bone marrow remains the primary site of 
hematopoiesis during steady state conditions, however 100-400 LT-HSCs may be 
found in circulation at any one time [54].  
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Figure 2-3: Hematopoietic Ontogeny in the mouse. Hematopoietic stem cells first 
arise from specific endothelial cells within the AMG region of the developing embryo 
at around 9 DPC. Following the generation of definitive hematopoiesis in the AGM, 
HSCs are know to migrate to fetal liver were they undergo a massive expansion in 
vivo. Prior to birth and following the process of endochondral ossification of long 
bones, hematopoiesis moves to the bone marrow where it is to remain under normal 
homeostatic conditions. (Image generated by Nathalie Brouard, PhD) 
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2-4: THE HEMATOPOIETIC MICROENVIRONMENT 
 
 The hematopoietic microenvironment (HM) is classically thought of as a 
mileau of cells (hematopoietic and non-hematopoietic stroma), extra-cellular matrix 
proteins and growth factors associated with the ECM (Figure 2-4) [55, 56]. The term 
stroma is derived from Greek and essentially refers to the physical entity (bed) upon 
which somethings lays. In hematopoiesis, the stroma is considered the substrate or 
scaffold unpon which hematopoiesis occurs [85]. The progressive identification of 
the hematopoietic microenvironment dates to the early 1960s, where initial studies 
noted that in lethally irradiated animals that were reconstituted by transfusion with 
BM cells, hematopoietic colonies develop only in the BM and spleen [30]. 
Furthermore when high doses of radiation were given to destroy the stromal 
elements of the BM a resulting permanent state of aplasia followed. And hence, a 
sequential regeneration of the marrow stromal cells preceded resumption of 
hematopoiesis in the bone marrow [57, 58]. However, some of the most convincing 
evidence of the role of the microenvironment came from using genetic mouse 
models. Mice with mutant recessive alleles in either the Sl/Sld and W/WV loci gave 
rise to macrocytic anemia. Interestingly, bone marrow cells from Sl/Sld mice were 
able to rescue lethally irradiated wild-type littermates and W/WV mice [59]. These 
studies conclude that the defect in Sl/Sld mice was expressed phenotypically as a 
failure of the HM. It is now understood that the W locus encodes the c-Kit pro-
oncogene and the Steel locus encodes for its ligand, stem cell factor.  
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 Later studies by Dexter and colleagues in the mid 1970s resulted in the 
establishment of a culture system that maintained primitive mouse hematopoietic 
progenitor cells in vitro [60, 61]. From these observations the authors conclude that 
the maintenance of hematopoiesis in vitro was dependent on an adherent layer of 
marrow derived cells whose composition reflected the phenotypic diversity of the 
stromal elements in the BM in vivo [61]. The historical importance of these findings 
allowed Ray Schofield to formulate his niche hypothesis in which he states that, 
  “the stem cell is seen in association with other cells which determine its 
 behavior. It becomes essentially a fixed tissue cell. Its maturation is 
 prevented and as a result its continued proliferation as a stem cell is 
 assured. Its progeny, unless they can occupy a similar stem cell ‘niche’, 
 acquire a high probability of differentiation”  [16].  
 Since the inception of the regulatory role of the BM stroma governing 
hematopoietic stem and progenitor cell behavior, there has been an increasing 
interest to identify cells and molecules responsible for orchestrating HSC 
quiescence, self-renewal, differentiation and proliferation. Two primary approaches 
have been applied to the discovery of such regulatory molecules; one approach has 
been through the use of mouse genetics and the other has been to use in vitro 
assays of either long-term marrow cultures or suspension cultures as an 
experimental tool to identify both cellular and molecular constituents that control 
HSC behavior. Several factors have been identified to have a genetic requirement 
and include stem cell factor (SCF), Thrombopoeitin (TPO), CXCL12 (SDF-1), 
osteopontin, and angiopoietin (Ang-1) [15, 62]. As such, most investigators in search 
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of additional regulatory mechanisms controlling HSC expansion in vitro have used 
several combinations of these factors in soluble form. However although essential in 
vivo, combinations of these molecules are unable to support either the maintenance 
or expansion of purified HSCs in vitro. Additional efforts have traditionally been to 
use adherent stromal cells from hematopoietic tissues as a means to identify cells 
with the ability to support and expand transplantable HSCs in vitro. In this regard, 
the adult bone marrow has been met with little success, however work from Ihor 
Lemischka’s lab in the late 1990’s was able to identify a fetal liver stromal line with 
the ability to support the maintenance of HSCs [63]. Although significant advances 
have been made in the pursuit to identify HSC governing molecules, there was 
previously a lack of evidence regarding the in vivo identification of the specific cells 
responsible for these molecules as well as a continued difficulty in isolating such 
cells. However, recently significant progress has been made and has begun to 
elucidate a more precise location of hematopoietic niches and the regulatory 
networks involved in governing HSC behavior. 
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Figure 2-4: Schematic representation of hematopoietic microenvironment 
(HME). The bone marrow HME is comprised of a diverse group of non-
hematopoietic stromal cells, including adventitial reticular cells, stromal progenitor 
cells (CFU-F), endothelial cells, osteoblast and adipocytes and hematopoietic 
macrophage cells. These cell types generate both critical extracellular matrix and 
soluble regulatory molecules governing hematopoietic cell biology. (Modified from 
image generated by Nathalie Brouard, PhD) 
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2-5: IDENTIFICATION OF THE HEMATOPOIETIC STEM CELL NICHE 
  
 Due to the difficulty of studying bone tissue in situ and limitations in 
technology, it was not until several years later that a more exact location and cellular 
composition of the hematopoietic bone marrow microenvironment began to be 
identified [17-26]. Current data suggest that pre-osteoblast cells lining the endosteal 
region serve a functional niche referred to as the endosteal niche, while HSCs have 
also been found residing adjacent to the sinusoidal endothelial and perivascular 
stromal stem/progenitor cells. 
THE ENDOSTEAL NICHE 
 Early reports suggested that the endosteal zone of the bone marrow is highly 
enriched in cells which form multi-lineage colonies in the spleens of irradiated mice 
making it a candidate location of the hematopoietic niche [64]. A subsequent study 
by Nilsson et al. provided additional evidence in support of an endosteal niche, when 
labeled HSCs were transplanted and shown to localize to the endosteal region of the 
bone marrow [65]. Additionally, in vitro co-culture studies showed osteoblasts 
support hematopoietic progenitors [66]. However, a more exact role of osteoblast as 
a component of the endosteal niche was later highlighted by two seminal reports. 
Using two different genetic models both groups demonstrated that an increase in 
osteoblast cells lining the endosteum was followed by a concomitant increase HSC 
frequency within the bone marrow [18, 19]. Since these initial reports, many 
functional studies have now identified both positive and negative regulators 
generated by osteoblasts at the endosteal region, including osteopontin [67, 68], 
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angiopoietin-1 [69], thrombopoietin [70, 71] and SDF-1 (CXCL-12) [72]. Several 
studies support the role of adhesion molecules such as Jagged-1 and N-cadherin in 
establishing direct cell contact between HSCs and cells lining the endosteal surface 
[18, 19]. It was proposed that these adhesion molecules where important in 
maintaining proper HSC functioning in vivo, however conditional deletion of Jagged-
1 in bone marrow cells suggests it is not necessary for HSC maintenance in vivo 
[73]. Furthermore, Sean Morrison’s group has recently shown that N-cadherin is not 
expressed on LT-HSCs [74] and the conditional deletion of N-cadherin in HSCs has 
no effect on bone marrow cellularity or the frequency of HSCs [75], suggesting that 
N-cadherin is not necessary for maintaining HSCs in vivo. Although the exact 
molecular mechanisms underlying the support of HSC by osteoblastic cells remain 
to be fully elucidated, there remains significant evidence supporting the role of the 
niche in regulating HSC quiescence and maintenance [17, 76].  
The Vascular Niche 
 Throughout ontogeny the sites of hematopoiesis change and interestingly, 
data suggest that in each of these developmental stages HSCs share close 
interactions with endothelial cells [77]. More recent evidence supports the 
hypothesis that embryonic endothelium give rise to multilineage hematopoietic cells, 
termed hemogenic endothelium [48, 51, 52, 78]. It is important to note that 
hematopoiesis occurs prior to the development of bone during embryogenesis, 
which suggests that HSCs are maintained primarily in vascular or perivascular 
microenvironments early during ontogeny as well as in areas of extra-medullary 
hematopoiesis such as the spleen [78]. Work by Shahin Rafii’s group has led to the 
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concept of a proliferative zone surrounding the vascular microenvironment. This 
notion is supported by in vitro and in vivo studies that suggest that adult bone 
marrow endothelial cells promote the proliferation and differentiation of 
hematopoietic progenitors [79] and support the expansion of HSCs in vitro [80].  
 In 2005, the Morrison lab identified the close association of highly enriched 
LSKCD48-CD150+ HSCs with sinusoidal endothelial cells of the bone marrow 
suggesting the presence of a vascular niche for regulating HSCs [20]. Recent 
reports using CXCL12-GFP knockin [21, 24] and Nestin-GFP transgenic [23] mouse 
models have demonstrated that perivascular reticular cells were critical for 
maintaining the HSC pool in vivo (Figure 2-5) [23, 24] and selective ablation of these 
cells leads to a 50% reduction of phenotypically identified HSCs. However, it is not 
clear from these studies if there is an actual decrease in functional HSCs. These 
data support previous reports in human BM, which demonstrated that CD146+ 
subendothelial adventitial reticular cells function as both osteoprogenitor cells (MSC) 
and HSC niche constituents [22]. Furthermore, the existence of a 
vascular/perivascular niche is supported by the observation that HSCs are rapidly 
mobilized into circulation following cytokine treatment [81] and that the regeneration 
of sinusoidal endothelial cells following myeloablation treatment  is necessary for 
hematopoietic reconstitution to occur [82]. 
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 Figure 2-5: Schematic representation of the vascular niche in adult 
mouse bone marrow. HSCs are localized directly adjacent to endothelial sinusoids 
and are often in direct contact with the cellular processes of adventitial reticular cells 
situated along the abluminal surface of vessel sinuses. Additional stromal cells 
within the inter-sinusoidal spaces make up a complex stromal reticulum providing a 
scaffold for HSC and mature hematopoietic cell migration throughout the bone 
marrow. 
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2-7: UNRESOLVED QUESTIONS 
  
 To date the exact location, cellular constituents and molecules involved in 
regulating hematopoietic stem cells remains a highly contentious and active area of 
research. It remains to be determined if two distinct niches exist and if so do they 
have different functional roles in regulating HSCs. Recently there has been an 
emergence of data using specialized imagining techniques which show the 
endosteal zone as being highly vascularized [83, 84]. These findings demonstrate 
that the vascular niche containing perivascular stromal cells would lie in close 
proximity to the proposed endosteal niche and raise an important question of 
whether or not distinct niches exist. It is possible that HSCs are found next to 
endothelial and perivascular cells during times of migration in and out of circulation 
as well as during homeostasis [15, 25] while only a very minor portion actually reside 
along the endosteal surface. However, in light of recent advances in imaging it is 
unlikely that HSCs located along the endosteal surface are completely removed from 
any potential interaction, be it physical or from soluble molecules, with vascular and 
perivascular cells. Data from our own studies presented in this dissertation and 
elsewhere have demonstrated that the vascular/stromal system is a vast and 
complex network which encompasses the entire bone marrow diameter from one 
endosteal surface of a femur to the other, and continues along the full length of a 
femur from the hypertrophic cartilaginous zone at the growth plate up to the 
trabecular region of the femoral head.  
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 Although the use of genetic mouse models previously mentioned have proved 
useful in identifying perivascular stromal cells that provide critical support for 
maintaining HSC behavior, there is little evidence of specific immunophenotypes for 
these candidate cell populations which can be used for prospective identification and 
isolation. In particular, these mouse models are not commercially available which 
further hinders progress in the field by limiting the labs, which can reproduce and 
validate these reports. Within the following chapters, I provide evidence of distinct 
immunophenotypes, which allow prospective isolation of candidate cell populations, 
both stromal and vascular, and data that supports the hypothesis that perivascular 
stromal stem/progenitor cells are the major cellular constituents of functionally 
critical hematopoietic regulatory molecules. 
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CHAPTER 3: 
ISOLATION OF THE STROMAL-VASCULAR FRACTION FROM 
ADULT MURINE BONE MARROW [28] 
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3-1: PREFACE 
  
 In this chapter, I describe a methodology I developed based on a step-wise 
enzymatic disaggregation of bone marrow tissue, which led not only to a significant 
improvement in the yield of clonogenic stromal cell progenitors (CFU-F) but also 
revealed a previously unappreciated complexity in the composition and organization 
of cells that comprise the bone marrow stromal compartment [28]. The initial findings 
presented within this chapter led us to further hypothesize that the adult mouse 
bone marrow contains phenotypically distinct populations of MSC, which 
contribute to the maintenance of HSC niches and are prospectively isolatable 
by distinct immunophenotypes.  
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3-2: THE NON-HEMATOPOIETIC STEM CELL COMPONENT OF THE BONE 
MARROW: MARROW STROMAL STEM CELLS (MSC) 
  
 The post-natal bone marrow of adult mammals is comprised of both 
hematopoietic and non-hematopoietic cellular elements, each of which is supported 
by a specific stem cell population, HSC and mesenchymal stem cells (MSC), 
respectively. Thus, not only does the bone marrow harbor two distinct populations of 
stem cells, but recent data also suggest that these two stem cells physically co-
localize within the marrow, an interaction that is functionally required for the 
maintenance of HSC. The anatomical structure of the bone marrow tissue is made 
up of highly branched vascular network consisting of arteries, arterioles and large 
dilated sinusoids and a heterogeneous stromal cell reticulum of perivascular and 
inter-sinusoidal cells, whereby the multitude of hematopoietic lineages reside [55, 
56].  
 The BM stroma encompasses a heterogeneous group of cell types found 
between the inner endosteal surfaces of bones and the outer surface of blood 
vessels including non-hematopoietic adipocytes, perivascular reticular cells and 
osteoblast [26]. Existing within the marrow stromal elements is a rare population of 
multi-potent stem/progenitor cells historically referred to as “stromal” stem cells. 
More recently, the term “skeletal” or “mesenchymal” stem cells  (MSC) [85, 86, 87-
91] (Figure 2-6) has been extensively used to describe these cells in the literature. 
The multi-lineage differentiation capacity of MSC and their corresponding 
regenerative potential along with a unique ability to suppress T cell proliferation, has 
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engendered a considerable amount of interest in the potential application of these 
cells in a range of cellular therapies.  
 Circumstantial evidence demonstrating the existence of a non-hemtopoietic 
adult stem/progenitor cell within the BM stromal compartment can be found in early 
studies by Crosby and colleagues. Following physical or irradiation damage, the BM 
stromal tissue was found to undergo a process of complete regeneration  [57, 58]. 
Additional studies demonstrated the osteogenic potential of bone marrow stromal 
cells, which were able to generate histologically proven bone ossicles complete with 
a surrounding layer of cortical bone and a cavity filled with active hematopoietic 
marrow supporting stromal cells and adipocytes following transplantation of 
boneless fragments of BM to an ectopic site [26, 92]. Subsequently in a series of 
pioneering studies, Friedenstein and colleagues provided a direct demonstration of 
stromal stem/progenitor cells by characterizing a population of clonogenic adherent 
cells derived from the BM of rodents, which resembled fibroblasts in morphology and 
nature leading to the term, colony forming unit-fibroblast (CFU-F) [86, 91, 93]. Since 
these initial observations, there has been a considerable interest in identifying the 
source of stromal clonogenic precursors in nearly all mammalian tissues examined. 
A defining feature of marrow CFU-F is the heterogeneity frequently observed 
regarding colony size, an indication of proliferative differences in the founding CFU-F 
progeny, and the differentiation potential of individual colonies [86, 88, 120]. 
Following these observations mentioned above, Owen and colleagues hypothesized 
that in the adult BM a stromal cell hierarchy exists, which is constituted of a rare 
‘pluri-potent stromal stem cell’ that through the processes of self-renewal and 
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differentiation gave rise to the entire non-hematopoietic stromal system (86). 
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Figure 3-1: Schematic diagram of bone marrow stromal stem cells 
development potential. A rare population of stromal stem cells gives rise to 
highly proliferative clonogenic progeny in vitro (CFU-F). CFU-F can undergo 
multi-lineage differentiation into osteogenic, adipogenic and hematopoietic 
supporting stroma lineages in vivo and generate adipogenic and chondrogenic 
progeny in vitro.  
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 The apparent multilineage differentiation potential of bone marrow stromal 
tissue was first illustrated by the seminal studies of Tavassoli and Crosby [92]. In 
these experiments, transplantation of bone-free pieces of bone marrow tissue to 
ectopic sites generated histologically proven bone ossicles complete with a 
surrounding layer of cortical bone and a cavity filled with active hematopoietic 
marrow supporting stromal cells and adipocytes. These studies were the first to 
reveal the intrinsic osteogenic potential of BM and invoked the existence within the 
marrow of a population(s) of cells with the differentiation potential to generate bone 
and the other stromal tissues of BM.  
 Subsequently, early pioneering work by Friedenstein and colleagues 
described a population of plastic-adherent, clonogenic progenitors, which, based on 
the fibroblastic morphology of their progeny in the colonies, he termed colony-
forming unit-fibroblast (CFU-F) [93]. Additional studies by Friedenstein and 
colleagues further substantiated Tavassoli and Crosby’s initial findings by 
demonstrating the in vivo multilineage differentiation capacity of CFU-F [88, 94]. 
What was most striking about these studies was that hematopoiesis was maintained 
within these ossicles only after bone was formed and vascular endothelial cells of 
host origin had invaded the ectopic ossicles, demonstrating a sequence of events 
that mimic the developmental events of bone and bone marrow formation [95]. 
Currently, it is hypothesized that a portion of the founding cells that give rise to CFU-
F are derived from the subendothelial adventitial reticular cells (Westen-Bainton 
cells). Interestingly, this subendothelial region of the marrow sinusoids is not only the 
location of the HSC vascular niche, but is also proposed to comprise the stromal 
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stem cell compartment as well. In support of their role as a stromal stem/progenitor 
cell in vivo, work from Bianco and colleagues lab demonstrated that some of the 
adventitial reticular cells generate mature marrow adipocytes while others give rise 
to the more heterogeneous population of bone marrow stromal cells [96].  
 These studies along with the pioneering work of Dexter and colleagues, 
previously mentioned, have provided key insights into the nature and biology of 
establishing and maintaining the hematopoietic microenvironment, highlighting the 
key role of the non-hematopoietic stromal stem cells in these processes and an 
invaluable resource in allowing Ray Schofield to formulate the ‘niche hypothesis’. 
Within the hematopoietic stem cell niche field, the stromal stem/progenitor 
population is beginning to emerge as the key player in coordinating endogenous 
tissue turnover and in establishing and maintaining the hematopoietic 
microenvironment. 
 Although originally identified in mice, many labs have subsequently isolated 
BMSCs, some of which contain stem/progenitor activity (MSC), from human, rat, 
rhesus monkeys, dog, and pig based on there inherent ability to attach to tissue 
culture plastic, undergo limited ex vivo expansion and are able to differentiate into 
osteogenic, adipogenic and chrondrogenic progeny in vitro and in vivo (Figure 3-1) 
[70-101].  
 However it is important to note that the majority of progress regarding the in 
vivo localization and immunophenotype for prospective isolation of MSC has been 
made using human BM samples, with few publications focusing specifically on MSC 
derived from mouse BM. This is largely due to the difficulty in isolating 
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homogeneous populations of murine BM-derived MSC, a problem exacerbated by 
the extreme rarity of CFU-F in murine bone marrow, which furthermore varies with 
the mouse strain tested. The reported incidence of CFU-F in C57BL/6 mice, the 
strain used for the majority of studies reported in this thesis, is in the range 0.3 - 
2/1,000,000 nucleated bone marrow cells [97, 102, 106].  An additional issue is the 
persistence of hematopoietic cells (principally macrophages) that contaminate MSC 
cultures derived from mouse BM even after prolonged culture [102-106]. Although 
repeated passage of mouse stromal cell cultures has been reported to reduce the 
incidence of contaminating hematopoietic cells, a significant drawback of this 
strategy is the likelihood of proliferative exhaustion of the low numbers of initiating 
CFU-F progenitor cells and conversely, the potentiation of spontaneous 
transformation of cells following long term culture [107]. 
 Although most data support the low incidence of CFU-F in mouse BM, there 
are studies in which significantly higher CFU-F frequencies have been reported 
ranging from 35-115/1,000,000) BM cells. This higher colony-forming efficiency is 
dependent on the addition of irradiated guinea pig stromal feeder layers [108]. 
Although the use of feeder cells has only been reported by a single lab, it 
nevertheless illustrates an important point that optimal conditions for initiating colony 
growth from mouse BM CFU-F have yet to be defined. Additional increases in   
CFU-F numbers have been reported following protocols, which involve mechanical 
dissociation, and trypsin digestion of the remaining bone marrow clumps as describe 
by Freidenstein and colleagues [109].  
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 Taken together, the low numbers of CFU-F obtained by routine 
methodologies, the persistent contamination by hematopoietic cells, the fact that the 
majority of mouse BMSC data is based on retrospective analysis of cultured cells, 
and the lack of suitable markers of prospective isolation of a purified mBMSC 
population, has significantly hindered progress in the mBMSC field, impairing the 
ability to address fundamental questions regarding MSC biology through the use of 
genetic mouse models but also the development and preclinical testing of proposed 
therapeutic applications of MSC in the mouse.  
 While the majority of labs seeking to understand the nature and biology of 
mouse BMSCs use the standard method of flushing BM from long bones, some labs 
have attempted to improve the purity of BMSC cultures by additional methodologies 
including positive or negative selection and low plating densities [102-106, 109-111] 
while other labs have been successful in isolated a sub-population of bone derived 
progenitor cells by crushing and digesting compact bone [112-114]. However, these 
protocols have not significantly improved the yield of clonogenic progenitors and as 
a result have not been standardized nor widely adopted.  
 We, therefore, sought to develop an alternative strategy for the isolation of 
murine BMSC, which would provide a platform to maximally increase the stromal cell 
yield and allow populations of BMSCs to be prospectively isolated from freshly 
prepared tissue. In developing this methodology, we considered two key points 
regarding the structure of the BM stromal-vascular system and the localization of 
candidate populations. First, histological studies demonstrate that the BM 
hematopoietic microenvironment is organized as a complex network of stroma 
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including fibroblastic reticular cells and highly branched vascular arterial and dilated 
venous sinuses (references).  Second, experimental evidence has demonstrated a 
perivascular location of MSC in many adult tissues, including the BM [22, 115].  
 Early ultra-structural studies of rat BM stroma by Leon Weiss [55] 
demonstrated that the reticular cells expand throughout the BM and form a three-
dimensional reticulum of long cytoplasmic processes that make up the majority of 
the marrow parenchyma amongst which hematopoietic cells exist and interact. 
Interestingly, some of the marrow cells, which make up the parenchyma are mature 
macrophages of hematopoietic origin, while others initially characterized by 
membrane bound alkaline phosphatase (ALP) activity are fibroblastic in nature and 
are of mesenchymal origin. The ALP positive reticular cells are located within the 
intraparenchyma and perivascular along the sinus walls and are often referred to 
throughout the literature as Westen-Bainton cells as previously mentioned [116].  
 Taking both points into consideration along with the delicate nature of the BM 
structure, we initially hypothesized that the low frequencies of CFU-F reported by 
others is a consequence of the rigorous flushing and trituration of the bone marrow 
cavity used to prepare single cell suspensions and that the subsequent destruction 
of the marrow vasculature would lead to a diminution in the potential recovery of 
stromal stem/progenitor cells localized to perivascular regions along the abluminal 
surface of the marrow vessels. In light of our hypothesis, we developed a 
reproducible methodology to isolated BMSCs based upon the initial preservation of 
the marrow vasculature by first removing an intact plug of BM from the central cavity 
of long bones. Single cell suspensions are then prepared by sequential enzymatic 
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digestion of BM plugs, which simultaneously yields both stromal reticular and 
vascular endothelial cellular components of the BM. Interestingly, this novel 
methodology has facilitated the identification and direct isolation of phenotypically 
and anatomically discrete subpopulations of BMSCs. In the following chapters, I 
characterize, through well-validated in vivo and in vitro assays, distinct populations 
of clonogenic BMSCs that function as both “mesenchymal” stem/progenitor cells 
(Chapter 4) and as hematopoietic stem cell niche constituents (Chapter 5).  
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3-3: RESULTS 
 
REMOVAL OF INACT BONE MARROW ‘PLUG’ MAINTAINS THE STRUCTURAL 
INTEGRITY OF THE MARROW VASCULTURE 
 Our initial hypothesis was that the mechanical destruction of the marrow 
vasculature ultimately destroys the stromal progenitor cells intimately associated 
with the vascular walls. To test this hypothesis, we developed an alternative 
procedure based on the removal of intact ‘plugs’ of BM from murine long bones by 
gentle flushing of the bones with media (Fig 3-2A). This methodology leads to the 
removal of the central bone marrow tissue and leaves behind a thin layer of cells 
associated with the endosteum region (Fig 3-2 B&C). The marrow ‘plugs’ were then 
subjected to a detailed histological analysis of the plugs either embedded in resin or 
subjected to whole mount staining. As revealed in Figure 3-2 B, D & E, the marrow 
vascular structure remains well preserved, with both arterioles and sinusoids 
conserved, and is comparable to BM in situ. Furthermore, whole mount staining of 
BM plugs, using a combination of the endothelial cell-reactive antibodies MECA32 
and VE-Cadherin, demonstrated a complex vascular network that spans the width of 
a femur (Fig 3-2 E). Having confirmed the presence of an intact vascular structure, 
we next sought to obtain a single cell suspension from which we could begin to 
characterize the various elements of the non-hematopoietic stromal-vascular 
fraction. 
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Figure 3-2: BM plug isolation and histological assessment of intact vascular 
structures in BM plugs. (A) Representative images of denuded bones, removal of 
metaphysis and isolated intact bone marrow plug. (B-D) Resin embedded sections 
of BM plugs (B&D) and remaining bone tissue (mid-diaphysis) (C) following removal 
of marrow plug were sectioned as 5µm thick longitudinal sections and stained with 
H&E demonstrates intact vascular structures. (E) Whole mount image of BM plug 
stained with a combination of the endothelial cell-reactive antibodies MECA32 and 
VE-Cadherin reveals a well-organized vascular reticulum throughout the marrow. 
BM plugs were stained with DRAQ5 to provide a nuclear counterstain and then 
immersed in prolong gold anti-fade mounting medium (Molecular Probes). After 
applying a glass coverslip and sealing with nail hardener, specimens were inverted 
and allowed to cure overnight in the dark at RT prior to confocal imaging. Images 
were collected using 63x oil immersion objective of a Leica TCS SP5 confocal 
microscope and processed with the Leica LAS AF lite software. Z-stacked images 
were collected in 0.2 µm slices at depths of 15-25 µm with a pinhole of 1 (x63).  
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi 
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow 
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood. 
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.) 
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 We then experimentally determined that three sequential digestions, each of 
which was 15 minutes in duration at 37 degrees C (Figure 3-3), with a combination 
of collagenase type I and dispase enzymes was sufficient to recover all cells as a 
single cell suspension and leaving behind only an acelluar matrix. This point is 
further illustrated in Fig 3-4 A, which demonstrates that the total number of nucleated 
cells recovered from each digestion as compared to the nucleated cell recovery from 
the standard method of rigorously flushing BM is not significantly different. 
SEQUENTIAL ENZYMATIC DISAGGREGATION OF BM PLUGS MARKEDLY 
ENHANCES THE RECOVERY OF CFU-F 
 After having determined that three sequential enzymatic digestions was 
sufficient to obtain a single cell suspension, we then conducted a series of 
preliminary experiments to compare the frequency of CFU-F in sequentially digested 
BM (DBM) from each fraction to that obtained by the standard flushing method. As 
demonstrated in Figure 3-4 B, each fraction of DBM contained a significantly higher 
colony forming efficiency (CFE) than in the flushed BM samples, with a higher CFE 
within each successive fraction of DBM. Interestingly, the colony forming efficiency 
of CFU-F was on a range of 25 – 40 fold higher from each of the three fractions than 
the CFE obtained from an equivalent number of nucleated cells from flushed marrow 
samples. Furthermore, these date demonstrate that CFU-F progenitors revealed  
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Figure 3-3: Schematic diagram of enzymatic disaggregation of bone marrow 
plugs. Intact plugs of BM are gently expelled from the central cavity of long bones 
and transferred to an enzymatic solution of collagenase type I and neutral dispase 
and incubated in a water bath at 37° C for three sequential rounds at 15 minutes 
each. Following each successive round of digestion, the tissue becomes smaller, 
more disorganized and pale. Following the third incubation period only an acellular 
matrix remains. 
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that each fraction of DBM contained significantly more CFU-F than that obtained 
from flushed BM, leading to a potential recovery of 3066 CFU-F per femur/tibia pair 
to approximately 80 CFU-F recovered from flushed BM, with approximately 62% of 
CFU-F being isolated following the first digestion, 31.4% of CFU-F isolated following 
the second digestion and 6.9% of CFU-F isolated following the final digestion (Fig. 3-
4 C).  
 Additionally, we conducted a series of experiments comparing the frequency 
of CFU-F obtained by pooling the three fractions together as a more representative 
sample of the stromal progenitor population as a whole within BM.  Data from these 
experiments demonstrated a 196.4 fold increase in the frequency of CFU-F in the 
pooled DBM with approximately 1/104 mononuclear cell forming a colony, as 
compared to that in flushed BM (Fig 3-4 D). These observations correspond to a 
113.95-fold enhancement in the CFU-F recovered by this newly developed 
technique and optimized growth conditions at 5% O2 (Fig 3-4 E). In parallel, we also 
tested the effects of oxygen concentration of CFU-F formation. To do this, single cell 
suspensions of pooled DBM and flushed BM samples were plated in growth media 
at either 20% oxygen, normoxia (n=4) or at 5% oxygen, low oxygen (n=8). The CFE 
of DBM under low oxygen tension (5%) was nearly 30-fold higher than the CFE of 
DBM at normal oxygen tension (20%) (Fig 3-5), signifying perhaps a more 
physiologically relevant environment in vitro and a growth requirement in vivo.  
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Figure 3-4: Evaluation of clonogenic stromal progenitor cells (CFU-F) 
recovered from sequential enzymatic disaggregation of bone marrow plugs. 
(A) Average mononucleated cell yields obtained from either standard flushing 
methods or from each successive digestion (n=4). (B) Incidence of CFU-F obtained 
from either standard flushing technique (5x10^6 mononuclear cells/well) or from 
each fraction of digested marrow plugs (2.5x10^5 mononuclear cells/well) plated in 
triplicate. (C) Recovery of CFU-F from flushed BM and each fraction of DBM 
calculated per femur-tibia pair. (D) Incidence of CFU-F obtained from flushed BM 
versus the pool of DBM fractions (1-3) (n=8). (E) Recovery of CFU-F from flushed 
BM and the pool of DBM fractions (1-3) calculated per femur-tibia pair. Only colonies 
containing >50 stromal cells are scored. CFU-F data are presented both as 
incidence of clonogenic cells (CFU-F/1x10^6 mononuclear cells) and as the total 
number of CFU-F recovered from a given number of bones (CFU-F per total 
nucleated cells). Data are represented as mean + SD. Statistical analysis of CFU-F 
incidence was performed with SigmaStat version 3.5 and significance was assigned 
to p<0.05.  
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi 
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow 
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood. 
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.) 
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 Although the increase in DBM CFU-F frequency observed in these 
experiments exceeded the CFU-F frequency obtained from flushed BM samples by 
at least 2 orders of magnitude, we sought to determine the CFU-F frequency 
obtained from DBM samples more quantitatively by limit dilution analysis (LDA). To 
do this, single cell suspensions prepared from DBM were plated at a range of 
dilutions in 24 replicates (n=3). From these analyses, we observed the frequency of 
CFU-F in pooled DBM samples to be 1/2635 BM mononuclear cells (Fig 3-6), which 
corresponds to a recovery of 9087.7+2996 CFU-F per femur/tibia pair with a noted 
incidence approximately 634-fold higher than that recovered from the same amount 
of tissue prepared by flushing BM. Taken together, our data demonstrates that this 
newly developed methodology yields significantly more   CFU-F as measured by 
both the incidence and recovery as compared to that obtained by standard flushing 
of BM samples and represents significance advancement in the study of BM stromal 
stem/progenitor cells.  
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Figure 3-5: Effect of oxygen tension on CFU-F. Whole bone marrow from 
sequential enzymatically disaggregated BM plugs was plated in triplicate at 20% 
oxygen (5x10^5 cells/well) or 5% oxygen (2x10^5 cells/well) for 14 days. Colonies 
were stained with 0.1% Toluidine Blue. 
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi 
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow 
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood. 
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.) 
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Figure 3-6: Limit Dilution Analysis of Bone Marrow CFU-F. CFU-F incidence was 
quantified by limit dilution analysis (LDA). Limit dilution assays were performed by 
plating bone marrow mononuclear cells at various cell doses (500, 1,000, 2,500, 
5,000 and 10,000 cells/well in 24 well plates) with 24 replicates per dilution. Data are 
from 3 independent experiments were scored and negative wells enumerated from 
each plate at each dilution. Data was analyzed with L-calc software (Stem Cell 
Technologies, Vancouver, BC) and plotted as a negative linear relationship to 
identify the frequency of colony forming cells. 
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi 
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow 
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood. 
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.) 
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PRIMARY MOUSE BONE MARROW CULTURES DERIVED FROM 
ENZYMATICALLY DISSOCIATED BM PLUGS CONTAIN THE MARROW 
STROMAL-VASCULAR FRACTION 
 In our initial experiments, we observed that when BM cell suspensions, 
prepared by enzymatic disaggregation, were plated at non-clonal densities of 1x10^6 
mononuclear cells/cm2 the cultures became 100% confluent by 5-7 days. From this 
observation, we next attempted to characterize the immunophenotype of these 
primary cultures by testing a number of antibodies directed to extra-cellular 
molecules by immunocytochemistry and multi-parameter flow cytometry. We 
reasoned that, because the vascular structure was initially intact within BM plugs 
(Fig 3-2 B, D&E), these cultures would contain endothelial populations as well as 
heterogeneous stromal cell populations. Taking into consideration the fact that 
stromal cells and vascular endothelial cells have different in vitro growth 
requirements and differential adhesive capabilities to adhere to tissues culture 
plastic, we conducted a series of experiments to optimize the growth for each 
respective cell type.  
 For these experiments, DBM was plated at non-clonal cell density (1x106 
nucleated cells/cm2) in either αMEM basal media supplemented with 20% fetal 
bovine serum on tissue culture plastic or in endothelial basal growth medium 
supplemented with a combination of endothelial growth factors (EGM2-MV) on 
fibronectin coated tissue culture plates in order to optimize the growth of stromal and 
endothelial cell constituents. Following a period of 5-7 days at 5% oxygen in either 
growth condition, primary (P0) cultures were first stained in situ with antibodies to 
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Figure 3-7: Immunostaining of P0 cultures and isolation and characterization of 
BM vascular endothelial cells. (A i-vi) In situ staining of P0 cultures plated on 
fibronectin coated chamber slides (LabTek, Nunc, Rochester, NY), cultured in EGM-
2MV for 5-7 days.  Vascular endothelial cells were identified by staining with a 
combination of VE-Cadherin-Alexa 488 and MECA32-Alexa 488 antibodies and 
stromal cells were stained with rat anti-mouse PDGFRα/β (purified) antibodies and 
revealed with donkey anti-rat Cy3 and counterstained with DAPI.  IgG2a and IgG1 
isotypes were used for controls (A iv-v). (B) Gating strategy for FACS purification of 
vascular endothelial cells from P0 cultures plated on fibronectin coated 10cm2 dishes 
at 1x10^6 mononuclear cells/cm2 and cultured in EGM-2MV for 5-7 days and stained 
as described in methods. (C) Phase contrast images of 
LinNEGCD105BRIGHTPDGFRαβNEG cells at passage 3 and functional analysis of 
DiAcetylated-LDL uptake. (D) In situ staining of LinNEGCD105BRIGHTPDGFRαβNEG 
cells at passage 3 for endothelial markers including VEGFR2 (Di.), VE-Cadherin 
(Dii), CD31 and eNOS (Diii), MECA32 (Div), CD105 (Dv) and isotype controls (Dvi-
vii). Nuclei were counterstained DAPI. Imaging was performed on an inverted 
fluorescence microscope (Olympus BX51) at both x10 and x40 original magnification 
and captured with an Olympus DP71 camera.  
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi 
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow 
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood. 
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.) 
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both PDGF receptors, α and β, for stromal cell identification and with a combination 
of endothelial specific antibodies to VE-Cadherin, MECA32 and CD31. As shown in 
Figure 3-7A (i-vi), we observed discrete staining of clusters of endothelial cells 
surrounded by a monolayer of PDGFRαβPOS stromal cells. Interestingly, the size of 
endothelial clusters was substantially larger under the more endothelial permissive 
growth conditions of fibronectin coating and EGM-MV growth media (data not 
shown). When P0 cultures were established from flushed BM cell preparations and 
grown under identical conditions, we failed to identify any CD31/VE-
Cadherin/MECA32+ endothelial cells in keeping with our initial hypothesis and were 
able to only identify rare colonies (CFU-F) of PDGFRαβPOS stromal cells (data not 
shown).  
 We next used multi-parameter flow cytometric analysis, in order to both 
quantify the incidence of stromal and vascular endothelial cells as well as assess the 
feasibility of being able to isolate both populations from primary (P0) cultures. By flow 
cytometric analysis, we demonstrated that 51.38+16.4% (n=5) of the adherent 
population was negative for hematopoietic lineage markers (LINNEG) while 
64.68%+15.4% of the LINNEG cells demonstrated staining for PDGFRα and 
PDGFRβ, identifying them as stromal cells. Interestingly, the LinNEGPDGFRαβPOS 
population exhibited distinct subpopulations when used in combination with the cell 
surface marker CD105 (endoglin). These two populations were represented at 
nearly equal frequencies with 45.2+2.7% of the cells expressing CD105 
(CD105POS) and 43.5+3.6% demonstrated low/negative expression for CD105 
(CD105NEG).  
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An additional 15.66%+10.6% of the LINNEG cells contained phenotypic properties of 
vascular endothelial cells with high levels of CD105 expression and uniformly 
expressed CD31, with modest levels of VE-Cadherin and MECA32 staining, while 
lacking expression of both PDGFRα and PDGFRβ (Figure 3-7B).  While the majority 
of hematopoietic lineage negative cells within primary cultures of DBM consisted of 
stromal and vascular endothelial cells, the remaining 20% of cells appeared to be 
erythroid precursors based on morphology and the expression of CD71 and were 
unable to attach to tissue culture plastic (data not shown).   
 Once having identified an immunophenotype consistent with known 
endothelial cell markers, we used Fluorescence Activated Cell Sorting (FACS) to 
isolate the LinNEGPDGFRαβNEGCD105bright cells from P0 cultures. Upon isolation, the 
cells adhered to fibronectin coated tissue culture plates, displayed characteristic 
cobblestone morphology (Figure 3-7C) and were able to undergo limited serial 
passaging in EGM2-MV media. At passage 3, the LinNEGPDGFRαβNEGCD105bright 
population demonstrated uniform uptake of DiI-Ac-LDL (Figure 3-7C) and continued 
to express all endothelial markers tested including VEGFR2, CD31, eNOS, CD105, 
MECA32 and VE-Cadherin (Figure 3-7D). Additionally, whole mount staining of BM 
plugs revealed an identical immunophenotype as the vascular endothelial cells in 
primary cultures identified as LinNEGPDGFRαβNEGCD105BrightCD144POSMECA32POS 
(Figure 3-8) and this phenotype can be used in the isolation of endothelial cells from 
single cell suspensions based on a lack of hematopoietic lineage cell surface 
markers, high expression of CD105 and intermediate levels of VE-Cadherin and 
MECA32 and lacking expression of PDGFRαβ (Figure 3-8 B).  
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Figure 3-8: Bone marrow vasculature differentially expresses CD105. The 
expression of endothelial cell surface markers in vivo was determined by whole 
mount staining and flow cytometry. (A) BM plugs were removed, fixed and stained 
as a whole mounts with antibodies to VE-Cadherin, MECA32 and CD105. High 
powered confocal imaging revealed distinct staining patterns for arteriole and 
sinusoidal vessels. Smaller vessels express high levels of VE-Cadherin and 
MECA32 and lower levels of CD105 cell surface expression. Larger dilated sinusoid 
vessels demonstrate high levels of CD105 staining and low levels of VE-Cadherin 
and MECA32 staining. (B) Prospective isolation of BM endothelial cells from DBM 
single cell suspensions and phase contrast image of isolated cells demonstrating 
cobblestone morphology. 
B. 
A. 
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LINNEG PDGFRαβNEG CELLS EXHIBIT THE PHENOTYPIC AND FUNCTIONAL 
PROPERTIES OF BMSCs  
 In parallel to using FACS to isolate the endothelial fraction from P0 DBM 
cultures, we also isolated the stromal cell population as a whole based on the 
LinNEGPDGFRαβPOS phenotype (Figure 3-9A). Upon isolation and serial passaging in 
αMEM media supplemented with 20% FBS, the LinNEGPDGFRαβPOS population 
exhibited a typical polygonal stromal morphology (Fig 3-9 Bi) and demonstrated 
homogeneous expression for both chains of the PDGF receptors, α and β, 
consistent with the original phenotype used for their isolation (Fig 3-9 Bii). 
Additionally, we used a panel of cell surface markers routinely used by many other 
labs to characterize, retrospectively, the adherent population of stromal cells from 
mouse BM by flow cytometric analysis. Consistent with the current literature, the 
LinNEGPDGFRαβPOS population demonstrated expression of CD29, CD51, CD73, 
CD105, CD146 and Sca-1 (Figure 3-9C). However, we did observe considerable 
differences in the level of heterogeneity of cell surface phenotypes from cells 
obtained by the current enzymatic disaggregation protocol (Figure 3-9D) as 
compared to cells obtained by standard method of flushing BM (Figure 3-9C) 
analyzed following identical number of passages. Additionally, the 
LinNEGPDGFRαβPOS population isolated from DBM demonstrated a substantially 
greater degree of heterogeneity in the cell surface immuno-phenotypes for CD90, 
Sca-1 and CD105 (Figure 3-9 B&D), which likely represents a more accurate 
reflection of the level of stromal cell heterogeneity seen in vivo.   
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Figure 3-9: Isolation and phenotypic analysis of long-term cultured 
LinNEGPDGFRαβPOS bone marrow stromal cells. (Ai-ii) Representative gating  
strategy of viable cells for FACS isolation of LinNEGPDGFRαβPOS cells from P0 
cultures. (Aii-iii) Phase contrast image and PDGFRβ immunostaining at passage 3. 
(B) FACS analysis of MSC markers in cultures of passage 3 LinNEGPDGFRαβPOS 
cells (n=3). FACS analysis demonstrating phenotypic differences between flushed 
BM (C) and DBM cells (D). FACS data was collected on BD LSR II and post-
acquisition analysis was performed with BD FACS Diva 6.1.3. Data are represented 
as mean + SD. 
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi 
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow 
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood. 
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.) 
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 As noted previously, a subpopulation of multipotent stem/progenitor cells 
exists within the non-hematopoietic bone marrow stromal cell reticulum [85-91] of 
adult mice. These multipotent stem/progenitor cells are hypothesized to be the 
founder source for all CFU-F activity and have been shown to contain multi-lineage 
differentiation potential by forming histologically proven bone, mature adipocytes, 
hematopoietic supportive stroma and cartilage by rigorous in vivo transplantation 
assays [91]. We, therefore, sought to evaluate the differentiation potential of the 
LinNEGPDGFRαβPOS population obtained as described above. LinNEGPDGFRαβPOS 
cells isolated from C57Bl/6mice were collected at passage 3, loaded onto 
osteogenic scaffolds (GelFoam®) and allowed to attach for 1-2 days at 37°C at 5% 
oxygen. Additionally, empty scaffolds treated identically were used as controls. The 
scaffolds were then implanted subcutaneously into immune-deficient (NOD-SCID) 
mice by blunt dissection along the dorsal surface.  
  At 12 weeks post implant, animals were sacrificed, some of which were 
subjected to microCT imaging and scaffolds were recovered for histological analysis. 
In all scaffolds containing cells (n=8), we observed an outer layer of mineralized 
bone tissue surrounding an inner core of bone marrow comprised of donor derived 
adipocytes and hematopoietic supporting stroma and host derived hematopoiesis 
and blood vessels (Figure 3-10 Aii–iv), whereas control scaffolds (n=6) contained 
only fibrous connective tissue (Figures 3-10 Ai).  
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Figure 3-10: Multi-lineage differentiation capacity of LinNEGPDGFRαβPOS 
BMSCs. (Ai-iv) Histology of subcutaneous transplants of either empty scaffolds (Ai) 
or LinNEGPDGFRαβPOS MSC (Aii-iv). Gelfoam scaffolds loaded with 
LinNEGPDGFRαβPOS MSC were either decalcified and embedded in paraffin for H&E 
staining (Aii-iii) or non-decalcified and embedded in methylmethacrylate resin for 
Von Kossa staining (Aiv). (B) 3D pellet cultures of LinNEGPDGFRαβPOS MSC 
embedded in paraffin and stained with Toluidine Blue (0.1% w/v) (Bi), Alcian blue 
(Bii), collagen type II (Biv) and mouse IgG1 isotype (Biii). (C) Oil red O staining of 
LinNEGPDGFRαβPOS MSC following adipogenic differentiation for 14 days.  
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi 
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow 
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood. 
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.) 
 
  66 
 
 
 
 
 
 
 
 
 
 
 
  67 
 Complementary in vitro differentiation assays were also used to validate the 
differentiation potential, whereby the LinNEGPDGFRαβPOS cells demonstrated  
robust chondrogenic activity under standard micromass pellet culture conditions as 
evidenced by collagen type II expression and the deposition of a sulphated 
proteoglycan-rich ECM revealed by staining with Toluidine Blue and Alcian Blue 
(Figure 3-10 Bi-iv). In vitro adipogenic differentiation, following exposure to PPARγ 
agonists, was also observed in which LinNEGPDGFRαβPOS cells generated prominent 
lipid containing vacuoles revealed by Oil Red O staining (Figure 3-10 C). 
 
PROSPECTIVE ISOLATION OF STROMAL PROGENITOR CELLS FROM 
FRESHLY PREPARED ENZYMATICALLY DISAGGREGATED BONE MARROW  
 Collectively, the novel methodology described here demonstrates a robust 
reproducible approach as a means to isolate a phenotypically defined BMSC 
population as a whole, some of which maintain functional properties of marrow 
stromal stem/progenitors cells. We next sought to examine the utility of this 
methodology to isolate an identical population within freshly prepared DBM single 
cell suspensions given that the above data were obtained from LinNEGPDGFRαβPOS 
cells following a brief period of in vitro culture. Single cell suspensions from 
enzymatically disaggregated BM, prepared as previously described, were analyzed 
by flow cytometric analysis as either whole BM (WBM) or following the removal of 
hematopoietic lineage cells using Dynalbeads (Invitrogen). Noticeably, we observed 
a discrete population of LinNEGPDGFRα/βPOS cells within WBM from C57Bl/6 and 
BALB/c mice (Figure 3-11A), representing 0.087+0.014% and 0.84+0.64%, (n=3) 
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respectively. When DBM samples were subjected to immunomagnetic bead 
depletion of the hematopoietic lineage positive cells, the frequency of the 
LinNEGPDGFRα/βPOS population increased to 51.5% in C57Bl/6 mice and 89% in 
BALB/c mice (Figure 3-11B). Upon prospective isolation, the LinNEGPDGFRα/βPOS 
population contained the all CFU-F activity and demonstrated colony-forming 
efficiencies (CFE) of 0.475% and 2.95% from C57Bl/6 and BALB/c DBM (Figure 3-
11C), respectively. Interestingly in samples prepared by digesting BM from C57Bl/6 
and BALB/c mice, we also observed the presence of the PDGFRα/βNEGCD105brght 
endothelial cell population in WBM, which was completely absent in samples 
prepared by flushing BM (Figure 3-11A). Taken together, these data support our 
hypothesis that the flushing of BM leads to a destruction of the marrow vasculature 
and a diminution of stromal stem/progenitor cells physically associated with 
vasculature surface.  
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Figure 3-11: Prospective isolation of LinNEGPDGFRαβPOS clonogenic 
progenitors from DBM. (A) Gating strategy (left panel) and FACS analysis of whole 
bone marrow from C57Bl/6 and BALB/c mice demonstrating the frequency of 
LinNEGPDGFRαβPOS bone marrow stromal cells obtained from either standard 
flushing or sequential enzymatic disaggregation of BM plugs. (B) Gating strategy 
(left panel) for prospective isolation of LinNEGPDGFRαβPOS population from C57Bl/6 
and BALB/c inbred mouse strains. (C & D) Incidence of CFU-F from prospective 
isolation of LinNEGPDGFRαβPOS BM stromal cells from C57Bl/6 and BALB/c mice.  
(Colonies > 50 stromal cells; Clusters represent 10-49 stromal cells). 
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi 
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow 
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood. 
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.) 
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ASSESSMENT OF THE IN VIVO LOCALIZATION OF BONE MARROW 
STROMAL CELL RETICULUM 
 Once having determined the distinct immunophenotype for clonogenic 
stromal progenitor cells and vascular endothelial cells, we next sought to determine 
the anatomical localization of each population within freshly prepared plugs of BM 
using whole mount staining. To do this, we chose a combination of cell surface 
markers that where useful for identifying respective cell populations in primary 
cultures of DBM by either immunocytochemistry or flow cytometry. We used a novel 
whole mount staining methodology with a panel of antibodies directed against known 
endothelial cell surface markers including the combination of VE-Cadherin/MECA32 
and CD105. Interestingly, we observed a distinct pattern of staining that revealed a 
complex vascular network, spanning the entire cross-sectional distance of BM plugs 
removed from C57Bl/6 femurs and consisted of arterioles, smaller capillaries and 
larger dilated sinusoidal vessels (Figure 3-8A), with sinusoidal endothelial cells 
demonstrating the highest staining intensity to CD105.  
 Additional whole mount samples prepared with the combination of 
PDGFRα and PDGFRβ  antibodies as pan-stromal cell markers and VE-Cadherin 
and MECA32 antibodies for vascular endothelial staining demonstrated a complex 
stromal cell reticulum of PDGFRα/βPOS cells with long cytoplasmic extensions 
spanning across the hematopoietic space and interacting with VE-
Cadherin/MECA32 reactive vasculature (Figure 3-12) and hematopoietic lineage 
positive cells (Figure 3-13), while a subset of PDGFRα/βPOS cells were localized to 
perivascular regions of VE-Cadherin/MECA32POS arterioles (Figure 12) and CD105 
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reactive sinusoids (Figure 3-14) as well as within inter-sinusoidal regions. This 
staining pattern, therefore, is useful for identifying the precise localization of 
subpopulations of both stromal and endothelial cells and is consistent with our multi-
parameter flow cytometric analysis used to prospectively isolate the stromal vascular 
fraction of mouse BM. 
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Figure 3-12: PDGFRαβPOS stromal cells are localized to perivascular and inter-
sinusoidal regions in vivo. Whole mount staining of BM plugs. Vascular 
endothelial cells were identified with VE-Cadherin-Alexa 488 and MECA32-Alexa 
488 antibodies (I, upper left) and stromal cells were identified with PDGFRα/β 
antibodies and revealed with donkey anti-rat Cy3 (ii, lower left). Nuclei were counter 
stained with DRAQ5. Z-stack merged image (iii, upper right) and single step merged 
image (iv, lower right) identifying perivascular (asterisk) and intersinusoidal (arrow) 
localization. Images were collected using a 63x oil immersion objective on zoom 
factor of 3 with a Leica TCS SP5 confocal microscope and processed with the Leica 
LAS AF lite software. Z-stacked images were collected in 0.2 µm slices at depths of 
15-25 µm with a pinhole of 1. 
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi 
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow 
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood. 
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.) 
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Figure 3-13: PDGFRαβPOS stromal cells create a complex stromal scaffolding of 
cellular processes interacting with hematopoietic cells throughout extra-
vascular space in vivo. Whole mount staining of BM plugs. Vascular endothelial 
cells were identified with VE-Cadherin-Alexa 488 and MECA32-Alexa 488 antibodies 
(i, upper left) and stromal cells were identified with PDGFRα/β antibodies and 
revealed with donkey anti-rat Cy3 (ii, upper right). Hematopoietic lineage positive 
cells (iii, lower left) were identified with the lineage marker panel (see methods table 
1) conjugated to biotin and revealed with streptavidin-Alexa 594. Single step slice of 
Z-stacked merged image (iv, lower right). Images were collected using a 63x oil 
immersion objective with a Leica TCS SP5 confocal microscope and processed with 
the Leica LAS AF lite software. Z-stacked images were collected in 0.2 µm slices at 
depths of 15-25 µm with a pinhole of 1. 
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Figure 3-14: Subendothelial adventitial reticular cells adjacent to sinusoid 
vessels are PDGFRαβPOS stromal cells. Whole mount staining of BM plugs. 
Sinusoidal endothelial cells were identified with CD105 antibody (i, upper left) and 
stromal cells were identified with PDGFRα/β antibodies and revealed with donkey 
anti-rat Cy3 (ii, upper right). Nuclei were counter stained with DRAQ5 (iii, lower left). 
Single step slice of Z-stacked merged image (iv, lower right). Images were collected 
using a 63x oil immersion objective on zoom factor of 2 with a Leica TCS SP5 
confocal microscope and processed with the Leica LAS AF lite software. Z-stacked 
images were collected in 0.2 µm slices at depths of 15-25 µm with a pinhole of 1. 
Arrow-head indicates sinusoidal perivascular PDGFRα/β stromal cell.  
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3-4: SUMMARY 
 
 Taken together, these data represent a simple and robust methodology that 
allows the simultaneous identification and isolation of both the stromal and vascular 
cellular components of mouse BM with a yield of CFU-F that far exceeds that 
reported in any previous study. Purified BM stromal cell populations devoid of 
hematopoietic contamination are readily obtained by prospective isolation and 
demonstrate robust multilineage differentiation into bone, adipose and chondrogenic 
progeny using standard in vitro bioassays and in vivo transplant models. 
 Furthermore, by developing a novel whole mount staining methodology, we 
are able to obtain a detailed three-dimensional organization of the stromal-vascular 
reticulum. This methodology demonstrates the complexity of the stromal system 
within the bone marrow and localizes a subpopulation of stromal cells to perivascular 
niches while the remaining stromal cells are found to be dispersed throughout the 
marrow parenchyma and contain long cytoplasmic extensions which all appear to 
contact parts of the vascular structure providing the basis for a cellular scaffolding 
for hematopoietic adhesion and migration throughout the BM. By identifying the 
respective location and a cell surface phenotype leading to the prospective isolations 
of clonogenic progenitors (CFU-F), these studies will greatly enhance experimental 
strategies designed to analyze not only MSC identity and function in vivo, but also 
the function of the vascular hematopoietic stem cell niche. 
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CHAPTER 4:  
 
ISOLATION AND FUNCTIONAL CHARACTERIZATION OF DISTINCT 
POPULATIONS OF STROMAL PROGENITOR CELLS 
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4-1: PREFACE 
 
 In the following chapter, I investigate the identity and nature of the cells in 
mouse BM that give rise to cultures of stromal cells most commonly referred to as 
mesenchymal stem cells (MSC). I demonstrate, for the first time, that the cells 
commonly referred to in the literature as ‘mesenchymal stem cells’ are in fact 
derived from phenotypically and anatomically distinct subpopulations of stromal cells 
in mouse bone marrow not from a single population of stromal progenitors as implied 
by the vast majority of studies published to this point in time.  
 Much of the field of MSC biology is based on the characterization of culture 
expanded stromal cells using panels of antibodies directed at cell surface markers 
identified based on their abundant and homogenous expression on these cells. One 
such marker is CD105 (endoglin). In the previous chapter, I demonstrated using the 
improved methodology for isolation of CFU-F from DBM, that following in vitro 
passage up to passage 3 the stromal cells exhibited bimodal expression of CD105 
with distinct CD105POS and CD105NEG subpopulations. This was in marked contrast 
to cultures established using the standard BM flushing technique, which exhibited 
homogeneous CD105 expression in accord with previous reports in the literature. 
We postulate that this discrepancy is due largely to differences in the methodologies 
employed by investigators to obtain single BM cell suspensions. Specifically, that 
flushing of BM results in both quantitative and qualitative reductions in the yield of 
stromal progenitors cells and hence does not permit isolation of a stromal cell 
population that reflects the phenotypic diversity present in the intact mouse BM.  
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 In this chapter, I provide evidence that both CD105POS and CD105NEG 
subpopulations contain clonogenic stem/progenitor cell activity and both exhibit the 
functional properties of MSC as demonstrated by differentiation to bone, adipose 
and cartilage tissue using both in vitro and in vivo assays. Finally, transcriptional 
profiling was performed on the two subpopulations immediately following their 
isolation from the DBM to gain insight into their biological roles in vivo. Analysis of 
these data demonstrate that the LinNEGPDGFRαβPOSCD105POS population contains 
an over-represented list of genes involved in angiogenesis, blood vessel 
morphogenesis and blood vessel development consistent with the role of pericytes. 
However, The CD105NEG population contains a list of over-represented genes 
involved in biomineralization, ossification and skeletal development suggesting this 
population contains cells more committed to the osteoblast lineage and may serve 
as a source of direct progenitors for bone formation. 
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4-2: INTRODUCTION 
 
 In adult mammals, the bone marrow is the place of residence of two 
phenotypically and functionally distinct adult stem cell populations. The first of these 
are the hematopoietic stem cell (HSC), perhaps the most extensively studied and 
best characterized populations of adult or tissue stem cells in all of vertebrate 
physiology. The second stem cell population in the BM are non-hematopoietic 
multipotent stromal stem/progenitor cells originally identified through the pioneering 
studies of Friedenstein and colleagues who first described the multilineage 
differentiation properties (bone, cartilage and adipose tissue) of these BM-derived 
stem cells through rigorous in vivo transplantation assays [88]. By comparison with 
HSC, the non-hematopoietic stromal stem cells are a far less well-understood 
population of tissue stem cells. In part this is due to a lack of consistency in the 
terms used to describe such cells in the literature such as “osteogenic,” “stromal” 
and “skeletal” stem cells. However, the term mesenchymal stem cell (MSC), coined 
by Arnold Caplan’s lab in the early 1990’s, has more recently been ascribed to these 
cells and is the term most commonly referred to in current literature [117].  
 The multi-lineage differentiation potential originally identified by the seminal 
transplantation studies of boneless fragments of marrow conducted by Tavassoli 
and Crosby [92] in the late 1960’s, provided key founding evidence for what would 
subsequently emerge as the field of marrow stromal progenitor biology. Shortly 
thereafter in the 1970’s, Friedenstein and colleagues described a population of 
plastic-adherent, clonogenic stromal progenitors, after which he coined the term 
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colony-forming unit-fibroblast (CFU-F) [93], that were responsible for the formation of 
ectopic bone and transferring the hematopoietic microenvironment in vivo. It was 
proven that this process recapitulates the developmental origin of bone and bone 
marrow formation established by cells of mesenchymal lineage during endochondral 
ossification [118] and hence the term ‘stromal stem cell’ was born.  
 Taken together, these data demonstrate that a rare population of bone 
marrow stromal cells are both clonogenic in nature and contain the capacity to 
generate the diversity of cells found within the adult bone-bone marrow tissue. 
Furthermore, in humans it has been demonstrated, at a clonal level, that a single cell 
responsible for generating a CFU-F can be expanded in culture and go on to 
generate bone, fat and hematopoietic supporting stroma in vivo [119]. CFU-F 
derived colonies exhibit considerable morphological, phenotypic and functional 
heterogeneity as demonstrated both in vitro and in vivo [86]. The most striking 
evidence emerged from the seminal experiments of Friedenstein and colleagues 
who transplanted single colonies derived from mouse BM ectopically beneath the 
renal capsule in mice.  They found that a minor proportion of colonies (approximately 
15%) exhibited the capacity to generate a complete bone marrow organ beneath the 
renal capsule, comprising a bony ossicle, adipose tissue and a typical marrow 
stromal reticulum supporting the associated hematopoietic tissue (the latter derived 
from the host mouse) and hence appeared to exhibit a multipotent differentiation 
potential. In contrast, the majority of colonies either failed to generate any ectopic 
tissue, generated bone tissue only or a fibroblastic connective tissue sometimes 
containing adipose cells. Based on these data a hierarchy of stromal cell 
  85 
differentiation has been proposed [86] in which a multipotent self-renewing stromal 
stem cell at the apex of this hierarchy gives rise to more committed progenitors with 
reduced proliferative potential whose differentiation potential is restricted to one of 
the stromal cell lineages of the BM, bone, fat or cartilage (see Figure 3-1). Although, 
these data provide evidence that stromal stem cells are clonogenic and multipotent, 
it also highlighted a key fact that just as in the hierarchy described for hematopoietic 
stem and progenitor cells, clonogenicity per se does not equate to stem cell 
potential. 
 Historically, it has been suggested that a single population of multipotent 
stromal progenitors within adult murine bone marrow is responsible for all CFU-F 
activity and subsequently are the cells that are able to undergo multi-lineage 
differentiation. Initial observations by Westen and Bainton, suggested that 
subendothelial adventitial reticular cells expressing membrane bound alkaline 
phosphatase [116] were candidate founder cells for CFU-F and subsequent data in 
humans demonstrated that these cells generate adipocytes and osteoblasts in vivo 
[120]. Additional studies with human bone marrow identified an immunoglobulin 
superfamily adhesion molecule, Muc18/MelCAM/CD146 as a cell surface marker of 
the population of subendothelial BMSCs. When BM cells exhibiting high levels of 
CD146 were isolated by FACS all measurable CFU-F activity was restricted to the 
CD146+ fraction and these cells demonstrated the ability to generate ectopic bone 
and transfer the hematopoietic microenvironment in vivo. Interestingly, these authors 
also provided evidence that only the BMSCs and not bone derived cells, were able 
to transfer the hematopoietic microenvironment suggesting that BMSCs contain a 
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more primitive stem cell population [22]. Together, these data point to the 
subendothelial adventitial reticular cell as the likely in vivo MSC candidate. However, 
such experiments have not yet been performed in adult mice and data based largely 
on retrospective analysis of culture-expanded MSC is limited by the unproven and 
highly unlikely assumption that the pattern of gene expression of the multiply 
passaged progeny of MSC in vitro accurately reflects that of the founder stromal 
progenitor cell in-situ in the BM. Consequently, data based on analysis of the 
phenotypic properties of MSC in vitro cannot necessarily be relied upon to 
accurately predict a cell surface phenotype that will allow unequivocal identification 
and localization of the in vivo counterpart within the bone marrow tissue.  
 Recent data using transgenic reporter strains has begun to shed some light 
on a candidate subpopulation of stromal stem/progenitor cells in vivo. The 
chemokine stromal derived factor 1 (SDF-1/CXCL12) as implied by the name, is 
abundantly expressed by bone marrow stromal cells and plays a key physiological 
role as a chemoattractant for hematopoietic stem/progenitor cells by virtue of their 
expression of the counter-receptor for SDF-1, CXCR4. Using a CXCL12-GFP 
knockin model Omatsu et al. [24] demonstrated that GFP+ cells in the BM with their 
long cytoplasmic process and anatomical distribution both in association with the BM 
vasculature and in the intersinusoidal spaces exhibit features consistent with their 
identity as reticular cells. The authors further demonstrated that the GFP+ cells 
express alkaline phosphatase in vitro and are able to differentiate into osteoblastic 
progeny and give rise to adipocytes in vivo following 5-FU treatment [24]. Recent 
work from Frenette and colleagues, using a transgenic mouse model in which GFP 
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expression is under the control of the neural-specific regulatory elements of the 
nestin gene (Nes-GFP+), demonstrated that GFP+ cells in the BM were localized 
exclusively to perivascular regions [23]. In addition, GFP+ cells isolated from the 
bone marrow by FACS contained all measurable CFU-F activity and exhibited MSC 
activity as demonstrated by standard in vitro differentiation assays and by in vivo 
ectopic transplantation experiments. Consistent with the physiological role of Nestin 
expressing cells as MSC, when these authors performed lineage-tracing studies 
using a nestin-cre/Rosa LacZ mouse model, they identified some contribution to 
cartilage and bone in the developing mouse embryo. However, because not all of 
the developing bone appeared to be derived from the Nestin expressing cells, it 
suggests that there may be additional stromal stem/progenitor populations that also 
contribute to the developing bone and may also serve as an alternative source of 
resident stem/progenitor populations. Collectively, these two studies shed important 
light on the identity of stromal progenitors and in addition, are consistent with the 
notion that multiple stromal stem/progenitor populations may exist within adult 
murine bone marrow [25].  
 During bone development, mammals undergo a process of endochondral 
ossification where mesenchymal condensation generates hypertrophic cartilage, 
which is surrounded by osteoblast progenitors responsible for generating a bony 
collar [85, 118]. Following the formation of the outer bone periosteum, vascular 
invasion occurs bringing along perivascular cells, which then seed the newly formed 
marrow cavity.  
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 This developmental process has recently been very eloquently demonstrated 
by Kronenberg and colleagues using transgenic mouse models. Using two different 
mouse models to perform lineage tracing studies, these authors provide evidence 
that Osterix expressing precursors give rise to the bone marrow stromal cells, 
osteoblasts and pericytes in the developing bone marrow stroma, while more mature 
Collagen type I expressing osteoblasts were confined to the perichondrial regions 
and never moved into the developing marrow cavity [121]. These data illustrate at a 
cellular level that at least some of the adult BMSCs are originally derived from 
osteoblast precursors in the developing bone-bone marrow organ.  However, it is not 
clear from these studies if all of the adult bone marrow MSC and CFU-F are derived 
from the Osterix expressing precursor cells. It therefore remains possible that 
additional population(s) of cells with the functional properties of MSC remain to be 
identified in post-natal adult mouse BM which may differ in their developmental 
origins and/or may represent a distinct source of perivascular cells that colonize the 
adventitial surface of blood vessels at the time of the initial wave of vasculature 
invasion.  
 One potential source of such cells is suggested by the elegant lineage tracing 
studies of Nishikawa and colleagues whose data suggest that some of the stromal 
cell compartment is actually developmentally derived from the neural crest [122]. 
Again using lineage-tracing studies, these authors demonstrate with the use of a 
neural crest specific promoter driving expression in a temporal manner of Cre 
recombinase, P0-Cre/Rosa-EGFP, that some of the perivascular cells in adult BM 
are EGFP+.  P0 is a neural crest specific gene active during the wave of neural crest 
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migration and is not expressed in WT adult BM. Collectively, these two sets of data 
offer an intriguing hypothesis suggesting that BMSCs are derived from at least two 
distinct developmental origins.  
 Despite these recent important advances, the field of mouse BMSC biology is 
still beset by many uncertainties with regards to the defining characteristics of MSC 
in vivo. Furthermore although often cited, the existence of a hierarchy within the 
adult BMSC system within mouse BM remains largely hypothetical and has not been 
validated rigorously by retroviral gene marking and transplantation studies that have 
proved so powerful in defining the multilineage differentiation potential of HSC. Nor 
has it been possible to dissect, phenotypically by prospective isolation of distinct 
subsets, the cellular constituents of this supposed stromal stem-progenitor cell 
hierarchy as again has been achieved in very great detail in the hematopoietic 
system [reviewed in 3].  
 In the previous chapter, a novel methodology that greatly increases the yield 
of clonogenic stromal stem/progenitor cells was described that simultaneously 
allows for the prospective isolation of the stromal/vascular fraction from murine bone 
marrow. By means of this methodology we have identified subpopulations of stromal 
cells based on their distinct immunophenotypes, which have not been previously 
reported and whose physiological roles consequently remain unknown. The studies 
described in the following chapter have begun to resolve the identity and function of 
these distinct populations of stromal stem/progenitor cells. Here, I describe the 
isolation and characterization of distinct populations of clonogenic BMSCs with 
stem/progenitor properties by fractionating the LinNEGPDGFRα/βPOS population using 
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of the TGF-β family co-receptor, endoglin (CD105). Through various lines of 
investigation using both in vitro bioassays and in vivo transplantation studies, I 
demonstrate that the LinNEGPDGFRα/βPOSCD105POS and 
LinNEGPDGFRα/βPOSCD105NEG populations each contain independent clonogenic 
progenitors with the ability to generate ectopic bone and bone marrow. By means of 
transcriptional profiling of the prospectively isolated populations, evidence is 
provided consistent both with distinct anatomical localization in vivo and of 
potentially different biological functions. Such data form the basis of future 
experimental approaches to define putative stromal cell hierarchies in the mouse BM 
stromal cell system.  
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4-3: RESULTS 
 
Distinct populations of bone marrow stromal cells initiate both long-term 
stromal cell cultures and generate all CFU-F activity   
 We have previously identified a composite phenotype for the BM stromal cell 
population as a whole in fresh marrow based on the lack of hematopoietic lineage 
markers and expression of both the alpha and beta chains of the PDGF receptors 
(LinNEGPDGFRα/βPOS) [28], which interestingly exhibited a bimodal expression for 
CD105. We next sought to determine if stromal cell clonogenic activity could be 
further enriched for based on CD105 (endoglin) expression as suggested by most 
retrospective analysis in the reported literature. Within both primary cultures and in 
freshly prepared DBM samples, we identified a LinNEGPDGFRαβPOSCD105POS 
(referred to throughout as CD105POS) and a LinNEGPDGFRαβPOSCD105LOW/NEG 
(CD105NEG) population. We therefore asked the question whether or not these two 
populations exhibit different functional properties.  
 Primary cultures of BMSCs were obtained from enzymatically disaggregated 
BM plugs and plated at either nonclonal (1x10^6 cells/cm2) or at clonal densities 
(1x10^4 cell/cm2). In both cases, flow cytometric analysis demonstrated that clonal 
and non-clonal cultures exhibited a bi-modal expression for CD105 within the 
LINNEGPDGFRαβPOS stromal cell population at nearly equal frequencies (Figure 4-1A 
i-ii), with no significant difference in the percentage of each population. At nonclonal  
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Figure 4-1: PDGFRαβPOSCD105POS and CD105NEG cells initiate whole bone 
marrow CFU-F cultures. (A) Representative flow cytometric analysis of primary 
cultures of DBM plated at non-clonal and at clonal densities demonstrates equal 
frequency of each population within the hematopoietic lineage negative cells. (B) 
Quantification of flow cytometric analysis for CD105POS and CD105NEG populations. 
(C) Representative in situ immunocytochemical staining of individual CFU-F colonies 
demonstrates homogeneous expression for CD105 within individual CFU-F. (D) 
Quantification of CFU-F in situ staining from 3 independent donors plated in 
triplicate. A total of 12 colonies were scored per donor. Data represent mean + S.D. 
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density, the CD105POS fraction represents (45.2+ 2.65%) of the LinNEGPDGFRαβPOS 
population and the CD105NEG fraction represents (43.5+ 3.6%) of the population by 
flow cytometric analysis (Figure 4-1A i). Interestingly, when BM mononuclear cells 
were plated at clonal density, the CD105POS and CD105NEG populations were 
represented at nearly equal frequencies within the LINNEGPDGFRαβPOS population, 
48.2+ 15.03% and 40.0+ 12.5% respectively. In addition, in situ staining of primary 
cultures of DBM derived CFU-F revealed that single colonies were either all reactive 
or all negative for CD105 (Figure 4-1C), demonstrating that both CD105POS  
(44+19.6%) and CD105NEG (56+19.7%) cells initiate CFU-F colonies from whole 
bone marrow (Figure 4-1 A-D), with no significant difference in the number of 
colonies generated.  
 Next, we sought to determine the frequency of CFU-F generated within each 
population from freshly prepared DBM samples. By flow cytometric analysis, the 
CD105POS population represented significantly more of the LinNEGPDGFRαβPOS 
fraction with averages of 44.3% and 63.9%, in C57Bl/6 and BALB/c mice, 
respectively while the CD105NEG population represented 23.7% and 16.7% in the 
same two strains (Figure 4-2 B).  As shown in Figure 4-2 C, both the CD105POS and 
CD105LOW/- populations generate CFU-F, when prospectively isolated, however the 
CD105POS population contained significantly more CFU-F per 1000 cells plated in 
C57Bl/6 mice suggesting that this population is more enriched in CFU-F activity 
(Figure 4-2C). However, the difference in the number of CFU-F formed from each 
prospectively isolated population was not statistically different in BALB/c mice  
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Figure 4-2. LinNEGPDGFRαβPOSCD105POS and CD105NEG populations 
prospectively isolated from digested BM plugs are highly enriched in CFU-F 
activity. (A) Prospective isolation of CD105POS and CD105NEG populations from 
enzymatically prepared BM plugs in C57Bl/6 and BALB/c mice. (B) Quantification of 
the percentage of viable cells gated through hematopoietic lineage negative 
population. (C) Number of CFU-F colonies generated from sorted populations in 
C57Bl/6 and BALB/c mice. 
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highlighting a difference in the two strains of mice. Interestingly, this purification 
strategy for CFU-F isolation yields a 50-100 fold increase in the CFU-F obtained as 
compared to unfractionated whole BM samples. And while the percentage of the 
CD105POS population in vivo represents at least 50% more of the total 
LinNEGPDGFRα/β population (Figure 4-2 A&B), this observation suggests that it is 
more heterogeneous in terms of clonogenic activity and potentially function. Taken 
together, these data demonstrate that phenotypically distinct subpopulations of 
clonogenic stromal progenitor cells exist within mouse BM in vivo and equally 
contribute to the generation of CFU-F in culture. 
 Having previously noted that the bimodal expression of CD105POS and 
CD105NEG exists within total BM cultures up to passage 3 (Figure 3-9 B&D), we next 
wanted to determine if this bimodal expression would persist long term in culture 
over multiple additional serial passages or would change over time. To perform 
these experiments, DBM was plated in culture at non-clonal dilutions and multi-
parameter flow cytometric analysis was conducted following serial passaging at P0, 
P3, P6 and P9. We observed a significant and progressive increase in the 
percentage of CD105POS cells in the cultures after passage 3 and by passage 9, the 
entire LINNEGPDGFRαβPOS fraction homogenously expressed CD105 (Figure 4-3 
A&B).  
 This data suggests one of three possible scenarios; 1) a hierarchy exists 
whereby the CD105NEG cells represent a more primitive population that give rise to 
CD105POS cells more representative of a committed progenitor (Figure 4-4A); 
scenario 2) CD105POS cells have a greater proliferative capacity in vitro and 
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eventually overtake cultures following serial passaging (Figure 4-4B); or scenario 3) 
all stromal cells begin to express CD105 following extended culture periods 
representing an in vitro artifact (Figure 4-4C). To begin addressing each possible 
scenario, DBM single cell suspensions were fractionated by FACS into CD105POS 
and CD105NEG populations, and analyzed for their expression of CD105 by flow 
cytometric analysis following serial passaging. Up to passage 6, we were unable to 
detect any level of inter-conversion between these two immunophenotypes (Figure 
4-5) suggesting that distinct subpopulations within the bone marrow stromal 
compartment can initiate and maintain long-term marrow cultures, ruling out the 
likelihood of scenarios 1 and 3, and suggesting that CD105POS cells contain a 
greater proliferative capacity in vitro and eventually overtake cultures of 
unfractionated WBM. In support of this, the CD105NEG population failed to proliferate 
beyond passage 6, at which time the majority of cells became large flattened bi-
nucleated cells that stop dividing while at the same passage history, the 
CD105POSpopulation continued to proliferate at least to passage 9.  
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Figure 4-3. DBM cultures demonstrate homogeneous for CD105 expression 
following ex vivo expansion. (A) Representative FACS plots of whole bone 
marrow cultures prepared from enzymatic disaggregation of BM plugs. Gating is set 
according to isotype controls (B) Quantification of flow cytometric analysis 
demonstrating an increase in frequency of hematopoietic lineage negative cells and 
CD105POS cells concomitant to a complete loss of the CD105NEG population. Data 
are represented as the mean + Std. Dev. n=3. Statistical analysis was performed 
with student t-test and significance assigned to p<0.05 (*), and p<0.0001 (**). 
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Figure 4-4: Schematic diagram of possible explanations leading to 
homogeneous CD105 expression following extended culture. (A) Scenario 1: 
existence of a stem/progenitor hierarchy with CD105NEG population representing a 
more primitive stem/progenitors with limited self-renewal capabilities which undergo 
asymmetric divisions giving rise to more committed CD105POS progenitors. (B) 
Scenario 2: CD105POS cells demonstrate a greater proliferative capacity and over-
take cultures following extended passage history. (C) Scenario 3: All BMSCs begin 
to express CD105 following increasing passage history.  
  100 
 
Figure 4-5: LinNEGPDGFRαβPOSCD105POS and CD105NEG cells fractionated from 
freshly prepared BM samples maintain their original CD105POS or CD105NEG 
phenotype in culture.  Flow cytometric analysis demonstrating maintenance of the 
input phenotype with respect to CD105 expression following serial in vitro passage 
of mouse DBM derived BMSC.  
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A subpopulation of prospectively isolated LinNEGPDGFRα/βCD105POS cells co-
express mature pericyte and subendothelial adventitial reticular cell markers 
in vivo 
 Although all CFU-F are contained within the CD105POS and CD105NEG 
fractions, not all cells expressing either of these markers are able to form CFU-F 
suggesting that each population remains heterogeneous in regards to clonogenic 
activity. To further assess the level of heterogeneity within each population, we 
prospectively isolated LinNEGPDGFRα/β population as a whole by FACS and cells 
were used to prepare cytospins and dual labeled for CD105 in pair-wise combination 
with a panel of pericyte/mural cell markers, including NG2, alkaline phosphatase 
(ALP) and α smooth muscle actin (αSMA). Accordingly, the CD105POS and 
CD105NEG populations were represented at nearly equal frequencies by cytospin, 
57.9% and 41.6%, respectively, as that determined by flow cytometric analysis 
validating the use of this approach (Figure 4-6B). 100% of the cells exhibited 
staining with antibody to PDGFRβ, as expected, confirming the purity of the sorted 
cell population (Figure 4-6 A v&vi, & B). The percentage of CD105POS  cells 
exhibiting co-staining for these additional pericyte/mural cell markers is represented 
in Figure 4-6B. Approximately 18% and 28%, respectively, of CD105POS  cells 
expressed αSMA and NG2, suggesting that a minor subpopulation of cells within this 
phenotype are smooth muscle/perivascular cells.  Conversely, all of the cells that 
expressed either αSMA (A vii-ix), NG2 (A x-xii) or ALP (A xiii-xv) were also positive 
for CD105 (white arrows), demonstrating that cells exhibiting expression of the well 
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documented pericyte markers αSMA and NG2 are restricted to the 
LinNEGPDGFRα/βCD105POS subpopulation.  
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Figure 4-6: Prospectively isolated LinNEGPDGFRαβPOSCD105POS cells co-
express pericyte/mural cell markers in vivo.  (A i-xvi) Representative images of 
Immunohistochemistry staining of prospectively isolated PDGFRα/βPOS cells with a 
combination of cell surface markers to CD105, PDGFRβ, αSMA, NG2 and Alkaline 
Phosphatase or isotype controls. PDFGRβ was used as a positive control 
demonstrating 100% of sorted cells expressing PDFGRβ (A v-vi). A subpopulation of 
CD105POS cells (white arrows) express αSMA (A vii-ix), NG2 (A x-xii) and ALP (A 
xiii-xv). Isotype controls: Rb-IgG, Ms-IgG and Gt-IgG isotype controls (A i-iii). Nuclei 
were counterstained with DAPI in prolong Gold anti-fade mounting media. Images 
were captured on am Olympus 70x epifluorescent microscope with an Olympus 
camera under identical exposure time at 40x magnification. White arrows indicate 
double positive cells for CD105 and αSMA, NG2 and ALP. Yellow arrowheads 
indicate CD105NEG cells lacking expression for any additional markers tested. (B) 
Quantification of cells expressing each marker from 3-5 fields of view per slide. Data 
represent mean + Std. dev. (C & D) Flow cytometric analysis of transgenic mouse 
strains demonstrating expression of αSMA (C) and NG2 (D) within the CD105POS 
population. (E) Whole mount staining of WT BM plugs demonstrating a perivascular 
localization of PDGFRα/βPOSNG2POS cells along smaller arteriole vessels consistent 
with mature pericyte function in vivo. Images were captured using a 63x oil 
immersion objective of a Leica TCS SP5 confocal microscope and processed with 
the Leica LAS AF lite software. Z-stacked images were collected in 0.2 µm slices at 
depths of 15-25 µm with a pinhole of 1 (x63). 
 
  104 
 
 
 
 
  105 
 We next validated these results by flow cytometric analysis of two different 
transgenic mouse models, the first in which the αSMA promoter drives expression of 
RFP (αSMA-RFP; generously supplied by Dr Frank Marini, MD Anderson Cancer 
Center, Houston, TX) and the second strain in which the NG2 promoter drives 
expression of DsRed (Tg(Cspg4-DsRed.T1)1Akik/J [124]) (Figure 4-6 C&D). From 
each strain BM plugs were isolated and subjected to sequential enzymatic 
disaggregation as previously described to yield a suspension of DBM which was 
then analyzed for either RFP or DsRed expression (as appropriate) in combination 
with the Lineage panel, PDGFRα/β and CD105.  
 This approach confirmed the immunocytochemistry data demonstrating that 
all of the αSMA-RFP and NG2-DsRed expressing cells fell within the CD105POS 
fraction, representing 7.1% and 4.2%, respectively (Figure 4-6 C&D). Additionally, 
whole mount staining of BM plugs was performed to determine the in situ localization 
of NG2 positive cells within the BM. From this staining, we observed that the 
PDGFRα/βPOSCD105POSNG2POS cells were localized to smaller blood vessels which 
were reactive for both VE-Cadherin and MECA32 antibodies (Figure 4-6 E), a finding 
consistent with the known localization of pericytes [125]. Importantly, the 
PDGFRa/bPOSCD105POSNG2POS population was also assayed for its content of  
CFU-F and exhibited a CFE of 0.4% (4 colonies/1000 cells plated). Interestingly from 
the same mice, the LinNEGPDGFRa/bPOSCD105POSNG2NEG population contained a 
colony forming efficiency of approximately 1.2%. Taken together these data 
demonstrate that differential expression of CD105 allows the resolution of the 
stromal progenitor population of mouse BM into subpopulations that differ in their 
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phenotype and anatomical location within the BM and implies that they may be 
hierarchically related.  
LinNEGPDGFRα/βCD105POS and CD105LOW/- populations exhibit multi-lineage 
differentiation in vitro and generate ectopic bone tissue with associated 
hematopoietic bone marrow in vivo  
 We next, assessed the differentiation potential of the each population through 
a series of in vitro and in vivo differentiation assays. For these experiments, DBM 
from freshly prepared BM was fractionated based on LinNEGPDGFRα/βPOSCD105POS 
and CD105LOW/- phenotypes by FACS and expanded to passage 3. At passage 3 or 
4, each population was first subjected to in vitro multi-lineage differentiation assays. 
To assess differentiation along the osteogenic lineage, cultures were plated in basal 
medium for 2-3 days and followed by exposure to the standard osteogenic 
differentiation culture conditions (ascorbic acid, dexamethasone and inorganic 
phosphate; see Materials & Methods) for 14 days. At day 14, cultures were fixed and 
histochemical staining performed to reveal alkaline phosphatase activity as a marker 
of osteoblastic differentiation in combination with calcium-phosphate mineralized 
deposits (revealed using the von Kossa reaction). Under these conditions, both 
CD105POS and CD105NEG populations efficiently differentiated along the osteoblastic 
lineage (Figure 4-7A top panel). Additionally, when confluent cultures were grown in 
the presence of the PPARγ agonist IBMX for 14-21 days, both populations 
successfully differentiated along the adipogenic lineage containing clusters of 
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Figure 4-7:  LinNEGPDGFRαβPOSCD105POS and 105NEG populations contain MSC 
activity in vitro. (A) In vitro multi-lineage differentiation of CD105POS and 105NEG 
populations. Osteogenic lineage differentiation was evaluated by alkaline 
phosphatase (blue) and Von Kossa (brown) staining. Adipogenic lineage 
differentiation assessed by Oil red O staining of lipid vacuoles. Chondrogenic 
lineage differentiation was assayed in micro-mass pellet cultures and stained with 
Toluidine blue.  
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lipid-laden cells that stained with the neutral lipid stain Oil Red O (Figure 4-7 B 
middle panel). Chondrogenic differentiation was evaluated using standard 
micromass pellet culture assays. In these assays, both populations were able to 
generate chondrogenic pellets, revealed by the deposition of a sulphated 
proteoglycan-rich ECM stained with Toluidine Blue (Figure 4-7, bottom panels). 
These data provide evidence that both CD105POS and CD105NEG stromal cell 
subpopulations exhibit the capacity for multilineage differentiation to generate 
osteoblastic, adipose and chondrogenic progeny in vitro.                                                                                                   
 Although in vitro differentiation assays are readily used by many labs to 
assess multi-lineage differentiation potential, caution must be exercised in 
interpreting these assays since in vitro differentiation potential does not 
unambiguously predict their capacity for differentiation in vivo [126]. Therefore, we 
further tested the multipotency of each population using rigorous in vivo 
transplantation assays to determine the differentiation potential of the CD105POS and 
CD105NEG populations. For these assays, DBM cell suspensions were prepared from 
C57Bl/6 mice and fractionated by FACS on CD105POS expression. Following 
isolation, each population was expanded in culture to passage 3 or 4, at which time 
a portion of the cells were analyzed by flow cytometric analysis to validate the input 
pre-transplantation phenotype (see Figure 4-9 A). The remaining cells were loaded 
onto Gelfoam scaffolds at 5x10^5 cells/scaffold and implanted subcutaneously by 
blunt dissection into NOD-SCID mice as previously described [85, 88]. Initially,  
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Figure 4-8:  LinNEGPDGFRαβPOSCD105POS and 105NEG populations generate 
ectopic bone and transfer the hematopoietic microenvironment in vivo. In vivo 
ectopic bone tissue with associated hematopoietic bone marrow. Top panel 
represents empty scaffolds as controls (n=6), middle panels are representative bone 
formation from CD105POS population (n=8) and lower panel is from CD105NEG 
population (n=8) stained with H&E and Von Kossa (left to right).  
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scaffolds were recovered at 12 weeks post implant for histological evaluation. In all 
cases (8 out of 8), scaffolds contained an outer core of mineralized bone tissue 
surrounding an adipose rich BM tissue (Figure 4-8, middle and bottom panels) 
whereas only fibrous connective tissue was observed in mice transplanted with 
empty scaffolds as controls (n=6) (Figure 4-8, top panels). Thus both murine BM 
stromal stem/progenitor subpopulations also demonstrate the capacity to form 
histologically proven bone tissue and transfer the hematopoietic microenvironment in 
vivo.  
 While these data provide evidence that both LinNEGPDGFRαβPOSCD105POS 
and 105NEG stromal progenitor subpopulations demonstrate the capacity to generate 
an ectopic bone marrow organ it should be noted the transplants were performed 
using equivalent numbers of cells from each population and the formation of a bony 
ossicle was assessed at the one time point. This experimental design therefore does 
not preclude the possibility that the two populations may differ either in their potency 
or in the kinetics with which they each generate an ossicle. Furthermore this 
experimental approach also does not measure whether differences in the self-
renewal potential of the two populations exist as would be demonstrated by 
secondary CFU-F formation and the generation of secondary bone-marrow ossicle 
upon secondary transplantation. 
 To begin to address such questions a series of studies were designed using 
the heterotypic bone ossicle forming assay in which fewer input cells were 
transplanted and the transplants were of shorter duration. For these studies, BMSC 
subpopulations were isolated from UBC-GFP mice (n=6 per group) in order to track 
  112 
the fate and contribution to bone formation and hematopoietic supporting stroma by 
transplanted donor derived cells. Furthermore, the use of labeled cells facilitated 
analysis of the phenotype of the transplanted cells and the potential to re-isolate 
donor cells following transplantation by means of FACS. Previous experiments 
suggested that the CD105POS cells exhibited a greater proliferative advantage in 
culture (Figure 4-4) and generate significantly more CFU-F colonies (Figure 4-2 C) 
as well as generate qualitatively more larger colonies than CD105NEG cells further 
supporting evidence of a greater proliferative advantage in vitro (Figure 4-9 A i-iii).  
 To address the issues of potency and kinetics, CD105POSGFPPOS and 
CD105NEGGFPPOS cells were isolated from UBC-GFP mice as previously described 
and a some of the cells were plated for CFU-F assays to again confirm the 
clonogenic potential (Figure 4-9 Ai-iii) and the majority of isolated cells were 
expanded in culture to passage 3. At which time, cells were collected and a portion 
of the cells from each population were analyzed by FACS to confirm the pre-
transplantation immunophenotype (Figure 4-9 B) and the remaining cells were 
loaded onto Gelfoam scaffolds and transplanted subcutaneous as previously 
described.  
 At 12 weeks post-transplant, mice were sacrificed and subjected to MicroCT 
analysis to identify bone containing ossicles macroscopically (Figure 4-9 C). 
Scaffolds were then recovered and processed for histology following decalcification. 
H&E staining of scaffolds further demonstrated ectopic bone formation and GFP 
immunohistochemistry was used to confirm the contribution from donor-derived 
cells. In these experiments, both populations demonstrated contribution to 
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osteoblast bone lining cells, mature osteocytes embedded in bone matrix, immature 
adipocytes containing multiple lipid droplets and immature, unilocular adipocytes 
(Figure 4-9 D). Furthermore, some scaffolds were crushed, enzymatically digested 
and the cells recovered by this process subjected to flow cytometric analysis. In 
these studies, scaffolds recovered from CD105POSGFPPOSdonor cells demonstrated 
a bimodal expression for CD105 similar to the distribution seen in freshly prepared 
tissue (Figure 4-9 Ai), with 58.6% of the cells retaining CD105 expression and 40.5% 
of the GFPPOS cells expressing low to negative levels of CD105 expression (Figure 
4-9 E i&ii). However, CD105NEG donor cells remained negative for CD105 
expression (4-9 E iv&v). Interestingly, when cells recovered from these scaffolds 
were plated at equivalent numbers in culture for secondary CFU-F assays we were 
only able to find colonies from scaffolds derived from the CD105POS donor cells 
(Figure 4-9 Eiii), where as the CD105NEG donor cells grew scattered throughout the 
well without any evidence of colony formation (Figure 4-9 E vi). We were not able to 
accurately enumerate the colonies in this experiment due to overgrowth of host 
GFP-Neg fibroblasts in the tissue surrounding the implants.  
 Nevertheless, these data represent important evidence suggesting that 
following transplantation in vivo, CD105POS cells generate both CD105POS cells and 
CD105NEG subpopulations but under identical transplant conditions, CD105NEG cells 
only give rise to CD105NEG cells. These results imply that CD105POS and CD105NEG 
are not independent self-maintaining populations but represent a hierarchy of 
BMSCs.   
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 To address the issue of potency and kinetics, BMSCs fractionated as above 
on the basis of CD105 expression were again loaded onto scaffolds and 
transplanted subcutaneously at a dose of 1x10^5 cells per scaffold and transplanted 
for a total of 6 weeks (n=4). Histological analysis of these scaffolds demonstrated 
that although both populations generated bone tissue, only the CD105POS cells were 
able to generate adipose derived marrow (Figure 4-10 A), whereas the CD105NEG 
cells contributed mostly to bone formation (Figure 4-10 B) with only 1 of 4 scaffolds 
demonstrated a small area of marrow adipocytes. Because these transplantation 
assays were done with fewer input cells and for a shorter duration of time, these 
results suggest a potential difference in the potency of stem/progenitor cells within 
the two populations in vivo and in their differentiation kinetics.  
  Together, these transplantation studies demonstrate that although both 
populations contain clonogenic progenitors that are able to form ectopic bone at 
5x10^5 cells per graph during a 12 week time point, the CD105POS population 
exhibits greater proliferative potential in vitro and in vivo and suggest that this 
population as a whole is more enriched in primitive stromal stem cells as 
demonstrated by their ability to generate both bone and adipose rich bone marrow 
from fewer cells in a shorter period of time in vivo. Our preliminary data also suggest 
that the capacity to form secondary CFU-F (as a measure of self-renewal capacity) 
following ectopic transplantation is restricted to the CD105POS subpopulation. 
Additionally, because CD105POS cells give rise to CD105NEG cells in vivo in the 
heterotypic bone forming model, we reasoned that within the CD105POS population 
exists a hierarchically more primitive stromal stem cell, which sits atop of  
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Figure 4-9:  LinNEGPDGFRαβPOSCD105POS population contains stromal 
stem/progenitors with secondary CFU-F generating potential. (A) 
Representative FACS plot (i) and CFU-F images (ii-iii) from each population 
following prospective isolation. CD105POS (ii) population contains founder CFU-F 
with greater proliferative advantage compared to CD105NEG (iiii).  Arrows highlighting 
qualitative difference in colony size. (B) Pre-transplantation immunophenotype of 
passage 3 culture expanded CD105POS and CD105NEG populations. (C) Micro CT 
imaging of subcutaneous scaffolds at 12 weeks post-transplant. Arrows indicate 
ectopic bone. (D) GFP immunohistochemistry of recovered scaffolds demonstrating 
donor derived bone and adipogenic marrow stoma. (E) Ectopic scaffolds were 
recovered, digested and analyzed by flow cytometric analysis and CFU-F assay. (Ei 
& iv) GFP expression of donor cells recovered from scaffolds. (E ii & v) Flow 
cytometric analysis of GFP+ donor cells following 12 weeks post-transplantation 
demonstrating CD105POS donor cells generate CD105LOW/NEG cells in vivo. (E iii & vi) 
GFPPOS cells plated from scaffolds demonstrating secondary CFU-F potential by 
GFPPOSCD105POS donor cells.  
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a stromal cell hierarchy.   
 Although this proposed hierarchical model in the adult BM is largely 
speculative at this time, it is supported by studies from the Weissman lab using fetal 
bone-derived stromal cells [123]. This study described the ability of fetal bone 
derived stromal cells fractionated on CD105 and Thy1 expression to establish a 
stem/progenitor cell hierarchy in which CD105POSThy1NEG cells generated bone and 
HSC supporting BM in a kidney capsule ectopic transplant model while the 
CD105POSTHY1POS and CD105NEG populations generated bone tissue only. 
Furthermore, the authors provide evidence that the CD105POSTHY1NEG population 
follows the process of endochondral ossification, while the CD105POSTHY1POS 
population, expresses 5 fold higher levels of osteocalcin and appears to form bone 
without the cartilage intermediate [123]. 
Global transcriptional analysis of BM stromal stem/progenitor populations 
 After having established the existence of phenotypically distinct 
subpopulations that contain functional clonogenic osteoprogenitor cells, we next 
sought to determine if transcriptional profiling would provide additional evidence as 
to their biology and/or potentially point to a stromal stem/progenitor cell hierarchy. 
For these experiments, the LinNEGPDGFRα/βPOSCD105POS and 
LinNEGPDGFRα/βPOSCD105NEG stromal cell populations and hematopoietic lineage 
positive cells were prospectively isolated from three independent experiments.  
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Figure 4-10: Time dependent developmental potential of ectopic bone and 
bone marrow formation by subpopulations of BMSCs. The development of bone 
and bone-bone marrow tissue in ectopic sites is dependent on time and number of 
cells. (A & B) Representative images of scaffolds stained with H&E following 6 
weeks post-transplant. (Ai-ii) CD105POS scaffolds demonstrate the formation of bone 
and adipose rich bone marrow by 6 weeks, whereas CD105NEG scaffolds contain 
only bone. By 12 weeks (C&D), both populations form bone and adipose rich bone 
marrow tissue. Boxes indicate regions imaged at 20x magnification. 
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Endothelial cells were removed from the isolation strategy based on the 
CD105brightPDGFRαβNEG immunophenotype previously identified (see Figures 3-7 & 
3-8). Total RNA was extracted from each population and subjected to gene 
expression profiling using the Illumina Sentrix Beadchip Array Mouse WG-6.v2 
arrays. To ensure the purity of each population following isolation, post sort analysis 
was performed for each group and demonstrated purities for CD105POS at 
97.4+1.9% and CD105NEG at 94.1+2.5%.  
 Following hybridization and detection, we compared the genes in common to 
both stromal cell populations that were expressed at least two fold greater with a p-
value <0.01 to the genes expressed in hematopoietic lineage positive cells. From 
this analysis, we identified 1,798 annotated genes that were differentially expressed 
between stromal cells and all hematopoietic cells. As expected, the stromal cell 
populations demonstrated a clear mesenchymal signature in gene ontology analysis 
by DAVID (Table 4-1). A number of surface markers, extracellular matrix molecules 
and signaling pathways characteristic of mesenchymal cells were highly over-
represented within these two populations consistent with known stromal cell biology 
(Table 4-2). Of interest, GO functional annotation analysis yielded an over 
representation of genes involved in signaling pathways (493 genes), secreted 
molecules (226 genes), ECM proteins (86 genes), cell adhesion molecules (108 
genes), skeletal system development (74 genes), blood vessel development (62 
genes), mesenchymal cell development (12 genes), and growth factors (26 genes).  
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Table 4-1: Genes expressed in LinNEGPDGFRαβPOSCD105POS and 105NEG 
populations as compared to all hematopoietic cells by microarray and gene 
ontology analysis 
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Table 4-2: Gene Ontology functional annotation of over-represented gene list 
in stromal cells as compared to hematopoietic cells by DAVID 
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Additionally, PDGFRα and β was highly expressed within the stromal cell fraction 
consistent with the immunophenotype used for their isolation and 8 genes were 
over-represented in the PDGFR signaling pathway. Other genes over-represented at 
the RNA level and validated at the protein level with monoclonal antibodies by FACS 
include VCAM1 and CD51 (Integrin αv) (Figure 4-11 A&B).  
 We then compared the gene expression profiles between the CD105POS and 
CD105NEG populations and looked for genes that differed by greater than 2 fold in 
either group with a p-value<0.01. This approach generated a relatively short list of 
genes that began to delineate potential different biological roles for each population 
in vivo. Of interest, gene ontology analysis of genes over-represented in the 
CD105POS population suggests this population is more closely involved with blood 
vessel development and vasculature stability and would be consistent with at least a 
proportion of the cells with this phenotype exhibiting a perivascular location (Table 4-
3 & 4-4). This transcriptome analysis is also consistent the observations from the 
immunocytochemistry of sorted LinNEGPDGFRα/βPOS cells and the FACS analysis of 
both transgenic mouse lines suggesting that a fraction of the CD105POS cells 
express markers of more mature pericyte/mural cells (Figure 4-6). Of additional 
interest is the high level of expression of TGFβ receptor type II, which has been 
shown to form a complex with endoglin (CD105) in order to bind TGFβ 1 and act as 
a proliferation induced signal [127]. This may potentially also be a mechanism to 
augment TGFβ availability and its reported negative effects on endothelial cell 
proliferation. 
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Figure 4-11: Microarray validation at the protein level with monoclonal 
antibodies. (A) Gene list and average signal detection of RNA for cell surface 
markers identified by microarray analysis. (B) Validation of RNA targets at the 
protein level by flow cytometric analysis with monoclonal antibodies. 
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  The CD105NEG population, however, was enriched for a set of genes involved 
in skeletal development and bone mineralization. Some of the genes over-
represented in the CD105NEG population include markers of immature osteogenic 
cells such Col1a1, osteonectin (SPARC), alkaline phosphatase 2, as well as 
markers of more mature osteoblasts including bone sialoprotein (IBSP), osteocalcin 
(BGLAP) and osteopontin (SPP1). Additionally, the CD105NEG population is enriched 
in cartilage related genes such Col2a1, cartilage oligomeric matrix protein (COMP) 
and chondrocadherin (CHAD) [128 & 129]. These noted differences in transcriptional 
profile together with our data demonstrating decreased proliferation in vitro, 
decreased bone forming potency in vivo and the lack of secondary CFU-F 
generating potential, all point to the CD105NEG population as being enriched in 
progenitor cells more committed to the osteogenic and chondrogenic lineages. As 
well, the higher expression of osteoblast specific genes for extracellular molecules 
suggest that this population is likely located adjacent to the endosteal region and 
trabecular bone regions within the marrow cavity providing cells and ECM proteins 
for the maintenance of general bone tissue turnover (Table 4-3 & 4-5).  
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Table 4-3: Gene Ontology of genes enriched within CD105POS or CD105NEG 
populations. 
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Symbol Gene Name Genband ID p value Fold Change 
     
ANGPTL1 Angiopoietin-like 1 NM_028333.2 1.81623E-05 2.958333333 
DCN Decorin NM_007833.1 0.00604199 2.233201581 
ENG Endoglin (CD105) NM_007932.1 4.84317E-09 9.784090909 
SORT1 Sortilin 1  NM_019972.2 0.007979028 2.016632017 
LRP5 Low density lipoprotein receptor protein 5 NM_008513.1 2.30866E-05 3.607929515 
MEOX1 Mesenchyme hemeobox 1 NM_010791.3 0.002107609 2.215189873 
GPX1 Glutathione peroxidase 1 NM_008160.5 6.90256E-06 2.711608338 
CD248 Endosialin  NM_054042.2 8.87381E-05 8.819672131 
THY1 Thymus cell antigen 1, theta NM_009382.3 0.003093214 18.77852349 
SMO Smoothened homolog NM_176996.3 0.000100612 2.486803519 
IGSF10 Immunoglobulin superfamily, member 10 XM_913941.2 4.62296E-07 2.1046875 
FBLN1 Fibulin 1  NM_010180.1 3.01266E-07 2.57518797 
DLK1 Delta-like 1 homolog NM_010052.4 0.049367371 6.642857143 
TGFBRII Transforming growth factor, beta receptor II NM_009371.2 0.007696796 2.461538462 
LAMA2 Laminin, alpha 2 NM_008481.2 0.001017185 5.918032787 
 
Table 4-4: Lists of genes over-represented in the CD105POS population. 
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Symbol Gene Name Genband ID p value Fold Change 
     
IBSP Integrin binding sialoprotein NM_008318.1 3.07659E-05 2.67 
BGLAP1 Bone gamma carboxyglutamate protein 1  NM_007541.2 0.000176856 5.67 
BGLAP2 Bone gamma-carboxyglutamate protein 2  NM_001032298.2 0.000891292 6.55 
COL1A1 Collagen Type I alpha NM_007742.2 1.3889E-12 2.83 
COL2A1 Collagen Type II alpha NM_031163.2 0.000281482 5.22 
GHR Growth Hormone receptor AK053579 5.8483E-05 2.38 
FOXC1 Forkhead box C1 NM_008592.2 1.26119E-05 2.69 
ACD Adrenocortical dysplasia NM_001012638.1 2.80899E-05 2.03 
COMP Cartilage oligomeric matrix protein  NM_016685.1 1.24222E-20 14.13 
AKP2 Alkaline phosphatase 2 NM_007431.1 9.41673E-06 2.28 
CHAD Chondroadherin NM_007689.4 0.005079723 18.05 
SPARC Secreted acidic cysteine rich glycoprotein NM_009242.3 0.000236805 2.28 
CFD Complement factor D (adipsin) NM_013459.1 0.00465436 3.42 
ITGA10 Integrin, alpha 10  NM_001081053.1 0.002085691 2.31 
SPP1 Secreted phosphoprotein 1  NM_009263.1 0.002306057 2.71 
GNAQ Guanine nucleotide binding protein, alpha q AK085933 1.1452E-05 2.24 
 
Table 4-5: Lists of genes over-represented in the CD105NEG population. 
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4-4: SUMMARY 
 
 These studies describe the identification of two phenotypically distinct 
clonogenic stromal cell populations, based on the cell surface immuno-phenotype of 
LinNEGPDGFRα/βPOSCD105POS and LinNEGPDGFRα/βPOSCD105POS. Interestingly, 
both populations contribute independently to CFU-F and stromal cell cultures in 
whole bone marrow samples. However, following serial passaging WBM adherent 
cultures eventually become homogeneous for CD105 expression. However, when 
each subpopulation is isolated by FACS and cultured separately, no interconversion 
between the two phenotypes in vitro is observed. Studies designed to rationalize the 
discrepancy between these two observations demonstrated that the CD105POS 
population as a whole exhibits a greater proliferative ability and thus out-competes 
the CD105NEG cells. Additionally, it has been previously reported that endoglin 
(CD105) is essential for proliferating endothelial cells. CD105 functions as a TGF-β 
co-receptor by forming a complex with TGF-β receptors type I, II and III. This 
complex binds TGF-β1 and abrogates the growth inhibitory effects of TGF-β1 [127]. 
 Both populations contain stromal stem/progenitor elements that demonstrate 
tri-lineage differentiation capacity (osteogenic, adipogenic and chondrogenic) in vitro 
and in vivo as shown by the formation of histologically proven bone, BM adipocytes 
and hematopoiesis-supportive stroma. Interestingly, within the 
LinNEGPDGFRα/βPOSCD105POS fraction, we identified a subpopulation, which co-
expresses several markers of mature pericyte/mural cells and is enriched in genes 
related to blood vessel development and structure suggesting a perivascular nature 
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and function in situ. In contrast, transcriptome analysis of the CD105NEG population 
revealed a gene expression profile consistent with cells more committed to the 
osteo-chondro lineages suggesting this population represents a source of more 
immediate progenitors in vivo.  
 Together, these data suggest the identification of a stromal stem/progenitor 
cell hierarchy previously unrecognized within adult mouse BM. Based on these data, 
we propose a speculative model for a stromal stem/progenitor cell hierarchy in vivo 
within adult murine BM (Figure 4-12). Although we are not at this time able to 
conclusively prove the validity of this model, our functional assays and 
transcriptional profiling nevertheless suggest that these two populations are enriched 
in progenitor cells with over-lapping and distinct functions in vivo. However, because 
only a rare percentage of the CD105POS cells express either NG2 (4.2%) or αSMA 
(7.1%), this suggests that the majority of CD105POS cells are not mature perictyes, 
which raises an interesting question. Could the CD105POS population contain a 
stromal cell hierarchy with a primitive stromal stem cell  “MSC” population residing 
within the CD105POS fraction, which gives rise to additional subpopulations of cells 
expressing CD105 and/or lacking CD105 expression? If so, perhaps a greater 
biological difference exist between the CD105POS and CD105NEG stromal cell 
fractions in vivo that we are unable to determine with the current protocols. 
  One potential way to prove the existence of this proposed hierarchy would be 
to utilize candidate genes identified in our microarray analysis as a means to identify 
those genes with tightly restricted patterns of expression in either the CD105POS or 
CD105NEG populations and to utilize the promoters for these genes in lineage tracing 
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studies to follow the fate of each population under homeostasis and in injury models 
of bone tissue. These types of studies would also prove useful in identifying the 
original identity and localization in situ of the cells so often identified in vitro as   
CFU-F and MSC.  
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Figure 4-12: A speculative model for a stromal cell hierarchy. A rare 
subpopulation within the CD105 fraction gives rise to CD105POS and CD105NEG 
multi-potent clonogenic progenitors, which generate CFU-F and adherent marrow 
cultures. In vivo, the CD105NEG population is located a further distance away from 
the vasculature along the endosteum and provides committed osteoprogenitors for 
the maintenance of bone specific ECM components. The CD105POS progenitors 
primarily give rise to the reticular stromal network, adipocytes and mature pericytes. 
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CHAPTER 5: 
 
FUNCTIONAL ASSESSMENT OF AN IN VITRO MODEL OF THE 
HEMATOPOIEITC MICROENVIRONMENT 
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5-1: PREFACE 
 
 In Chapter 5, I evaluate the ability of each primary BM stromal subpopulation, 
described and characterized in the previous chapter, to recapitulate the functional 
properties of the hematopoietic microenvironment in vitro by determining their 
capacity, using co-culture assays, to maintain and/or expand long-term repopulating 
mouse HSCs. For these studies, a CD45.1/CD45.2 congenic transplant model was 
utilized to investigate the potential of ex vivo co-cultured mouse HSCs to provide 
long-term multi-lineage blood repopulation in lethally irradiated host. I began these 
studies by first, successfully employing the FACS-based methodology described by 
Kiel, et al. [20] to isolate HSCs from adult mouse bone marrow and demonstrated 
their potency in the F1 chimeric transplant model used for these studies. By using 
this well-validated transplant model along with rigorous long-term primary and 
secondary blood reconstitution assays, a quantitative assessment was conducted to 
determine the capacity of different stromal cell subpopulations to support the 
maintenance and/or numerical expansion of competitive long-term repopulating 
HSCs down to the single cell level. 
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5-2: INTRODUCTION 
  
 Adult stem cells are responsible for the overall tissue demands of the 
organism both during homeostasis and during time of stress and this is particularly 
true for highly regenerative tissues such as the intestine, skin and bone marrow 
[130, 131]. Within the bone marrow of adult mammals, HSCs act through a cellular 
hierarchy and give rise to all of the mature cells within the hematopoietic system. 
HSCs are functionally characterized by their ability to undergo extensive self-
renewal in vivo for the life of an organism and provide serial long-term reconstitution 
of the entire hematopoietic system when transplanted into lethally irradiated mice 
providing evidence of extensive differentiation potential [3, 15]. On a daily basis, the 
hematopoietic system must be prepared to meet the demands of the body included 
during normal homeostasis as well as disease and/or stress induced by infection 
and acute blood loss. Consequently, the hematopoietic system is poised to rapidly 
respond to these external demands and therefore is tightly controlled by the bone 
marrow microenvironment.  
 The balance between self-renewal (generation of self) and differentiation 
(production of daughter cells with progressively less self-renewal potential and more 
mature in function) [41] is a highly coordinated and regulated process, governed by 
both intrinsic (cell-autonomous) and extrinsic (non-autonomous) mechanisms [7] and 
a detailed understanding of these mechanisms stands at the forefront of 
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considerable interest in HSC biology for the purposes of regenerative medicine and 
gene therapy.  
 The advances made by identifying and isolating nearly homogeneous 
populations of HSCs has yielded significant amounts of information regarding cell 
intrinsic regulatory mechanisms controlling stem cell behavior. However because of 
many technical challenges in dealing with bone-bone marrow tissue, the role of 
regulatory molecules governing cell extrinsic behavior has been much slower to 
progress and as a consequence there currently remains a lack of complete 
understanding of this process. The persistence of HSCs throughout adult life is 
contingent upon the permissive microenvironment in which HSCs reside in vivo, 
originally proposed in the niche hypothesis [16]. In the adult mouse, the bone 
marrow is the primary site of hematopoiesis during homeostasis and several reports 
have documented the role of the bone marrow microenvironment in regulating HSC 
behavior as described in Chapter 2 of this dissertation. From these studies, several 
key molecules have been discovered which play essential roles in governing HSCs 
under normal growth conditions. Additionally, there is convincing evidence that the 
hematopoietic microenvironment may also contribute to abnormal conditions such as 
aplastic anemia and cancer and these observations have further driven interest in 
the microenvironment for the purpose of therapeutic targeting under disease 
conditions [132]. 
 One approach taken by many investigators to identify extrinsic regulators of 
HSCs has been through the use of mouse genetics. Several mouse models have 
been generated and have led to the identification of many genetically necessary cell-
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extrinsic factors for maintaining HSCs in vivo [15, 44]. Such molecules include SCF, 
Angiopoietin 1, CXCL12 (SCF-1), osteopontin, and Ca2+ ion. However, while the 
application of mouse genetics as applied to gain- and loss-of-function studies has 
resulted in significant discoveries of these genetically determined factors, there still 
remains a paucity of information and limitations as applied to this approach in 
identifying the specific cells types responsible for generating these regulatory 
molecules in vivo. This disparity can be partially attributed to several distinguishing 
complications in working with bone marrow tissue. To name a few, there is currently 
a lack of cell surface markers suitable for identifying subpopulations of candidate 
niche cells in vivo, few cell specific promoters which could potentially be used to 
drive Cre-recombinase in deleting specific molecules in specific subpopulations of 
stromal cells and the outstanding difficulty of imaging live animals through thick 
cortical bone tissue. 
 A second approach taken by many investigators has been to apply the long-
term bone marrow culture system first reported by Dexter and colleagues [60, 61] as 
a means to interrogate the heterogeneous microenvironment in vitro. As reviewed in 
the previous chapters, the bone marrow microenvironment is comprised of a diverse 
population of hematopoietic macrophage and non-hematopoietic stromal cells. 
Together these cell types comprise a complex three-dimensional scaffold upon 
which cells of hematopoietic origin migrate and receive various cues governing their 
behavior. Interestingly, long-term marrow cultures are largely comprised of adherent 
cells, which mimic the hematopoietic microenvironment in vivo and this culture 
system has yielded significant discoveries regarding extracellular regulatory 
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molecules in addition to the ones identified through a genetic based approach. 
However, although diverse in cell types, this current culture system does not allow a 
prospective analysis of the exact cells responsible for forming these adherent layers 
with HSC supporting behavior. Lastly, as demonstrated by Dexter and others, this 
culture system primarily supports the proliferation of hematopoietic progenitors with 
a progressive loss in HSC function [61].  
 Some of the hematopoietic cytokines which have been elucidated by these 
combined approaches and well-studied in vitro include Il-3, Il-6, SCF, TPO, Flt3-L, Il-
11 [133]. Resulting from these discoveries, many labs have attempted to study the 
role of these factors, alone or in various combinations, by in vitro based suspension 
culture approaches. Although some combinations have been reported to support the 
maintenance of HSCs [62], under these suspension culture conditions, HSC function 
is often rapidly lost and little ex vivo expansion of functional HSCs is observed. 
These studies indicate the need for additional cellular and/or molecular components 
more closely representative of the microenvironment in vivo. Since the initial studies 
conducted by Dexter and colleagues [61] demonstrating the necessary role of the 
adherent bone marrow stroma in maintaining primitive mouse hematopoietic 
progenitor cells, a great amount of interest has been placed on identifying the key 
cellular components within this heterogeneous layer, which provides the greatest 
supportive capacity.  
 Because long-term marrow cultures are performed in the context of a 
heterogeneous mixture of adherent cells, this approach does not lend itself to a 
prospective analysis of the cells responsible for providing either positive or negative 
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HSC regulatory functions. One popular method employed to overcome this limitation 
has been to generate cloned stromal cell lines and test their ability to support 
hematopoietic stem and progenitor cells in vitro. And while some success has been 
garnered using cell lines derived from fetal tissue, such as the fetal liver line 
AFT024, little evidence exists of cells with a similar capacity within the adult BM [63]. 
This raises the question of whether or not the correct cells responsible for supporting 
HSCs in vitro have ever been isolated.  
 Additional complications arising from these studies include the use of high 
concentrations of horse serum and a number of the reported studies use 
heterogeneous populations of hematopoietc cells enriched for stem/progenitor cells, 
but have not been demonstrated at a signle cell resolution to determine the 
proportion of cells that contain true LT-HSC repopulating ability. Taken together, it is 
not clear what combined negative effects these external factors may be contributing 
to the attrition of functional HSCs and the observed lack of HSC expansion. A key 
question still needing to be addressed is the nature and identity of the adult BM 
stromal cell(s) responsible for supporting the maintenance or expansion of HSCs 
both in vivo and in vitro. However, there has been an emergence of experimental 
evidence beginning to point to the stromal stem/progenitor cell as a key cellular 
constituent of the vascular niche. Interestingly, several lines of emerging data are 
resulting in a [134] unified notion that two stem cells not only occupy the same 
microenvironment, but also suggest that one stem/progenitor population, the MSC, 
is directly involved in the extrinsic regulation of the other, the HSC. And although, 
previous studies indicate the existence of two anatomically distinct niches [15, 44], 
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what most of these models leave out are the stromal cell reticulum, which spans the 
entire width and length of long bones. It appears for our own studies and those of 
others that non-hematopoietic stromal elements may provide the critical link in 
defining a unified HSC niche. 
  In the following chapter, we provide direct and indirect evidence that the dual 
properties of stromal stem/progenitor cells (MSC; osteoprogenitors) in generating 
bone and bone marrow tissue also coincides with their role as cellular constituents of 
the bone marrow microenvironmental ‘niche’. Having previously identified distinct 
subpopulations of BMSCs each with stromal stem/progenitor activity in vivo, we also 
demonstrate their ability to support the maintenance of HSCs in vitro by co-culture 
assays and in vivo transplantation studies. Furthermore, data from our transcriptome 
analysis of freshly isolated BMSC populations and analysis of a specific genetic 
mouse model suggests a direct role of these populations in establishing and 
maintaining the hematopoietic stem cell niche in vivo by governing HSC behavior. 
We therefore, hypothesized that the cellular constituents of the vascular niche in vivo 
would provide a discovery platform from which to identify cells with HSC 
maintenance capabilities in vitro and would additionally provide an experimental tool 
from which to identify novel HSC regulatory molecules in future studies.  
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5-3: RESULTS 
 
DISTINCT POPULATIONS OF BMSCs EXPRESS HIGH LEVELS HSC 
REGULATORY MOLECULES IN VIVO 
 Having identified perivascular cells that are LinNEGPDGFRα/βPOSCD105POS 
and direct osteo-progenitor cells (CD105NEG) each with the capacity to transfer the 
hematopoietic microenvironment in vivo using an ectopic transplantation model, we 
postulated that at least a portion of the cells within these two populations represent 
the cellular elements of the vascular/perivascular HSC niche. This notion was further 
supported by our transcriptome analysis of prospectively isolated 
LinNEGPDGFRα/βPOSCD105POS and CD105NEG populations. Based on these 
microarray studies, both populations were shown to express significant levels of a 
number secreted molecules known genetically to be involved in regulating HSCs in 
vivo, consistent with their proposed role as niche cells (Table 5-1). Additionally, both 
populations have high levels of transcripts for extracellular matrix components and 
adhesion molecules (Table 4-1, Chapter 4) that have also been implied as having 
established roles in regulating hematopoiesis within the context of the hematopoietic 
microenvironment [131, 135].  
 Furthermore in collaboration with Dr. Sean Morrison’s lab, we have 
demonstrated that both stromal cell populations, LinNEGPDGFRα/βPOSCD105POS and 
CD105NEG, represent the major cell source for stem cell factor (SCF) in vivo and 
their selective depletion leads to a 50% reduction in functional HSCs in the adult BM   
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[136, and personal communication]. Taken together, these data demonstrate a role 
for the LinNEGPDGFRα/βPOSCD105POS and CD105NEG populations in establishing and 
maintaining the vascular/perivascular niche in vivo, unifying the dual role of the 
stromal stem/progenitor population as both osteoprogenitors and HSC niche 
constituents. Based on these observations, we reasoned that both populations 
would recapitulate, in vitro, the supportive microenvironment function of maintaining 
HSCs and provide a platform from which to identify additional HSC regulatory 
molecules that would permit the ex vivo expansion of functional HSCs.  
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Table 5-1: Hematopoietic stem cell regulatory molecules expressed in vivo by  
LinNEGPDGFRαβPOSCD105POS and LinNEGPDGFRαβPOSCD105NEG populations. 
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ESTABLISHING THE TRANSPLANT MODEL 
 HSCs have been isolated to near homogeneity using a combination of cell 
surface markers referred to as the LSKSLAM immunophenotype (LSKCD48-
CD150+), based on the lack of expression of mature hematopoietic markers (Lin-), 
expression of Sca1 and c-kit (SK), lack of expression of CD48 (CD48-) and 
homogeneous expression of CD150 (CD150+) [20]. Although rigorously 
demonstrated by other labs, our lab had not previously used this specific 
immunophenotype to isolate HSCs so a formal limit dilution analysis of their 
repopulating ability was still lacking. Additionally, we used CD45.2 (C57Bl/6)/ 
CD45.1 (B6.SJL/Ptprc^aPep^3/BoyJ) F1 chimeric mice as a recipient source for 
these transplantation studies so it was essential to determine the repopulating ability 
of SLAM HSCs in these mice and to determine the reproducibility and reliability of 
detection of low numbers of input competitor cells, test cells and support cells for the 
analysis of the co-culture studies. Furthermore, this analysis would provide the 
foundation for determining the number of input cells to be used in our co-culture 
system.  
 To generate F1 chimeric mice, we crossed C57Bl/6 mice, with the CD45.2 
allele (Ly5.2) expressed in all hematopoietic cells, to B6.SJL/Ptprc^aPep^3/BoyJ 
mice which express the CD45.1 allele (Ly5.1) in all hematopoietic cells (Figure 5-1). 
The resulting F1 progeny contain both CD45.1 and CD45.2 alleles in all 
hematopoietic cells representing a double positive population by flow cytometric 
analysis with a combination of CD45.2 and CD45.1 monoclonal antibodies        
  144 
 
 
Figure 5-1: Generation of LT-HSC reconstituting transplantation model. Adult 
male CD45.2 (C57Bl/6) mice were mated to adult female CD45.1                 
(B6.SJL/Ptprc^aPep^3/BoyJ ) mice and the resulting F1 progeny are used as 
recipients for all reconstituting transplantation studies. 
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Figure 5-2: Schematic of F1 Peripheral Blood analysis in WT and following 
lethal irradiation and competitive transplantation. (A) Peripheral blood analysis 
of control F1 chimeric mouse using CD45.1 and CD45.2 monoclonal antibodies. (B) 
Peripheral blood analysis of an F1 mouse under competitive repopulating assay 
conditions. Following lethal irradiation F1 mouse transplanted with 100 HSCs 
isolated from CD45.2 mice along with 300,000 whole bone marrow cells isolated 
from CD45.1 mice.  
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(Figure 5-2 A).  Additionally, this model allows for the monitoring of transplanted 
hematopoietic cells in a direct competitive reconstitution assay, whereby donor cells 
can be competed against an HSC population of know reconstituting ability and also 
allow the determination of reconstitution provided by the recipient (support cells)   
(Figure 5-2 B).  
 To begin these studies, SLAM HSCs (Figure 5-3) were double sorted to 
ensure their purity from CD45.2 mice at 8-10 weeks of age and visually confirmed 
microscopically in terasaki wells to contain the appropriate number(s) of input cells 
(Figure 3-4 A). Next, we transplanted 3, 10, 30 or 100 SLAMHSCs into lethally 
irradiated F1 mice, 8-12 weeks of age along with 300,000 whole bone marrow 
(WBM) cells isolated from CD45.1 mice at 8-10 weeks of age. Hematopoietic 
reconstitution was measured by determining the percentage of donor type (test) cells 
in the peripheral blood at 6, 12 and 20 weeks and within the bone marrow at 20 
weeks. 
 In these experiments, mice receiving 3 SLAM HSCs demonstrated on 
average a 4.25% chimerism of CD45.2 donor HSCs (Figure 5-4 B) in the peripheral 
blood with 25% demonstrating long-term multi-lineage reconstitution. However, all 
mice transplanted with 10 (100%), 30 (100%) or 100 (100%) cells demonstrated 
multi-lineage reconstitution with 64-90% of the hematopoietic cells being donor 
derived out to 20 weeks post-transplant (Figure 5-4 B). Since 10 SLAM HSCs 
reproducibly provided significant levels of donor-derived multi-lineage reconstitution 
at 20 weeks post-transplant (Figure 5-5 A-C, D & E), we reasoned that 10 input  
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Figure 5-3:Gating strategy for the prospective isolation of SLAM HSCs. HSC 
sort gates are set to first determine the appropriate scatter profile and to select for 
single cells by a doublet exclusion gate. Next, viable cells are gated on to remove 
dead cells from the analysis. All viable single cells are the subjected to a 
hematopoietic lineage positive gate to remove mature hematopoietic cells and a 
stem and progenitor gate is used to enrich for HSC by gating on all c-kit & Sca1 
double positive cells. The final gates are set to enrich for a well-validated HSC 
population based on lack of expression for CD48 and positive expression of CD150. 
Finally the LSKCD48-CD150+ cells are resorted to ensure a pure population for LT-
HSC transplantations. 
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Figure 5-4: LSKSLAM cells are highly enriched for LT-HSCs. (A) Microscopic 
validation and enumeration of cells for transplantation. (B) Percentage of donor 
derived CD45.2 cells in peripheral blood at 20 weeks post-transplantation. (C) 
Representative FACS plots of peripheral blood analysis at 20 weeks post-transplant 
demonstrating high levels of donor derived multi-lineage reconstitution (D) with 10, 
30 & 100 freshly isolated HSCs at 20 weeks post-transplantation (n=5 mice per 
group). 
 
 
  149 
 
Figure 5-5: Donor derived multi-lineage blood reconstitution. Multi-lineage 
blood reconstitution was evaluated by flow cytometric analysis and the percentage of 
donor derived T cells (A), B cells (B) and myeloid cells (C) for each mouse was 
plotted for the 20 week post-transplant time point. Representative FACS plots for 
peripheral blood and bone marrow analysis demonstrating donor derived 
hematopoietic cells (D) and multi-lineage reconstitution (E) from 10 freshly isolated 
CD45.2 HSCs. 
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 Table 5-2: Global reconstitution of SLAM HSCs cells per input dose. 
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SLAM HSCs would be sufficient as the input dose for our initial series of co-culture 
studies.  
EVALUATION OF LT-HSC SUPPORTING ACTIVITY 
 We next set out to compare the ability of the CD105POS and CD105NEG 
populations to support long-term multi-lineage reconstituting HSCs in vitro by co-
culture assays. For these experiments, LinNEGPDGFRα/βPOSCD105POS and 
LinNEGPDGFRα/βPOSCD105NEG BM stromal stem/progenitor populations were 
isolated from F1 chimeric mice and allowed to reach confluence in 48 well plates 
coated with fibronectin. Approximately 5-7 days after isolation and plating in normal 
growth media, SLAM HSCs were double sorted from B6.SJL/Ptprc^aPep^3/BoyJ 
(CD45.1) mice (Figure 5-6 A) and 10 HSCs were visually counted (Figure 5-6 B) and 
added to each well containing a confluent layer of BM stromal stem/progenitor cells 
(Figure 5-6 C) in Stem Span serum free expansion media supplemented with a 
combination of the following cytokines each at 1/10th the optimal concentration: IL-6 
(10ng/ml), SCF, TPO and Flt3L (each at 5ng/ml).  As a control, 10 HSCs were 
added to wells coated with fibronectin, which did not contain any stromal layers in 
the presence of the 0.1X concentration of cytokines (Figure 5-6 C, top panel). 
Previous studies in our lab had determined that at a 0.1x cytokine concentration 
HSCs do not proliferate and most die. Therefore, this concentration would allow us 
to examine the direct contribution to HSC survival and expansion provided by the 
stromal layers.  
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Figure 5-6: Schematic of SLAM HSC isolation and co-cultures. (A) 
Representative FACS plots showing the gating strategy to double sort SLAM HSCs. 
(B) Microscopic image of a single terasaki well confirming an accurate count of 
HSCs. (C & D) Schematic drawing of co-culture conditions and images depicting the 
mouse model used as transplant recipients.  
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 The co-cultures were left undisturbed and maintained at 5%CO2, 5%O2 at 
37°C for a total of 10 days. 10 days after the initial seeding of wells with SLAM 
HSCs, we observed a significant increase in hematopoiesis in the wells containing 
either CD105POS (Figure 5-7, middle panel) or CD105NEG (Figure 5-7, right panel) 
stromal layers, however we could not detect any increase in hematopoietic cells in 
the control stromal-free wells under these culture conditions (Figure 5-7, left panel). 
Following the 10 days in culture, the entire contents of each well was collected with 
trypsin and placed into separate tubes on ice in PBS. Additionally, 300,000 WBM 
cells from F1 mice were added to each co-culture cell suspension. The entire 
contents of each tube was then transplanted into the retro-orbital sinus of lethally 
irradiated 8-12 week C57Bl/6-B6.SJL/Ptprc^aPep^3/BoyJ (CD45.1/CD45.2) F1 
chimeric mice.  
 Peripheral blood analysis from two independent experiments was evaluated 
for donor-derived reconstitution at 6, 12 and 16-18 weeks. Additionally, bone marrow 
was collected at the time of sacrifice and 1 million WBM cells were serially 
transplanted into lethally irradiated F1 secondary recipient mice from each 
experiment that contained multi-lineage reconstitution in the primary transplant 
recipients in order to assess in vivo self-renewal potential. In this experimental 
setting, all mice transplanted with the progeny of 10 HSCs from either CD105POS 
(100%) or CD105NEG (100%) stromal cell co-cultures demonstrated robust multi-
lineage reconstitution in primary (Figure 5-8) and secondary recipients (Figure 5-9).   
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Figure 5-7: Robust hematopoiesis in adult BM stromal-HSC cocultures. 
Representative images of robust hematopoietic activity from 10 input HSCs at day 
10 of cocultures with CD105POS and CD105NEG adherent stromal layers. HSCs 
cultured in suspension without stromal layers do not expand and most undergo rapid 
attrition and cell death. 
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 However, we could not detect any donor-derived reconstitution from 
suspension cultures (Figure 5-8 A&B). On average, the progeny of 10 HSCs co-
cultured with CD105POS BMSC gave rise to 65+23.6% donor derived CD45.1 cells in 
the peripheral blood while the progeny of 10 HSCs co-cultured on CD105NEG BMSCs 
provided 49.3+19.5% donor derived CD45.1 cells in primary transplant recipients 
(Figure 5-8 A&B). Although the CD105NEG population demonstrated slightly lower 
levels of blood reconstitution, the difference was not statistically significant. 
Successfully reconstituted primary recipients from CD105POS and CD105NEG BMSC 
co-cultures were able to reconstitute secondary recipients with 100% efficiency 
generating, 56.5+29.4% and 40.15+24.1% donor derived CD45.1, respectively 
(Figure 5-9 A&B). Furthermore, transplanted HSCs derived from CD105POS or 
CD105NEG co-cultures (10 input HSCs) were able to out-compete the 300,000 WBM 
cells (approximately 18 HSCs) demonstrating that both BM stromal cell populations 
maintain functional HSCs ex vivo.  
 
 
 
 
 
 
 
  156 
Figure 5-8: Maintenance of transplantable LT-HSCs is dependent on CD105POS 
and CD105NEG BMSCs. (A) Long-term multilineage reconstitution from 10 SLAM 
HSCs co-cultured on CD105POS and CD105NEG BMSCs. (B) Representative FACS 
plots from peripheral blood analysis at 18 weeks pot-transplant. 
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Figure 5-9: SLAM HSCs co-cultured on CD105POS and CD105NEG BMSCs 
demonstrate robust ability to undergo self-renewal in vivo. (A) Long-term 
multilineage reconstitution in secondary recipients provided by 10 SLAM HSCs co-
cultured on CD105POS and CD105NEG BMSCs. (B) Representative FACS plots from 
peripheral blood analysis at 18 weeks pot-transplant. 
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PRIMARY CD105POS BMSCs SUPPORT HSC EXPANSION EX VIVO 
 In order to begin addressing the question of whether or not either population 
supported the expansion of HSCs ex vivo, we conducted a series of additional 
transplantation experiments using either limiting numbers of the progeny cells 
derived from the HSC co-cultures or by initiating the co-cultures with a single SLAM 
HSC.  We first conducted a preliminary experiment to evaluate the potential 
numerical expansion of co-cultured HSCs based on a limit dilution analysis of 10 
input HSCs. For this experiment, 10 freshly isolated HSCs from CD45.1 mice were 
placed into co-cultures for 10 days under the identical conditions detailed above and 
transplantation assays were based on a limiting dilution of the cultured progeny. 
Following the 10 day co-culture period, lethally irradiated F1 mice were transplanted 
with either the total progeny from 10 input B6.SJL/Ptprc^aPep^3/BoyJ (CD45.1) 
HSCs, 1/2 the input progeny (5 cell equivalents), 1/3 the input progeny (3 cell 
equivalents) or 1/10th the input progeny (1 cell equivalent). Additionally, freshly 
isolated SLAM HSCs were double sorted from C57BL/6 (CD45.2) mice and 10 
(CD45.2) HSCs along with 300,000 WBM cells from F1 mice were added to each co-
culture cell suspension dilution. Based on the design of our transplant model, we 
were able to track in vivo the respective multilineage differentiation potential of each 
population (Figure 5-2 B) and to determine the ability of cultured HSCs to compete 
against prospectively isolated HSCs in vivo.  
 In this experimental design, the product of 10 HSCs from CD105POS co-
cultures outcompeted the 10 freshly isolated HSCs by more than 5/1-10/1 ratios 
providing on average 74.4% of the total hematopoietic content as compared to 6.3%  
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Figure 5-10: Competitive repopulation between co-cultured HSCs and freshly 
isolated HSCs. (A) FACS plots demonstrating a competitive advantage of 
CD105POS  BMSC co-cultured HSCs over freshly isolated HSCs, while CD105NEG 
BMSC co-cultured HSCs demonstrate equal potency to freshly isolated HSC in 
head-to-head competitive transplant setting. (B) Total blood reconstitution from mice 
transplanted with various cell equivalent doses of co-cultured progeny at 6, 12 and 
20 weeks post-transplant. (C) 1 SLAM HSC equivalent from CD105POS BMSC co-
culture demonstrates long-term multi-lineage blood reconstitution. 
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blood reconstitution derived from the freshly isolated CD45.2 HSCs (Figure 5-10 A, 
left panel). However, blood reconstitution levels were nearly identical between the 
progeny of 10 CD105NEG co-cultured HSCs (41.9%) as compared to 10 freshly 
isolated HSCs (32.8%) in the same mouse (Figure 5-10 A, right panel). In the mice 
transplanted with the product 5, 3 or 1 cell equivalents we did not observe a 
significant difference in total blood reconstitution (Figure 5-10 B), however, we did 
observe a significant difference in the level of multilineage reconstitution between 
the two groups at each of these cell doses. Specifically, with each cell dilution from 
CD105NEG co-culture we observed a significant decrease in cells of the myeloid 
lineage and at the 1 cell equivalent dose the CD45.1 donor cells were completely of 
the lymphoid lineage (Figure 5-10 C) suggesting that as HSCs divide in co-cultures 
with CD105NEG BMSCs the cells become biased towards the lymphoid lineage. 
 However, mice transplanted with each dilution of the progeny from the 
CD105POS co-culture all demonstrated multi-lineage engraftment out to 20 weeks 
post-transplant including those transplanted at the 1 cell equivalent dose          
(Figure 5-10 C). Perhaps more importantly, multiple mice demonstrated long-term 
multi-lineage engraftment at 20 weeks at the 1 cell equivalent dose from the 
CD105POS co-culture as compared to only 1 mouse surviving from the CD105NEG co-
culture at 1 cell equivalent dose. Collectively, these data suggest that the 10 input 
HSCs (CD45.1) from the CD105POS co-cultures under went expansion ex vivo, while 
HSCs from the CD105NEG co-culture did not expand but rather some were 
maintained as functional stem cells in culture. Although, mice transplanted with 
limiting numbers of CD105POS co-cultured HSCs did provide long-term reconstitution, 
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the lower numbers of input co-cultured progeny failed to outcompete the 10 freshly 
isolated C57Bl/6 (CD45.2) HSCs (Figure 5-10 C) suggesting that the level of 
expansion was not at a 10 cell equivalent dose.   
  To better address the prospect of HSC expansion, we set up a series of 
experiments to ask the question if a single co-cultured HSC could reconstitute 
lethally irradiated mice in a competitive transplantation assay. For these studies, a 
single double sorted B6.SJL/Ptprc^aPep^3/BoyJ (CD45.1) HSC was placed into 
culture wells containing confluent layers of either LinNEGPDGFRa/bPOSCD105POS or 
CD105NEG BMSC population (Figure 5-11). Following 10 days of culture, each well 
was transplanted into lethally irradiated F1 Chimeric mice that initially contained a 
single HSC. As shown in 5-12 A, co-cultures from the CD105POS group contained 
more hematopoietic progeny and when transplanted these cultures demonstrated 
significantly greater ability to provide long-term multi-lineage blood reconstitution in 7 
of 8 mice with an average level of CD45.1 reconstitution of 50.6+26.9% (Figure 5-12 
B &C, Figure 5-13 A-C). The CD105NEG co-cultures generated on average 
23.3+26.1% donor derived engraftment with only 4 of 8 mice surviving and showing 
donor derived reconstitution (Figure 5-12 B & C, Figure 5-13 A-C).  
 In this same set of transplantation studies, we also transplanted the progeny 
of a single co-cultured HSC into 10 mice to assess the level of HSC expansion from 
the single initiating HSC. Of note, 5 out of the 10 mice transplanted with the progeny 
of a single HSC co-cultured with CD105POS BMSCs demonstrated long-term 
observable levels of blood reconstitution (Table 5-3). However, levels of multi-
lineage repopulation were not equally distributed across mice and consisted of a 
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larger proportion of lymphoid reconstitution with some mice containing only low 
levels of myeloid reconstitution. These data suggest that HSCs can expand at a 
clonal level in vitro when cultured on CD105POS BSMCs. In agreement with our 
previous transplantation studies, none (0 of 10) of the mice from the single HSC 
CD105NEG co-culture showed any level of reconstitution (Table 5-3). Although, these 
results indicate a significant difference in the ability of the CD105POS BSMC 
population to maintain and expand transplantable HSCs at a clonal level compared 
to the CD105NEG population, more work is needed to formally quantitate this 
difference at the clonal level in primary and secondary recipients. By transplanting 
multiple mice with a variety of cell doses from clonally derived co-cultured HSCs one 
could determine by Poisson statistics the level of functional LT-HSC expansion. 
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Figure 5-11: Schematic of single HSC co-culture assays. SLAM HSCs were 
double sorted as shown previously and microscopically counted. Wells containing a 
single HSC were transferred to BMSCs co-cultures for 10 days and transplanted into 
a single lethally irradiate mouse or a single well was split into 10 mice. 
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Figure 5-12: CD105POS BMSCs support the expansion of single SLAM HSCs in 
long-term competitive transplantation assays. (A) Images of co-cultures derived 
from a single HSC at the time of transplantation. (B) Donor derived blood 
reconstitution at 6 and 16 weeks post-transplant from a single co-cultured HSC. (C) 
Representative FACS plots of peripheral blood analysis demonstrating multi-lineage 
reconstitution by single co-cultured HSC.  
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Figure 5-13: Long-term multi-lineage repopulation derived from clonal HSC co-
cultures with BMSC subpopulations. Peripheral blood reconstitution from donor 
derived T cells (A), B cells (B) and myeloid cells (C). Data represent mean + Std. 
Dev. (D) Schematic diagram demonstrating increased ex vivo expansion of clonal 
HSCs in CD105POS BMSC co-cultures. 
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Table 5-3: Reconstitution by clonally expanded HSC in to multiple mice. 
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5-4: SUMMARY 
  
 Taken together, these co-culture transplantation studies provide evidence for 
different roles in the CD105POS and CD105NEG BMSC populations in vitro. While both 
populations demonstrate the ability to support the maintenance of HSCs at a 10 cell 
input dose, only the CD105POS population was able to demonstrate any observable 
level of expansion of repopulating HSCs. These findings provide insight into 
potential different functional roles in vivo as well. It is possible that HSCs migrate 
away from the vascular niche and lose contact with the CD105POS perivascular niche 
cells, where they either enter into cell cycle and/or begin to differentiate along the 
long cellular processes of the intravascular CD105POS/NEG stromal reticulum, in 
accord with the model proposed by Nagasawa et al [25]. There is experimental 
evidence for this model in regards to B cell development [137]. Additionally, it is 
possible that HSCs closely associated with the CD105NEG osteo-progenitor cells 
along the endosteal region are exposed to qualitatively different growth factors that 
maintain HSCs in a more quiescent/dormant state [29 & 67-71]. Invoking such a 
model also implies perhaps a direct role for the involvement of the sinusoidal 
endothelial cells not only in governing HSC behavior, but perhaps more importantly 
a role in governing the behavior of the perivascular niche cells, which may support 
self-renewal divisions of HSCs localized to the vascular niche.  
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 In this dissertation, I have made progress towards addressing two key 
outstanding questions in the field of bone marrow stromal cell biology. First, I have 
presented experimental evidence of a robust reproducible methodology that 
simultaneously yields the non-hematopoietic clonogenic stromal population as well 
as the vascular fraction from adult murine bone marrow. This methodology has in 
turn enabled studies that have led to the in vivo identification and prospective 
isolation of distinct populations of BMSCs that each fulfill the criteria for defining 
‘stromal/mesenchymal stem cells’ based on the gold standard assay of in vivo 
heterotypic bone formation. Additional data provide evidence in support of the 
hypothesis that the two stromal cell subpopulations represent a stromal cell 
hierarchy in vivo. Furthermore, these studies have also provided evidence in support 
of the existence of a perivascular/reticular niche for HSCs, a transcriptional profile 
consistent with the role of these stromal cells as candidate HSC niche cells in vivo 
and in addition have resulted in the identification of a subpopulation of BMSCs that 
support transplantable HSCs in vitro.  
 The bone marrow has garnered considerable interest of many investigators 
from the perspective of basic science as well as regenerative medicine and stem cell 
based therapies. This interest can largely be derived from the observation that the 
bone marrow represents a rarely unique organ in that it is the residence of two 
widely studied adult stem cell populations, one is of hematopoietic origin 
(hematopoietic stem cells) and has been demonstrated at the single cell level to 
generate the entire hematopoietic system [20]. The other stem/progenitor population 
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is of a non-hematopoietic stromal origin, commonly referred to as stromal or 
mesenchymal stem cells (MSC) and by virtue of function as an osteoprogenitor has 
the proposed role of contributing bone physiology [120, 134]. The unique feature of 
the bone marrow’s system of dual stem cell components, which interact on a 
functional level, raises many promising opportunities for discoveries in the regulation 
of HSCs and bone biology in both normal and disease conditions [7,91, 132].  
 HSCs represent one of the most well characterized adult mammalian stem 
cell populations studied to date [1] while the canonical properties of MSCs, in 
contrast, have proven to be much more elusive. Progress in exploring the identity 
and physiological role of MSCs in the mouse model has been considerably 
hampered by the paucity of knowledge regarding cell surface markers suitable for 
both in situ identification and prospective isolation of these stromal stem/progenitors 
[27] and arguably, also by the inadequate methodologies that have been used to 
obtain MSC from bone marrow. This is in dramatic contrast to progress in the 
identification and purification of murine HSC using monoclonal antibodies to cell 
surface markers where it is now routinely possible to isolate HSC at near unity as 
demonstrated by complete regeneration of the entire hematopoietic system following 
transplantation of a single prospectively isolated HSC [20]. However, the derivation 
of MSC from the BM of mice continues to represent a particular challenge to those 
investigators who seek to exploit the power of mouse genetic models to answer 
questions regarding the basic biology of MSC or who wish to conduct preclinical 
studies in the mouse as a means to test newly developed MSC-based cellular 
therapies.  
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 A large focus of this dissertation was centered around addressing one of the 
major factors contributing to the difficulty in establishing homogeneous cultures of 
murine BM stromal cells, namely the low incidence of CFU-F in the BM which varies 
between 0.3 – 2 CFU-F/ million BM cells (C57Bl/6) up to approximately 3 CFU-F per 
million (BALB/c) across various mouse strains [97, 102, 109]. In accord with these 
data, in the current study C57Bl/6 BM prepared by standard flushing methods used 
in a majority of laboratories and assayed under the conditions described in these 
previous reports contains 0.22-2.33 CFU-F per million cells. However, when BM 
cells were isolated using the alternate protocol described in this dissertation, the 
frequency of CFU-F was increased to approximately 380 CFU-F per million 
mononuclear cells based on limit dilution analysis.  
 This dramatic improvement in the incidence and recovery of CFU-F was a 
consequence of several methodological improvements, the first and most significant 
being the means by which BM cell suspensions were prepared prior to CFU-F 
assay. We demonstrate that the generation of plugs of marrow with a preserved 
microvasculature followed by sequential enzymatic disaggregation of the plugs, 
consistently yielded CFU-F numbers at least 2 orders of magnitude greater than 
those obtained by the standard flushing technique. It will be noted that this approach 
is somewhat analogous to that used to isolate MSC from adipose tissue in which 
enzymatic digestion of the stromal vascular fraction is required to release MSC from 
their association with blood vessels [142]. The importance of the means by which 
BM is rendered into a single cell suspension on the recovery of CFU-F was also 
recognized by Friedenstein and colleagues [109] who reported enhanced CFE when 
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BM was prepared by mechanical dissociation followed by trypsin digestion of 
remaining clumps.   
 Also contributing to the improved recovery of CFU-F in presented here is the 
establishment of the assays at low oxygen tension. CFU-F cultures initiated at 5% 
O2 demonstrated a 30-fold increase in CFE compared to those established under 
normoxia, findings in keeping with previous studies [144]. Aside from their 
perivascular location, [22, 23, 115] little is currently known about the molecular 
composition of the niche occupied by CFU-F in the BM in vivo, but these findings 
would suggest that stromal progenitors, like hematopoietic stem cells, [145] occupy 
a hypoxic microenvironment. It should also be noted that the high plating efficiency 
of CFU-F demonstrated in these studies is occurring in the absence of exogenous 
mitogenic growth factors such as FGF2 or feeder cells as shown in previous reports 
[97, 108, 109] to be necessary for optimal CFE of CFU-F from mouse BM. Our data 
in no way exclude a role for accessory cells and their products in promoting the 
growth of CFU-F and it will be of interest to determine if the CFE reported here can 
be further improved following addition of feeder cells and/or growth factors and 
moreover, to define the requirements of CFU-F isolated using the new methodology 
for growth in serum-free conditions.  
 Growth of the DBM cells at high cell density resulted in adherent cell layers 
containing both stromal cells and vascular endothelial cells, in addition to 
hematopoietic cells, thereby demonstrating the ability of this new methodology to 
facilitate isolation of the BM stromal-vascular fraction. From these primary cultures 
we successfully isolated by FACS, vascular endothelial cells and were able to 
  176 
serially passage these cells in vitro as a largely homogeneously pure population. To 
our knowledge, this represents the first report demonstrating successful isolation 
and propagation of vascular endothelial cells from mouse BM and we anticipate this 
finding will significantly advance studies of these relatively poorly characterized cells.  
 In the same primary cultures, LinNEG/PDGFRα/βPOS cells were shown to 
comprise approximately 30% of adherent cells and upon FACS, generated cultures 
of polygonal fibroblast like cells which expressed a range of cell surface markers 
previously ascribed [27, 103, 104, 110] to murine BM-derived MSC, demonstrated 
robust multi-lineage differentiation in vitro and gave rise to bone ossicles containing 
bone marrow following ectopic transplantation. From the femora and tibiae of 5 mice 
prepared using the new methodology, we typically isolate by FACS between 1 – 2 
million stromal cells at P0 and up to 20 million by P3 over a 3 week time period. This 
compares with less than 1 million cells generated using the standard flush 
methodology at P3, which often times are still contaminated with hematopoietic cells. 
Such cultures were difficult to passage beyond P3 in contrast to those cultures 
initiated from DBM, likely a consequence of senescence due to exhaustion of the 
proliferative capacity of the markedly lower numbers of CFU-F recovered in flushed 
BM.  
 Further to these differences in cell generative potential, flow cytometric 
analysis of LinNEG/PDGFRα/βPOS cells prepared from flushed and DBM-derived 
cultures also revealed phenotypic differences. MSC derived from flushed BM 
exhibited high levels of Sca-1 and abundant expression of Thy-1 on the majority of 
cells as described previously whereas DBM-derived cells demonstrated 10-fold 
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lower levels of Sca-1 and low level Thy-1 on only 25% of the population. In addition, 
CD105 demonstrated bimodal expression on DBM MSC with distinct CD105POS and 
CD105LOW/- populations in contrast to the flushed BM MSC in which only the 
CD105POS population was evident. Although the significance of this observation was 
initially unclear, it was noteworthy that in freshly prepared DBM, the 
LinNEG/PDGFRα/βPOS population also exhibits the same bimodal expression of 
CD105 (see Figure 3-9). Our initial interpretation of this finding was that while DBM 
allows isolation of both subpopulations of BMSCs, BM prepared by the standard 
flushing technique may bias toward the CD105POS subpopulation perhaps as a 
consequence of their selective survival during BM isolation or preferential outgrowth 
in vitro, both of which became a question we sought to address. Further studies to 
explore the disparity in cell populations elicited by the two BM cell isolation 
methodologies were addressed in Chapter 4 of this Dissertation.  
 An important advance described in the current studies was the successful 
prospective isolation of CFU-F from BM of adult wild-type mice. Previous reports 
used either murine fetal bone [123] or were reliant on transgenic mice strains 
expressing specific reporters [23, 24]. Initially, by focusing on the 
LinNEG/PDGFRα/βPOS stromal cell population as a whole, we were able to show that 
all of the CFU-F activity in both C57Bl/6 and BALB/c mice was derived using this 
immunophenotype and the increased frequency of this population in BALB/c mice 
correlating with a significant increase in CFU-F incidence in this strain, in agreement 
with previous studies [102]. These data highlight the utility of this methodology and 
suggest its broad applicability to the isolation and quantitation of stromal progenitors 
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across different strains of inbred mice. Finally, in accord with our hypothesis that the 
low yield of MSC achieved by flushing of BM reflects the loss of these cells 
associated with the marrow vasculature, whole mount staining of BM plugs 
demonstrated LinNEG/PDGFRα/βPOS cells both in perivascular locations and as a 
network of stromal cells in inter-sinusoidal regions of the BM (see Figures 3-10, 3-11 
& 3-12).  
The notion that a single stromal stem/progenitor population is responsible for 
CFU-F activity within the bone marrow is a widely disseminated concept within the 
field of MSC biology. However, in this dissertation we provide direct evidence 
challenging this notion. With the development of the novel isolation and imagining 
strategies described in this dissertation and the identification of cell surface markers 
useful for in situ localization, we choose to further elucidate the physiological 
relevance of the bimodal distribution with respect to CD105 expression within 
primary adherent cultures as well as within freshly prepared DBM cell suspensions. 
To this end, we provided evidence that two phenotypically distinct populations within 
the adult murine BM both contribute to CFU-F activity as well as to the initiation of 
long-term MSC cultures (Figure 4-1 & 4-2).  
Although these two populations contributed to the generation of adherent 
stromal cell cultures at clonal and non-clonal plating densities at nearly equal 
frequency, the LinNEGPDGFRαβPOSCD105POS population represented a significantly 
greater number of total cells in freshly prepared tissue and in whole bone marrow 
cultures upon serially passaging. Additionally, the CD105POS population contains a 
significantly greater number of CFU-F when prospectively isolated from fresh BM 
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tissue. The question then becomes, why? Is there a functional and/or physiological 
difference in the activity of these two populations that might explain the difference in 
frequency?  
 To address these questions, we used a series of in vitro and vivo assays 
coupled with transcriptional profiling of prospectively isolated subpopulations to 
explore differences between the properties of these two stromal cell subpopulations. 
With the development of an isolation strategy to prospectively isolate BMSC 
subpopulations, we were in a unique position to address fundamental questions in 
the MSC field. In particularly, where are MSC located in vivo and what are their 
physiological functions. Unfortunately, the large body of data in the MSC field, 
especially regarding murine MSC, is based on what amounts to a retrospective 
analysis and characterization of ‘MSC’ performed following extensive serial 
propagation in vitro [27, 103, 104, 110]. Because, culture conditions are substantially 
different from the native in vivo environment, it is likely that these analyses will be 
significantly biased as a consequence of studying the properties of stromal 
stem/progenitor populations maintained under non-physiological conditions ex vivo. 
By defining a composite cell surface immunophenotype that demonstrates fidelity in 
vitro (Figure 3-9) and in vivo (Figure 4-1 & 4-2), these studies have provided 
evidence that the non-hematopoietic stromal elements in bone marrow are not 
entirely representative of the homogeneous populations most often studied and 
characterized in long-term cultures.  
 In addition to the isolation of distinct clonogenic (CFU-F) populations, we 
describe the existence of two BMSC populations that contribute independently to the 
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generation of ectopic bone complete with BM adipocytes and hematopoietic-
supportive stroma defining each population as having with stem/progenitor activity. 
Additionally, our transplantation data suggests that there is a difference in both the 
potency and kinetics ascribed to heterotopic bone ossicle formation by each of these 
populations. The stromal cell subpopulation identified as the 
LinNEGPDGFRα/βPOSCD105POS fraction is able to generate bone-bone marrow tissue 
at a faster rate in vivo with fewer cells than that determined within the 
LinNEGPDGFRα/βPOSCD105NEG fraction. Additionally we demonstrate that when 
recovered from ectopic bone tissue, the LinNEGPDGFRα/βPOSCD105POS fraction also 
gives rise to cells identified as CD105LOW/NEG suggesting that CD105NEG cells are a 
derivative of LinNEGPDGFRα/βPOSCD105POS cells. Furthermore, we provide evidence 
that mature pericytes/mural cells are also a subpopulation of the larger CD105POS 
population.  Does this data point to a potential model of a stromal stem progenitor 
hierarchy? 
 Evidence in support of this notion was derived from transcriptional profiling of 
prospectively isolated LinNEGPDGFRα/βPOSCD105POS and 
LinNEGPDGFRα/βPOSCD105NEG populations. Our microarray data demonstrates that 
the CD105NEG population contains a list of over-represented genes classically 
identified in skeletal development and bone mineral biogenesis, including markers 
such as Col1a1, osteonectin and alkaline phosphatase which are thought to be 
contained in immature osteogenic populations. The CD105NEG fraction also 
expressed genes at the RNA level consistent with cells of a more mature osteoblast 
nature, including bone sialoprotein, osteocalcin and osteopontin [22, 121]. 
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Additionally, the CD105NEG population is also enriched in cartilage related genes 
such Col2a1, cartilage oligomeric matrix protein and chondrocadherin (CHAD) [128, 
129]. Together, these data suggest that the CD105NEG population represents cells 
more committed to the osteogenic and chondrogenic lineages and thus are 
positioned further downstream of a stromal stem cell that may also give rise to cells 
of more mature pericyte function as well.  
 Emerging evidence from lineage tracing studies suggest that there are 
perivascular cells within adult mouse bone marrow developmentally derived from 
two distinct embryological origins, the mesoderm [121] and neural crest [122]. 
However, these authors do not address whether or not the labeled cells seen in 
these models are the same cells routinely used and characterized as MSC from 
adult BM tissue. So the question from these studies remains open as to whether or 
not adult BM stem/progenitor stromal populations are derived from different 
development lineages. Our data suggests that the population often characterized in 
the literature as being CD105POS in culture is of the same mesodermally derived 
source as the CD105NEG progenitor population. From these findings, we speculate 
that the CD105POS population contains a rare population of immature 
stem/progenitor cells which gives rise to the cells of a mature pericyte function [125] 
as well as cells of the CD105NEG population which serve as more direct 
osteoprogenitor cells closely aligned with the endosteal region, growth plate and 
potentially bone trabeculae serving as the major reservoir of committed cells 
providing bone and cartilage specific ECM proteins potentially contributing to the 
overall maintenance of bone tissue turnover.  
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 Together, these data suggest the identification of a stromal stem/progenitor 
cell hierarchy previously proposed [86], yet largely unrecognized within the BM 
stromal cell field. Based on these data, we propose a speculative model describing a 
stromal stem/progenitor cell hierarchy in vivo within adult murine BM (Figure 4-12). 
Although we are not at this time able to conclusively validate this model, our 
functional assays and transcriptional profiling data suggest that these two 
populations are enriched in clonogenic progenitor cells with over-lapping and distinct 
functions in vivo. Additionally, similar evidence has been provided in fetal derived 
bone tissue [123]. It will be of great interest to the field of MSC biology as well as 
studies focused on defining the formation and maintenance of HSC niches to 
determine how these two populations interact to form distinct microenvironments 
with perhaps different biological functions in vivo.  
  One potential way to provide additional experimental evidence for this 
proposed hierarchy would be to utilize genes identified in our microarray studies that 
are differentially expressed and conduct extensive lineage tracing studies to follow 
the fate of each population under homeostasis in the embryo and the adult as well 
as in injury models of bone tissue in the adult. If this model is correct and the 
CD105NEG population represents a more committed progenitor downstream of the 
CD105POS stem/progenitor population, then we would not expect to see any 
contribution to the CD105POS population from labeled cells derived from transgenic 
mice expressing Cre-recombinase under the control of promoters identified from our 
microarray studies of over-represented genes in the CD105NEG population similar to 
studies conducted using the Col1A1 promoter described by Maes et al. [121]. It 
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would be of great interest to use this strategy to identify the source of cells that not 
only form the bone marrow stromal tissue during development, but more importantly 
those cells that serve as the endogenous source of adult stromal stem cells. Are 
they truly perivascular cells as suggested and if so do they have their own unique 
microenvironment contributing to self-renewal? These types of studies would also 
prove useful in identifying the original identity and localization in situ of the cells so 
often identified in vitro as CFU-F and MSC. 
 Within the adult BM, functional HSC activity is maintained through interactions 
with stem cell niches. Two current models suggest the existence of distinct HSC 
niches, one proposed niche involves osteoblast cells closely associated with the 
internal surface of the bone, referred to as the endosteal niche [18, 19, 29, & 69]. 
While subsequent studies have identified a vascular/perivascular niche comprised of 
sinusoidal endothelial cells and perivascular stromal cells [20-26]. And with the use 
of mouse genetics several key regulatory molecules have been identified as being 
necessary to maintain functional HSCs in vivo [14-15 &44]. However, it is currently 
not known which cell types are the primary sources responsible for generating these 
regulatory molecules in vivo. Currently, it is the interest of many laboratories to 
dissect specific regulatory networks, which govern HSC behavior in an extrinsic 
mechanism and to identify the primary cells contributing to this direct extrinsic 
regulation. In Chapter 5 of this dissertation, we begin to elucidate to identity of 
stromal cell subpopulations, which are the major source of genetically necessary 
HSC regulatory molecules and contribute to the maintenance and expansion of 
HSCs ex vivo.  
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 To this end, I describe a well-validated transplantation model to tract in vivo 
the blood reconstitution derived from co-cultured HSCs, which are directly competed 
against freshly isolated HSCs. From these studies, we demonstrate that two BMSC 
populations are able to maintain functional HSCs in culture; however only the 
CD105POS BMSC population demonstrated the ability to significantly outcompete 
freshly isolated HSCs. Furthermore, I developed a co-culture system that allows for 
the study of the expansion of functional clonally derived HSCs. In these 
experiments, CD105POS co-cultured HSCs (100%) demonstrated a significant 
increase in donor derived multi-lineage reconstitution, while only 4 of 8 mice (50%) 
from CD105NEG -single HSC co-cultures demonstrated blood reconstitution, 
suggesting a more limited expansion of functional stem cells. Taken together, these 
results demonstrate that the PDGFRαβCD105POS stromal cell subpopulation is 
distinguished by a unique capacity to support the expansion of long-term 
reconstituting HSCs in vitro.  
  In this experimental setting, it is possible to determine the fate of 
individual stem cells in a well-validated transplant model. Furthermore, single cell 
qPCR and microarray analysis could be applied to gain a better understanding of the 
extrinsic regulation governing these differences in HSC behavior. When done in 
combination with lineage tracing studies of the candidate niche cells, it could, for the 
first time, be a method to identify different microenvironments in vivo with different 
functional roles. Although, the evidence provided in this dissertation makes 
significant advances to the field of MCS and HCS niche biology, there is still much 
more work that needs to be done in order to better address each of these 
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outstanding questions that have largely been unanswerable. With the development 
of this novel approach to the isolate phenotypically defined BMSC subpopulations 
comprising the stromal tissue of mouse BM, it is to be hoped that these studies will 
ultimately contribute to a greater understanding of the role of stromal cell 
subpopulations in regulation of hematopoiesis, and will complement efforts currently 
underway in other laboratories based on the use of transgenic mouse models. 
 The isolation and characterization distinct clonogenic BMSC populations with 
different functional roles in vitro and in vivo are the major findings of this dissertation. 
Taken together, we propose a model (Figure 6-1) in which a stromal cell hierarchy 
lays the foundation for creating distinct microenvironments in vivo with different 
functional roles in regulating HSCs. We propose that the CD105POS BMSC 
population contains a subpopulation of perivascular stromal stem cells closely 
associated with the abluminal surface of sinusoidal vessels comprising the vascular 
niche. Within this microenvironment, HSCs are able to undergo self-renewal to 
maintain the stem cell pool and contribute progenitor cells for the daily requirement 
of mature effector cells continuously released into the blood stream. Additionally, the 
CD105POS population generates mature pericyte cells associated with the smaller 
vessels and generates cells comprising the intersinusoidal reticular network. 
Whereas, in support of previous publications [29, 67-71] the CD105NEG osteo-
progenitor cells associated with the endosteal region contributes to the regulation of 
quiescence/dormant HSCs as well as the differentiation of lymphoid progenitor cells 
generating mature B-cells [137]. In support of these proposed roles, our functional 
data and microarray analysis points to both populations as being cells comprising 
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the CXCL-12-GFP (CAR) cells  [24, 25, 137] and those identified using Nestin-GFP 
[23] and SCF-GFP [136] mouse models. 
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Figure 6-1:Schematic of the Bone Marrow Microenvironment. Proposed model 
for a stromal cell hierarchy providing stromal progenitor cells responsible for 
generating both perivascular and endosteal niche cellular consitutents in vivo. 
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MATERIALS AND METHODS     
 
Animals 
8-12 week old C57BL/6, B6.SJL/Ptprc^aPep^3/BoyJ, BALB/c and NOD-SCID mice 
originally purchased from Jackson Laboratories and breed in our animal facility were 
used as the source of bone marrow tissue and transplant recipient animals. 
Additional mice used as a source of BM cells include; transgenic mice harboring the 
NG2-DsRed transgenic mice (Tg(Cspg4-Ds Red.T1)1Akikj) were purchased from 
Jackson Laboratories and αSMA-RFP mice were a generous gift from Dr. Frank 
Marini at MD Anderson Cancer Center and UBC-GFP mice originally purchased 
from Jackson Laboratories were a generous gift from Dr. Mikhail Kolonin at the 
University of Texas at Houston. For competitive transplantation assays, C57BL/6 
and B6.SJL/Ptprc^aPep^3/BoyJ mice were crossed to generate F1 chimeras which 
were used as transplant recipients. Animals were caged under standard conditions 
and fed a laboratory diet and acidified water ad libitum. Care and use of the 
laboratory animals was according to animal protocols/guidelines established by the 
University of Texas Health Science Center at Houston Animal Welfare Committee. 
Isolation of Murine Bone Marrow cells     
Mice were sacrificed by CO2 asphyxiation and cervical dislocation, femora and tibiae 
were excised, cleaned of attached muscle tissue and stored on ice in harvest 
medium (PBS supplemented with 2% v/v FBS). To prepare BM cells by flushing, a 
23-gauge needle (BD Bioscience) was inserted into the growth plate of femora or 
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tibiae from which the epiphyses had been removed at the metaphysis below the 
marrow cavity and the bone marrow removed by flushing in 5 mls of PFE (PBS 
supplemented with 2% FCS and 2mM EDTA). The resulting suspension was then 
triturated several times to break up clumps, drawn through a 20-gauge needle and 
filtered through a 70µm cell strainer (BD Bioscience).  
To isolate BM plugs, the ends of the tibiae and femora were removed as above and 
a 1ml syringe fitted with 23-gauge needle (BD Bioscience) containing ice-cold PFE 
was inserted into the growth plate and the BM plug gently expelled from the cut ends 
of the bones in 1 ml of PFE. BM plugs were transferred to 15 ml conical tubes 
(Falcon) containing a mixture of Collagenase Type I (3mg/mL; Worthington, 
Lakewood NJ) and Dispase (neutral protease, grade II; 4mg/mL; Roche) in PBS and 
incubated for 15 minutes at 37°C. Following a brief vortex for 10-20 sec on low 
setting, undigested BM was allowed to settle and BM cells in suspension transferred 
to a new tube containing 10mls of PFE and placed on ice. This fraction is referred to 
as fraction 1. To the undigested BM tissue remaining after the first incubation was 
added additional Collagenase/Dispase solution and the process repeated an 
additional two times yielding fractions 2 and 3, respectively. Each fraction was then 
either filtered separately through 70µm cell strainer (BD Bioscience) or the three 
fractions were pooled prior to filtration (referred to throughout text as DBM). The 
cells were washed twice by centrifugation in PFE prior to plating under various 
conditions, as described below.  
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CFU-F Assays 
For assay of clonogenic fibroblast colony-forming cells (CFU-F), single cell 
suspensions of BM cells prepared by the standard flushing methodology or DBM 
were plated in triplicate over a range of plating densities in 6-well plates (BD 
Bioscience) in 2mls of complete growth medium comprising alpha-MEM (Invitrogen, 
Life Technologies, Carlsbad, CA) supplemented with 20% (v/v) lot-selected fetal 
bovine serum (Hyclone, Thermo Scientific, Rockford, IL), sodium pyruvate (1mM/ml, 
MP Biomedicals), gluta-MAX (2mM/ml), penicillin (100U/ml) and streptomycin 
(100µg/ml) (all from Gibco, Life Technologies). Cultures were incubated at 37°C in a 
humidified incubator at 5% CO2 and 5% O2 for 72 hours washed with medium and 
re-fed with complete growth medium for an additional 11 days. On day 14, wells 
were briefly rinsed with PBS and then stained with 0.1% Toluidine blue in 4% 
formalin (both from Sigma, St. Louis, MO) to allow enumeration of colonies. Only 
colonies containing >50 stromal cells were scored. Additionally for CFU-F assays 
from prospectively isolated BMSCs, clusters containing 10-50 cells were scored.  
Establishment and Characterization of Primary cultures of DBM (P0 culture)  
DBM from digestions 1 – 3 was also plated at non-clonal densities (1 x106/ cm2) to 
allow growth both of stromal cells and of vascular endothelial cells. Cells were plated 
on dishes or chamber slides (LabTek, Nunc, Rochester, NY) coated with fibronectin 
(Sigma) at 5µg/cm2 in either alpha-MEM supplemented with 20% FBS or in EGM2-
MV (Lonza, Switzerland). Cultures were placed in a 37°C humidified incubator at 5% 
CO2 and 5% O2, washed at 72 hours and maintained under these conditions with 
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media changes every 3 days until attaining confluence and were designated P0 
cultures.  
Characterization of the Cellular Composition of P0 cultures 
A.) In-situ staining:    P0 cultures established in chamber slides slides were placed 
on ice for 30 minutes and washed x3 in ice-cold basal αMEM (Gibco). Cultures were 
first incubated with purified rat mAbs, washed and revealed with donkey anti-rat Cy3 
(1:500) (Jackson ImmunoResearch, West Grove, PA). Following washing, Fc block 
was added for 20 minutes prior to the addition of flurochrome conjugated rat mAb 
(see table S1) for 30 minutes on ice. Following mAb staining, cells were fixed in 4% 
PFA (Electron Microscopy Sciences,  Hatfield, PA) for 15 minutes at room 
temperature, washed 3 times in PBS and then coverslipped in Prolong Gold 
containing DAPI (Molecular Probes). Imaging was performed on an inverted 
fluorescence microscope (Olympus BX51) and captured with an Olympus DP71 
camera.  
B.) Flow cytometric analysis: P0 cultures or cells at subsequent passages were 
detached at day 7 of culture by addition of 0.05% trypsin-EDTA (Gibco) washed in 
PFE and filtered through a 40µm cell strainer to obtain a single cell suspension. 
Cells were resuspended in 100µl of PFE and blocked in Fc block for 20 minutes on 
ice, followed by staining with flurochrome conjugated or isotype control antibodies on 
ice for 20 minutes. Prior to analysis, cells were resuspended in PFE containing 0.6 
µg/ml DAPI (Invitrogen) and either analyzed on an LSR II (BD Bioscience) or 
subjected to FACS using a FACS Aria II (BD Bioscience, San Jose, CA) fitted with a 
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100µm nozzle and Blue Diode 488, HeNe 633 and UV 355 lasers to isolate stromal 
cells and/or vascular endothelial cells. For complete list of antibodies used for FACS, 
see table S1. 
Prospective isolation of CFU-F from fresh BM  
BM cells freshly prepared from DBM plugs as described above were labeled with the 
biotinylated hematopoietic lineage antibody cocktail (Table S1) on ice for 20 
minutes, washed, filtered and then incubated with sheep anti-rat Dynal beads 
(Invitrogen) according to manufactures instructions. Following removal of bead 
bound lineage positive cells, the unbound fraction was incubated in Fc block for 20 
minutes on ice and stained with monoclonal antibodies as described above.   
Marrow Stromal Cell Differentiation Assays  
(A.) in vitro:  Purified bone marrow stromal cells isolated by FACS were expanded 
in culture in aMEM-20% FBS to passage 3 at which time cultures were used for in 
vitro differentiation assays as described elsewhere [102, 104, 138]  Briefly, for 
osteogenic differentiation, cells were plated at a density of 4.2x103 cells/cm2 in 
αMEM supplemented with 20% FBS, 10-8 M dexamethasone, 5mM inorganic 
phosphate and 100uM ascorbate-2 phosphate (ASC-2P) (all from Sigma)  and 
cultures for 14 days prior to Von Kossa and alkaline phosphatase staining (Vector 
Blue Alkaline Phosphatase substrate Kit; Vector Labs). For adipogenic differentiation 
cells were plated at a density of 2.1x104 cells/cm2 in αMEM supplemented with 20% 
FBS until the cells reached confluence at which time the medium was changed to 
DMEM supplemented with 10% FBS, 10% horse serum, 10-8 dexamethasone, 500 
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µM IBMX and 60 µM indomethacin and cultured for 21 days and adipose 
differentiation was evaluated following oil red O staining. 
Chondrogenic differentiation was carried out according to previously established 
protocols [102, 139].  Briefly, 250,000 BM stromal cells were pelleted and cultured in 
chondrogenic serum-free media (Lonza) supplemented with 10ng/ml TGF-β3 (R&D 
Systems, Minneapolis, MN) in 15ml falcon conical tubes for 21 days. Pellet cultures 
were fixed overnight in Zn fixative (Shandon/Thermo, Waltham MA) at 4°C and 
processed for standard embedding in paraffin wax according to standard 
procedures. Morphological assessment of 5 µm sections was assessed by means of 
standard H&E staining and sulfated polysaccharides were revealed following 
staining with Toluidine Blue (0.1% w/v; Sigma) and with Alcian Blue 8GX (Sigma) 
followed by brief counterstaining using fast nuclear red (Vector Laboratories) 
according to standard procedures. Immunohistological staining for collagen type II 
was performed by incubating pellet sections with antibody 2B1.5 (Thermo-Scientific) 
or isotype control antibody followed by immunoperoxidase staining using the mouse 
ABC kit (Vector Laboratories) as previously described [140]. 
 
(B.) in vivo:  To determine their capacity to form bone in vivo, LinnegPDGFRα/βpos 
cells at P3 were collected by brief trypsinization and 1.5x10^6 cells were 
resuspended in 50µl αMEM-20% growth media, loaded onto Gel-foam sponges 
(Baxter, Deerfield, IL) and covered in a fibrin clot (Sigma) at 37°C. Scaffolds were 
then subcutaneously transplanted into 2-3 month old NOD-SCID mice as described 
[141]. At 12 weeks, mice were sacrificed, scaffolds were recovered, fixed overnight 
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in 10% buffered formalin at 40C and decalcified for 1 week in 10% EDTA, embedded 
in paraffin and stained with H&E or Masson’s Trichrome according to standard 
procedures. Additional scaffolds were not decalcified and embedded in methyl 
methacrylate resin (Lawrence Bone Disease Program of Texas Bone Core, MD 
Anderson Cancer Center, Houston, TX) and sections stained using the von Kossa 
reaction and with Goldner’s Trichrome.   
Whole mount immunofluoroesence staining of bone marrow plugs 
Intact bone marrow plugs prepared as above were fixed in freshly prepared 2% 
paraformaldehyde for 10 minutes at RT and then washed thrice in DPBS for 15 
minutes. Using a scalpel, each plug was cut in two and each half transferred to a 
single well of a 96-well round bottom plate (BD Bioscience) for antibody staining. BM 
plugs were first incubated overnight at 4°C in blocking buffer comprising DPBS with 
3% BSA (Sigma), 2% FCS, 2% horse serum and 2% normal donkey serum (Jackson 
ImmnoResearch). BM plugs were then incubated overnight with gentle rocking at 
4°C with purified anti-PDGFRα and anti-PDGFRβ antibodies or isotype controls. BM 
plugs were then washed throughout the following day at 4°C and incubated 
overnight with donkey anti-rat Cy3 diluted 1:500 in blocking buffer. Next, the 
samples were washed throughout the day in DBPS supplemented with 2% normal 
rat serum (Jackson Immunoresearch) and then incubated overnight with MECA32-
Alexa 488 and VE-Cadherin-Alexa 488 or with rat IgG1 and IgG2a-Alexa 488 isotype 
controls. After washing, the BM plugs were counterstained with DRAQ5 (1:1000; 
Biostatus Limited) for 30 minutes at RT, transferred onto cover slips and surrounded 
by several layers of 120µm SecureSeal imaging spacers (Grace Biolabs, Bend, 
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Oregon) to provide a depth of approximately 300-500µm and then immersed in 
prolong gold anti-fade mounting medium (Molecular Probes). After applying a 
coverslip, specimens were inverted and allowed to cure overnight in the dark at RT 
prior to confocal imaging.  
Characterization of vascular endothelial cells 
Purified LinnegCD105brightPDGFRα/βneg cells were cultured on fibronectin coated wells 
in EGM2-MV. At passage 3, cells were plated into (LabTek,) slides coated with 
fibronectin and cultures were analyzed for the presence of endothelial markers by in 
situ staining described above. Additionally, cells were plated at 70% confluence and 
the following day incubated with 10µg/ml DiI-Ac-LDL (Biomedical Technologies, 
Stoughton, MA) for 4 hours at 37°C. Cultures were washes x3 in PBS and imaged 
on an inverted microscope for the presence of Ac-LDL uptake.  
Isolation of Hematopoietic stem cells 
Bone marrow was rigorously flushed with a 25-gauge needle and 5mls of ice cold 
PBS-2% FBS, 2mM EDTA and filtered through 40 micron cell strainer (BD 
Bioscience). Cell suspensions were subjected to ammonium chloride potassium (BD 
Bioscience) for lysis of red blood cells, Fc blocked and stained with antibodies to 
mature hematopoietic lineage cells (LIN-), c-Kit, Sca1, CD150, CD48 (all from 
Biolegend).  LSKCD48-CD150+ HSCs were double sorted on a FACS Aria (BD 
Bioscience). 
Co-culture and Long-term competitive reconstitution assay 
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Fractionated stromal cell populations were plated in fibronectin coated 48 well plates 
at 5,000-10,000 cells/well in complete growth media until reaching confluence. At 
which time, LSKCD48-CD150+ HSCs were double sorted from 8-10 week old 
B6.SJL/Ptprc^aPep^3/BoyJ and resuspended at 10 cells/µl in Stem Span serum free 
expansion media (Stem Cell Technologies). To validate accurate cell numbers, 1µl 
of HSC cell suspension was added to a single micro-well in a terasaki plate and the 
entire well was imaged and counted. Wells containing 10 cells were then transferred 
to a single well of established stromal layers in 500µl of Stem Span supplemented 
with Flt3L (10ng/ml), IL-6 (2ng/ml), Kit-ligand (10ng/ml) and TPO (5ng/ml). 
Suspension cultures without stromal layers were used as controls. Cultures were 
placed at 5%CO2, 5%O2 37°C for 10 days. Following 10 day co-culture period, entire 
content of a single well was collected, resuspended in 100ml of PBS with a radio 
protective dose of 300,000 WBM cells from 8 week old F1 mice and 10 freshly 
prepared LSKCD48-CD150+ HSCs from C57BL/6 mice. The entire cell suspension 
was drawn into a 1ml insulin syringe and injected into the retro-orbital venous sinus 
of 8-12 week old F1 recipient mice that received 2 doses of 550 rad whole body 
radiation with 2 hours of rest between each dose. Mice were maintained on normal 
diets with acidified water at libitum. Peripheral blood was obtained at 6, 12 and 18 
weeks in EDTA coated micro-tubes (BD Bioscience) and bone marrow was collected 
at 16-20 weeks depending on the experiment. Samples were subjected to 
ammonium chloride potassium (BD Bioscience) for lysis of red blood cells, Fc 
blocked and stained with antibodies to CD45.1, CD45.2, B220, Mac-1, CD3 and Gr1 
(all from Biolegend). Following mAb staining cells were washed, filtered and 
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resuspended in PFE contain 0.6mg/ml of DAPI and analyzed on a LSRII. 
Additionally, 1x10^6 WBM cells collected at 18-20 weeks were transplanted in 
lethally irradiated F1 secondary recipients and analyzed as described above.  
Illumina Gene expression Analysis 
All analyses were performed using GenomeStudio software (Illumina, Inc.) by The 
Microarray Core Lab, University of Texas Medical School at Houston. Bone marrow 
samples prepared as described above were sorted from 8 week old BALB/c mice 
into four groups (Hematopoietic Lineage positive cells, 
LinNEGPDGFRα/βNEGCD105BRIGHT, LinNEGPDGFRα/βPOSCD105POS and 
LinNEGPDGFRα/βPOSCD105LOW/-) for a total of three independent experiments and 
total RNA was isolated using RNeasy RNA isolation kit (Qiagen). Each experimental 
sample was kept separate to represent 3 independent biological replicates. Total 
RNA amplification and microarray hybridization was performed as follows. We used 
300 nanograms of total RNA for all amplifications. Amplification of purified total RNA 
samples was done according to the manufactors recommendations using the 
Illumina TotalPrep RNA Amplification Kit (Ambion, Cat# IL1791). Briefly, first strand 
cDNA synthesis was performed with RNA, T7 oligo(dT) primers and reverse 
transcriptase mix and incubated for 2 hours at 42 ºC. Additionally, second strand 
cDNA synthesis was performed by first preparing a master mix containing RNase H 
and DNA polymerase.  The RNase H and DNA polymerase master mix was 
immediately added following the completion of the first strand reverse transcription 
reaction mix and was incubated for 2 hours at 16 ºC. cDNA filter cartridges (part of 
the amplification kit) were used to remove RNA, primers, enzymes and salts that 
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would inhibit in vitro transcription. The synthesis of biotinylated cRNA was performed 
by in vitro amplification for a 14-hour amplification step in the presence of a dNTP 
mix containing biotin-dUTP and T7 RNA polymerase. Following amplification, the 
concentration of purified cRNA was determined by a NanoDrop ND-1000 
Spectrophotometer (NanoDrop Technologies, DE). Microarray hybridization on the 
Illumina Sentrix Beadchip Array Mouse WG-6.v2 arrays was performed as follows. 
1.5 micrograms of amplified cRNA product was loaded onto the Illumina Mouse WG-
6.v2 arrays and hybridization was performed for 17 hours at 58ºC in an Illumina 
Hybridization Oven (Illumina, Cat# 198361). Immediately following hybridization, the 
chips were washed and the detection of biotin-labeled cRNA on the arrays was done 
by incubation with straptavidin-Cy3. Next, Illumina bead arrays were allowed to dry 
and subsequently scanned with the Illumina BeadArray Reader (Illumina, CA). All 
sata analysis was performed with the GenomeStudio software (Illumina, CA). 
Additionally, GenomeStudio and Ingenuity Pathway Analysis (Ingenuity Systems, 
Inc.) softwares were used for clustering and pathway analysis, respectively. 
Quality control and pre-processing 
Raw signals of all the build-in controls were checked as quality control for the 
performance of the arrays. Sample-independent controls were used to check:  
a. Hybridization (control molecules at low, medium and high concentrations);  
b. Signal generation (background, noise, biotin labeling and hybridization at high and 
low stringency).  
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Housekeeping genes were used as sample-dependent controls. Background was 
subtracted and arrays were normalized using quantile. The reproducibility of 
biological or technical replicates was checked through comparisons among 
individual samples. Outliers were removed if necessary. The remaining samples 
were grouped and the average signal intensities of samples within the group were 
used for differential expression analysis.  
Statistical Analysis 
Statistical analysis was performed with SigmaStat version 3.5 with significance being 
assigned to p < 0.05. 
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Table 7-1: List of Antibodies 
Antibody Clone Company Dilution 
  CD31-FITC   MEC 13.3 BD Bioscience   1/100 
MECA32-Alexa 488   MECA32 Biolegend   1/100 
VE-Cadherin-Alexa 
488  BV13 eBioscience    1/100 
VEGFR2-purified  Avas 12a1 BD Bioscience   1/100 
PDGFRb purified  APB5 Biolegend   1/100 
PDGFRb-APC  APB5 Biolegend   1/100 
PDGFRa-purified APA5 eBioscience    1/100 
PDGFRa-APC APA5 eBioscience    1/100 
CD105-purified MJ7/18 Biolegend   1/100 
CD105-PECy7 MJ7/18 Biolegend   1/100 
    
Hematopoietic 
Lineage Cocktail    
CD45-Biotin 30-F11 Biolegend   1/100 
CD11b-Biotin M1/70 Biolegend   1/100 
Gr1-Biotin RB6-8C5 Biolegend   1/100 
F4/80-Biotin BM8 Biolegend   1/100 
CD3-Biotin 17A2 Biolegend   1/100 
B220-Biotin RA3-6B2 Biolegend   1/100 
CD19-Biotin 6D5 Biolegend   1/100 
Ter119-Biotin Ter1119 BD Bioscience   1/100 
CD45-APCCy7  30-F11 Biolegend   1/100 
CD11b-APCCy7 M1/70 Biolegend   1/100 
F4/80-APCCy7  BM8 Biolegend   1/100 
CD3-APCCy7  17A2 Biolegend   1/100 
Gr1-APCCy7  RB6-8C5 Biolegend   1/100 
B220-APCCy7 RA3-6B2 Biolegend   1/100 
CD19-APCCy7 6D5 Biolegend   1/100 
Ter119-APCCy7  Ter119 BD Bioscience   1/100 
CD16/32 93 eBioscience    1/100 
    
Polyclonal Abs    
eNOS Rb Poly BD Bioscience   1/100 
GFP Goat poly  Gentex 1/100 
NG2 Rb poly  Millipore 1/100 
Donkey anti-rat Cy3   Jackson ImmunoResearch 1/500 
Steptavidin-594  Invitrogen 1/500 
Streptavidin-ACPCy7   eBioscience 1/100 
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